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Summary 
Promyelocytic Leukaemia proteins (PML), the core component of PML nuclear bodies (NB), 
are implicated in many critical cellular functions. One of those is confronting virus infection: 
DNA and RNA viruses target PML-NB and interact with PML proteins and this is thought to 
facilitate efficient replication by interfering with their antiviral functions. One of those 
viruses is human adenovirus type 5 (Ad5). Its early E4Orf3 protein interacts specifically with 
PML isoform II (PML-II), disrupting PML-NB into track-like structures to inhibit PML- 
antiviral responses. PML-II has been shown to be a positive regulator of type I interferon 
responses, as are typically induced by virus infection, through regulating the transcription 
factors that control this innate immune response. Given this role of PML-II and its 
interaction with Ad5 E4Orf3, the first question that addressed here is how does PML-II 
affect the progress of Ad5 infection under normal conditions? 
PML-NBs are also involved in cellular stress responses, being disrupted by heat shock and 
other stresses. Thermo-tolerance due to mild heat conditioning protects cells from more 
aggressive stresses such as higher temperatures through triggering the heat shock 
response, which helps in re-folding the affected cellular proteins. Interferon and other 
cellular cytokines are also induced in response to heat shock, suggesting a mechanism 
whereby heat stress might affect infection, possibly dependent on PML-NBs. The second 
question addressed here was whether cells became more resistant to infection by pre- 
stressing them and if so would PML-II have a role in that resistance? 
To address these questions, PML-II-depleted cells were first engineered by lentiviral vector 
delivery of specific shRNA. Physical and functional knock-down was confirmed by 
measuring mRNA levels for PML-II and for genes normally induced by NF-kB activation. The 
biology of Ad5 infection in these cells was then assessed in comparison with control cells.  
Ad5 gene expression displayed substantial increases with the transient or permanent 
depletion of PML-II in HeLa and MRC5 cells. This effect was particularly marked for late 
gene expression; hexon mRNA and all other late proteins showed substantial increase in 
PML-II depleted cells compared to several distinct control cell lines. This increase reached  
up to 100% with PML-II removal, quantified by flow cytometry. Virus yield also showed a 3-
fold increase in PML-II depleted cells. This effect was only partly due to the impaired 
interferon pathway in these cells, which would be expected to augment Ad5 gene 
expression. The more significant factor in that increase was the overexpression of HSP70 
chaperone, a specific member of the heat shock protein family, in PML-II depleted cells. 
siRNA-mediated HSP70 reduction caused a drastic decrease in Ad5 gene expression in PML-
II Kd cells to more or less the same level seen in control cells . This effect was not NF-kB-
dependent but HSP70 depletion did increase expression of interferon response genes such 
as ISG56. 
Pre-exposure of cells to mild heat stress made them significantly more resistant to Ad5 
infection: such treatment reduced viral gene expression, in particular hexon and other late 
mRNA and protein expression, in HeLa cells and MRC5 cells. Ad5 genome replication was 
also reduced in pre-stressed cells compared to the control conditions. Consistent with 
previous studies of more extreme heat stress, mild heat stress affected the morphology of 
PML-NB. It also affected expression of PML protein and specifically showed an increase in 
PML-II mRNA expression after 3 hours of exposure to 40 ̊C compared to the control 
conditions. In light of the enhanced infection seen when PML-II was depleted, this 
increased expression of PML-II following heat stress might play a role in the reduced 
infection efficiency in such cells. Indeed, PML-II removal reversed the negative effect of the 
mild heat stress on Ad5 infection: such cells showed more late gene expression after heat 
stress than control cells.  
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Section I: Adenovirus 
1.1 Adenovirus Structure and life cycle 
Adenovirus was firstly identified as adenoid degeneration agent in 1953 by (Rowe 
et al., 1953) when this factor showed no ability to be cultivated in bacterial growth 
media. Adenoviruses were classified according to their ability to haemagglutinate 
experimental erythrocytes or according to their GC content to six subgroups A to F 
(Pina and Green, 1965, Bailey and Mautner, 1994). Group C human adenoviruses 
represent more than 70% of the causative agent of mild upper respiratory tract 
infection and 14% of the lower respiratory tract infection in young children (Brandt 
et al., 1969, Avila et al., 1989) and are also reported by another study as the  
common cause of lower respiratory tract infection reached to 40% as itself or mixed 
with other viruses (Yun et al., 1995).   
Adenovirus type 5 (Ad5) is a human virus within adenovirus species C assigned to 
the genus Mastadenovirus, it has a double-stranded linear DNA genome of 36 kbp 
in length. Both of the genome ends terminate with 103bp inverted terminal repeats 
(ITR) where the terminal protein (TP) is covalently linked. The DNA associates with 
protein V, mu and the histone homologue protein VII to form the virus core which is 
surrounded by a shell which consists of main (hexon, penton and fibre) and 
secondary structural proteins (cement proteins). Capsid surfaces consist of hexon 
(protein II) in its trimeric form (240 capsomers); the other 12 capsomers which form 
the vertices of the capsid, are pentons (protein III); these serve as an anchor where 
the fibre (protein IV), the virus protein which is responsible for attachment to the 
cell surface, is attached.  The other minor capsid proteins are IIIa, VI, VIII and IX 
which participate in stabilising the capsid structure of the virion. The Ad5 also 
encodes a 23kDa protein (23k protease). Ad5 protease plays a role in virus 
maturation and then in un-coating upon infection (Fig.1.1) (McConnell and 
Imperiale, 2004, Leppard, 2008). 
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Fig.1.1. Schematic diagram for the structure of adenovirus. Hexon, fiber and penton base 
compose the virus shell according to results that were gained by cryo-electron microscopy 
and X-ray crystallographic analyses. At the inside, the core resides and consists of pV, pVII 
and Mu but its precise location is stylised. Virion stabiliser proteins include pVIII, IX, IIIa and 
VI bridge between the shown here in capsid and the core and project from that the inner 
side of the capsid proteins (Russell, 2009). 
Ad5 enters the cell through a well-organised process that includes attachment, 
internalisation and transferring the viral genome to the nucleus where transcription 
and genome replication take place as well as final assembly after synthesis of the 
structural proteins in the cytoplasm. Ad5 attaches to the cell through Coxsackie 
Adenovirus receptors (CAR): expression of such receptors in non-permissive 
hamster cells increases their susceptibility to infection about 100 times (Bergelson 
et al., 1997). The virus attaches to CAR via its fibre knobs, the distal ends of fibre 
structural protein, but is not internalised. Adenovirus internalisation needs another 
kind of receptor, namely integrins which belong to the class of integrin heterodimer 
adhesion molecules known as nectin-binding integrins, αvβ3  and αvβ5 Those two 
molecules are required for an efficient viral internalisation (Wickham et al., 1993). 
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Internalisation is followed by series of events which lead to transfer of the viral 
genome to the nucleus to initiate the viral transcription and replication. Once the 
virus is internalised within membranous vesicles, endosomes, the virus loses several 
viral proteins such as fibre and protein VI and is released to the cytoplasm, the 
latter has a role in the virus entry as it expresses membrane lytic activity (Wiethoff 
et al., 2005). With more viral proteins continuing to be cleaved and dissociated 
from the particle, the viral core is then transferred by microtubules to the nucleus 
to start the next stage of the infectious cycle (Fig.1.2) (Leppard, 2008, Meier and 
Greber, 2004) 
 
 
 
Fig.1.2. Entry pathway stage of adenovirus infection. A. Virus attachment to the plasma 
membranes through the fiber knob. B. Particle internalisation into the cytoplasm through  
interaction of penton with integrin heterodimer  receptors. C. Particle uncoating by 
releasing  hexon,  IIIa and VI leaving the core intact. D. Acidification of lysosome internal 
environment ruptures the endosomal membrane releasing the hexon shell with the intact 
core. E. Hexon shell and core dock at the nuclear membrane. F. The viral core enters the 
nucleus targeting cellular enxymes to initiate transcription. The innate immune response is 
represented red (inflammatory and interferon response) (Russell, 2009).  
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In brief, adenovirus genome replication requires cooperation between virus 
proteins and cellular proteins. Ad5 DNA polymerase forms a heterodimer with the 
pre-terminal protein (pTP) which functions as a protein primer for DNA synthesis. 
Two cellular transcription factors, NFI/CTFI and NFIII/Oct-1, enable the viral DNA 
polymerase to bind to the origin of DNA replication to initiate replication. Then, 
with the help of the viral single-stranded DNA binding protein (DBP), replication 
starts and DNA synthsis continues through a strand displacement mechanism (Liu et 
al., 2003). At the onset of replication, the major late transcriptional unit (MLTU) is 
activated to produce most of the packaging proteins such as hexon trimers in the 
cytoplasm which are transferred back to the nucleus to start the assembly. Viral 
DNA is encapsidated into pre-formed immature empty particles by a process that 
requires series of viral proteins including IVa2, L1-52/55K and L4-22k and a specific 
packaging sequence in the DNA. A further step in maturation is required to make 
the virus particle infective, in which the viral 23K protease cleaves a series of viral 
component proteins including IIIa, VI, VII, VIII, X and TP. The mature virions are then 
released from the infected cells to infect neighbour ones (Leppard, 2008). 
1.2 Ad5 gene expression 
Ad5 gene expression is highly regulated and is divided into two main stages: early 
(E) and late (L) which are separated only by the onset of DNA replication and 
intermediate transitional stage (Fig 1.3). The early comprised 4 regions; E1, E2, E3 
and E4. All proteins that are encoded by those 4 regions enable the virus to 
establish an efficient replication process, modulate late gene expression, confront 
the antiviral response and shut off cellular translation except the cellular factors 
that play positive roles in the adenovirus life cycle. The intermediate gene products 
of the closely related virus Ad2 start to accumulate in the cytoplasm between 10 to 
12 hours post infection (Binger and Flint, 1984). This transitional stage is important 
in switching from the early to the late gene expression and some of its products (for 
example IVa2) are important in activating the recently described L4 promoter and 
hence in activating the whole late gene expression (Morris et al., 2010). The other 
intermediate encoded-protein is L4-22K which is critical for posttranscriptional 
regulation (Guimet and Hearing, 2013). Protein IX is involved also in transcriptional 
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regulation since transfection of IX induces the major late promoter activity in a 
dose- dependent manner (Lutz et al., 1997). 
The major late promoter (MLP) which drives adenovirus late gene expression is not 
shut off completely at early time points of infection, instead it generates L1 52/55K 
product. This suggests some overlap Ad5 gene expression between the early and 
the late stages. The whole genomic regions of Ad5 are illustrated in (Fig.1.3). Once 
DNA replication starts, late mRNAs are expressed that encode  viral proteins that 
make the capsid and are involved in DNA encapsidation and maturation of the 
virion.
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Fig.1.3. Human adenovirus type 5 gene expression. A. There are four different stages of adenovirus infection; immediate-early, early, intermediate and the 
late. B. detailed adenovirus gene expression map; E:  represents early genomic transcription units and numbered to refer to each region, L: represents the 
late genomic transcription unit and numbered to refer to each region and each gene is written with boldface.  The genome is represented by a straight thin 
black line that is divided to 7 regions with a 5kb scale. Drawing key: Vertical continuouslines= RNA polymerase III promoters. Vertical discontinuous lines= 
Poly A.Horizontal continued colour line = Expressed mRNA. The discontinued lines within each solid line= exons, each mRNA coloured to represent the 
phase that it is expressed within: green= immediate early, blue= early, orange= intermediate and red=late. Roman numbers= Structural proteins.
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1.2.1 Early gene expression 
1.2.1.1 E1 region products 
Products of the E1 region are profoundly important in transactivation of all other 
early regions, transforming certain cell types, DNA replication, efficient late gene 
expression and protein synthesis. E1A region products are transcribed early in 
infection within 45 minutes, reaching a maximum at 3 hours post infection then 
maintaining a steady level at 6 hours post infection (Nevins et al., 1979). E1A 
protein products are essential for the production of early adenovirus mRNAs. dl312 
(E1A deleted mutant)-infected HeLa cells fail to produce mRNAs from the E2,E3 and 
E4 regions compared to wild type Ad5–infected HeLa cells. This defect is manifest 
as a massive reduction in the transcription rate of the E1B, E2, E3 and E4 regions in 
dl312 mutant compared to wild type Ad5 at 5 hours post infection.  In contrast, E1A 
transcription is totally independent of any viral protein synthesis (Nevins, 1981).   
Classification of E1A as an intermediate early gene 
E1B 19K or (175R) protein has no distinctive role in enhancing the expression of 
adenovirus early region. This protein displayed no role in enhancing the production 
of E1A 13S or E1A 12S in non- permissive cells CREF at 10 hours post infection. This 
suggests that this protein does not have any posttranscriptional impact on E1A 
expression. Consistent results were obtained in permissive cells like HeLa cells but 
at shorter time post infection (Herbst et al., 1988) although it shows an important 
role as anti-apoptotic protein. The function of this viral protein mimics the 
functional properties of Bcl2. It was found that E1B 19K binds to Bcl2 and 
sequesters it in cytoplasm in order to block its transcriptional repression function 
(Kasof et al., 1999). 
 In contrast, the same protein has a potent role in transforming normal cells (White 
and Cipriani, 1990). E1B 19K in a specific cooperation with one of the two E1A 
products, 13S protein, could transform BRK cells. Using flow-cytometry technique, it 
has been shown that E1B19K interferes with the effects of cisplatin, an anti-tumour 
agent, by preventing drug-induced apoptosis (Subramanian et al., 1993). 
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E1B55K has critical functions in viral and cellular gene expression. In the late phase, 
this protein, in cooperation with another early viral protein, E4Orf6, controls the 
shuttling of late viral mRNA from the nucleus to the cytoplasm (Bridge and Ketner, 
1990). This effect appeared to be through reducing the phosphorylation of eIF2α 
and PKR activation during the late phase of adenovirus infection (Spurgeon and 
Ornelles, 2009). Manipulating the nuclear export signal of E1B 55K causes defects in 
a series of Ad5 activities including replication, late protein mRNA export and protein 
synthesis (Schmid et al., 2011). In addition, E1B55K modulates the pattern of late 
gene expression by changing the ratio of long and short late mRNA splicing for 
example switching from producing L155/55K to L4100K. This selectivity in E1B55K 
effect might introduce the idea that this protein is participating in creating 
favourable conditions for the virus to produce late proteins and guarantee an 
efficient level of virus yield (Leppard, 1993). 
Regarding its effect on the cellular machinery, the protein displays a role in 
different cellular activities including the cell cycle, apoptosis, transcription and 
stress and immune responses. In normal human lung cells, it was found that many 
genes like CDC25A (cell division cycle), hsp70A, hsp706 and IL-6 were modulated by 
more than 2.5 fold in cells infected with E1B-deleted mutant virus compared to the 
wild type (Rao et al., 2006). In order to enable adenovirus to replicate successfully, 
E1B55k in particular shows a specific direct physical interaction with the tumour 
suppressor p53 and subsequently abolishes its transcription activation function 
(Martin and Berk, 1998, Sarnow et al., 1982a). 
E1B55K shows its effect on p53, in cooperation with another early viral protein, 
E4Orf6. Both of those proteins reduce the accumulation of p53 that is caused by 
E1A expression through degrading p53 via the proteasome. Reduction was revealed 
by a consistent and time-dependent drop in p53 expression post Ad5 infection. The 
decline started at 10 hours post infection and reached a maximum at 25 hours. The 
effect of E1B 55K and E4Orf6 is attributed to shortening the half-life of p53 from 2.5 
hours to only 20 minutes (Querido et al., 1997). E1B55K/E4Orf6 achieve this by 
recruiting and retargeting cellular cullin- complexes to ubiquitinate p53 (Querido et 
al., 2001). 
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1.2.1.2 E2 region products 
 Proteins that are produced from the E2 region are principally direct participants in 
viral DNA replication, but they also participate in many viral activities throughout 
the infectious cycle; they modulate transcription from E1A and the major late 
promoter, and inhibit transcription of theE4 region. The E2A protein, also termed 
the DNA binding protein  (DBP) is a protein of a molecular weight of 72K (Lewis et 
al., 1976), and has a distinctive role in modulating adenovirus type 5 gene 
expression at the transcription level. This was indicated by the substantial 3-fold 
increase in E1A and major late promoter (MLP) expression. In contrast, DBP showed 
an opposite effect on the E4 promoter, which was inhibited with DBP expression. 
Such an effect was detected at the transcriptional level as the increase with DBP 
expression was at the rate of transcription initiation with no change in the half-life 
of RNA  (Chang and Shenk, 1990). One of the suggested mechanisms of the effect of 
DBP on the transcription level is cooperation between DBP and nuclear factor I 
(NFI). Initiation of Ad2 replication was increased with the addition of purified NFI 
and this increase was positively regulated by the concentration of DBP in vitro. 
Cooperation between DBP and NFI was explained by the effect of DBP in increasing 
the affinity of NFI for Ad origin of replication. In addition, DBP alters the kinetics of 
NFI binding to a given DNA template, increasing the rate of association and 
decreasing the dissociation of NFI (Cleat and Hay, 1989). 
The other products of the E2 region are the E2B Ad DNA polymerase and terminal 
protein precursor, pTP. E2B has been extensively studied in the use of adenoviruses 
in gene therapy. HAdv type 5 and type 2 replicate very efficiently in the infected cell 
which can produce one million copy/cell within 40 hours (Hoeben and Uil, 2013). 
Most of the first generation Ad vectors have deletions in the E1A and E3 regions: 
including an E2B deletion in those vectors has improved their efficiency in terms of 
carrying capacity and lowering the risk of producing replication competent-
adenovirus. One of the remarkable advantages of deleting the Ad DNA polymerase 
is the defect in producing the late gene expression besides further deficiencies in 
Ad replication (Amalfitano et al., 1998). 
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1.2.1.3 E3 region 
The early region E3 products are mainly important in counteracting the innate and 
inflammatory response to infection, inhibiting NF-kB activation and guaranteeing 
persistent infection in immune cells. It is well known that this region has no effect 
on adenovirus replication in standard epithelial cell lines in culture. One of the 
pieces of early evidence about the function of the E3 region arose from a study in 
the lungs of cotton rats. The study compared the effect of wild type and E3-deleted 
mutant adenoviruses infection. Although H2dl801 and H5dl327 (which both lack the 
E3 region, with a larger deletion in the second mutant) replicated as well as the wild 
type, the pathological consequences for the mutants were much greater than in the 
wild type. Such elevated virulence was attributed to the effect of E3-19K 
glycoprotein. Mutating the region encoding this product increased the expression 
of MHC class I on the surface of infected cells to levels comparable to those 
expressed by uninfected cells, allowing greater immune recognition of the infection 
(Ginsberg et al., 1989). It was also found that E3-19K can interact with MHC I and 
prevents its expression on the cell surface (Burgert and Kvist, 1985).  
The other E3 region product which shows direct inhibitory effect on innate immune 
response is E3-14.7K. Compared to uninfected mice, Ad5 mice infected with 14.7K 
showed a substantial reduction in two pro-inflammatory cytokines, IL-6 and IL-12 
(Carmody et al., 2006). In contrast, those two cytokines were elevated significantly 
in mice that were infected with E1/E3 Ad5-deletion mutants. Stimulation of NF-kB 
with different Toll-like receptor (TLR) ligands was significantly inhibited by the 
expression of E3 14.7K. This inhibition in NF-kB-driven transcription occurs 
downstream the latter activation and translocation to the nucleus. Specifically, the 
14.7 K protein binds to the p50 homodimer (a member of the NF-kB family) and 
prevents its DNA binding (Carmody et al., 2006). In another way to establish 
persistent infection in immune cells, E3-14.7/E3-10.4 complexes work together to 
block cytotoxic T-cell induced apoptosis through reducing the expression of cell 
surface Fas (CD95), a TNF-α receptor superfamily member (Shisler et al., 1997), the 
complex similarly acts to down-regulate NK cell recognition and killing (McSharry et 
al., 2008). 
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1.2.1.4 E4 region products 
Products that are encoded by the E4 region are critically essential for the viral gene 
expression at the level of RNA processing, export and stability. Mutants that lack 
this region showed a defect in mRNA accumulation. In terms of interaction with the 
cellular machinery, the products of the E4 region are important in silencing host cell 
translation (Halbert et al., 1985). Protein products for example have an important 
role in controlling late gene expression, since it is reduced significantly in mutants 
that lack either E4Orf3 or E4Orf6. This reduction in late protein synthesis was a 
consequence of lower cytoplasmic mRNA levels; there is no direct effect on DNA 
replication but there is lower efficiency in forming plaques compared to the wild 
type (Bridge and Ketner, 1989). E4Orf3, independently of E1B55K/E4Orf6, 
inactivates p53 responsive genes by forming a blocking network at p53 target 
promoters.  E4Orf3 forms de novo H3K9me3 heterodimer which blocks p53-DNA 
binding (Soria et al., 2010). E4Orf3 also targets the cellular antiviral response that is 
mounted by PML and also targets the transcription factor TIF1α in a step that is 
highly conserved among different adenovirus serotypes (Ullman et al., 2007, Vink et 
al., 2012). E4Orf6, has a distinctive role in inactivating the p53 transcriptional 
activity through a direct interaction with the latter in a TAFII31 independent 
manner (Dobner et al., 1996). Other E4 region products such as E4Orf1 and E4Orf4 
can enhance viral replication through activating the regulator of mRNA translation 
initiation, mammalian target of rapamycin (mTOR) (O'Shea et al., 2005). The 
E4Orf2, protein has been detected during the lytic cycle of Ad5 infection but with 
no functional role or any interaction with any cellular factor yet described (Thomas 
et al., 2013, Dix and Leppard, 1995). E4Orf4 was found to have a role in p53- 
independent apoptosis with a small contribution of E4Orf6 protein (Marcellus et al., 
1998). E4Orf6/7 is implicated in trans-activation of the E2a promoter through E2F-
binding stabilising its interaction with the promoter (Obert et al., 1994). 
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1.2.2 Adenovirus late gene expression 
 
Although the adenovirus life cycle is clearly distinguished into two stages, early and 
late phases, there is some overlap between those two stages. One of the early 
observations about the regulation of Ad2 late gene expression was the early 
minimal activation level of late mRNA during the early stage of infection. Although 
this level was less than the level activated late in infection it was as active as early 
transcription. At this early stage of infection the critical step of the late 
transcription was termination rather than initiation. It is well-established that at 
that early stage the mRNA transcripts are only from L1, L2 and L3 and transcription 
was shown to stop before proceeding to the rest of the late transcription. This 
could be due to the fact that both the Late transcription unit and the E2 region are 
located to give convergent transcription and hence the E2 region transcription will 
block the transcription form the late promoter (Nevins and Wilson, 1981). The 
intermediate stage products (IX and IVa2) are not expressed unite DNA replication 
happens. However, the late transcription starts 14 hours post infection (Binger and 
Flint, 1984). The L1 region has an alternative splicing character which enables it to 
switch from producing its different encoded proteins. This enables the L1 region 
from shifting the production of L152/55K mRNA to the production of IIIa mRNA as 
they are encoded by the same 5' splice site but two different 3' splice site  (Kreivi et 
al., 1991). 
The cloned full length MLTU expresses all the late adenovirus proteins and at the 
same relative levels as those produced during wild type infection. Truncated forms 
of this unit cause deficiency in late gene expression and fail in complete switching 
from the early to late pattern of adenovirus late gene expression. Plasmids that 
express regions from L1 to L3 express only very low levels of L1 IIIa, L2 penton and 
L2 V with undetectable levels of hexon (Farley et al., 2004). MLTU plasmids that 
failed to express the L4 and L5 regions also failed in switching from early to late 
phase while the MLTU that fully possessing the L1 to L5 showed a progressive 
infection represented by two distinctive phases: early and late which contained all 
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the typically expressed Ad5 late proteins which are normally expressed during 
Ad5wt300 infection.  This difference in late protein expression was very well 
reflected at the RNA level since the L3 hexon, L1 IIIa and L2 penton were expressed 
at approximate 50, 10 and 50 fold lower levels respectively. The other factor that 
affected the switch between those two phases with L1 to L5- plasmid is the loss of 
Ad5 DNA replication during the natural infection. MLTU plasmids that contained 
additional sequences from L3 and extended to the L4 polyA site showed very similar 
levels of all the late proteins: IIIa, penton, V and hexon. In particular, L4-100K and 
L4-33K were important in such increases in Ad5 gene expression; the L4-33K effect 
being detected at the posttranscriptional level (Farley et al., 2004). The 55KDa and 
52KDa products of the L1 region are selectively produced early during infection 
while mRNAs encoded by late regions like L2 and L3 were not detectable. Bigger 
mRNA products could be produced later and those which could be involved in the 
transition from early to late stage. Alternative and time-dependent production of L1 
mRNA was noted, the 55KDa and 52KDa products being detected during the early 
stage of infection. This abundance was replaced with the significant production of 
IIIa protein later on infection. Such switching in producing different L1 region 
products was explained by virus-controlled abundance mechanism which is 
employed by the virus to manage the levels of each single protein. This mechanism 
depends on the presence of a U-rich region where transcription of RNA Polymerase 
III terminates. In the Adenovirus type 2 genome the termination signal of VA RNA1 
is located in a site which is separated from the splice junction for 55KDa and 52KDa 
by 11 nucleotides. VA RNA1 might recognise the U rich region in the acceptor site of 
55KDa and 52KDa and then this preferable accumulation of 55KDa and 52KDa 
mRNA might be explained (Akusjarvi and Persson, 1981). 
1.2.2.1 Structural and non-structural late adenovirus proteins 
Hexon is the major adenovirus capsid protein with a molecular weight of 109 KDa 
and there are 240 trimers of it in each mature virion (van Oostrum and Burnett, 
1985). In hepatocytes, it was found that an important factor regulating the 
efficiency of adenovirus vectors in delivering their transgenes is the presence of 
hexon. Human coagulation factor X binds to the top of hexon trimers in a way that 
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facilitates the entrance of the virus into the hepatocytes, avoiding the need for an 
interaction between fibre and CAR. This binding showed 40 fold more affinity that 
the fiber (Kalyuzhniy et al., 2008). Serologically, it was found that hexon antibodies 
were the dominant species and secondly dominant antibodies were against fibres 
(Bradley et al., 2012). Penton is a pentameric structural protein with a molecular 
weight of 63.2 KDa, it is important in cell surface recognition and endocytosis and 
postendocytosis events in the virus life cycle (Karayan et al., 1997). The other 
structural protein is the trimeric fibre with a subunit molecular weight of 61.9 KDa, 
fibre protein is important as well in cell recognition. Fibr- penton assembly is critical 
for the for making the infective virion since mutations that cause the accumulation 
of fibre monomers had been proved to be fatal for adenovirus (Santis et al., 1999).    
The mature virion contains 74 copies of IIIa with a molecular mass of 63.2 KDa. The 
rest of the adenovirus polypeptides are V, VI, VII, VIII and IX with 41.6, 23.4, 19.4, 
14.5 and 14.3 KDa respectively (van Oostrum and Burnett, 1985). 
Three of four non- structural adenovirus proteins are products of the  L4 region, 
L4100 K and L4-33K. Those two proteins play an important role in the full 
transcription of the late adenovirus products from Major late Transcription unite 
(MLTU). Another two proteins, L4-22K and L4-33 K are responsible for the complete 
switch from the early to late phase immediately after DNA replication commences, 
when the level of MLTU activity increased from very low to about 50 times. The 
other L4 protein, 100K, is required only for hexon expression which was blocked 
completely in the absence of this L4 product (Farley et al., 2004, Morris and 
Leppard, 2009). 
The final intermediate-late non-structural protein is L1-52/55K. This protein enables 
the virus to make mature virions. Although, Ad5 replication and late gene 
expression were slightly reduced in cells infected with L1-52/55K-deleted viruses, 
the major effect of the mutation was on virus encapsidation. Analyses of particles 
manufactured by the wild type and L1-52/55K-deleted mutant revealed that the 
latter made empty capsids compared to the wild type which produced fully mature 
virus with fully synthesized DNA (Gustin and Imperiale, 1998). 
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1.3 Cellular factors that interact with early and late adenovirus products 
 
Although most of the cellular response to the early phase of infection was growth 
arrest and induced immune response (Granberg et al., 2006), many publications 
refer to positive roles of some cellular factors in adenovirus replication, 
transcription and translation. In adenovirus-infected HeLa cells, histones associate 
with the viral chromatin and viral core protein VII in a chimeric chromatin template 
to start the early phase transcription. Another cellular factor, Template Activating 
Factor (TAF-I) is also required to stimulate viral early mRNA expression which was 
reduced to about 50% in HeLa cells that lacked the TAF-I. Using ChIP analysis, viral-
bound TAF-I has been shown to function on the viral chimeric chromatin through 
binding to acetylated H3 close to E1A promoter. TAF-II plays a role in enhancing the 
recruitment of transcription factors in the presence of Ad-VII core protein through 
formation of TAF-II-:VII ternary complexes (Komatsu et al., 2011). 
Many cellular factors contribute to the enhancement or repression of late 
adenovirus gene expression. P53, a stress-responsive transcription factor, 
associates with the adenovirus type 5 L4 promoter at 12 hours post infection. This 
association enhances L4 promoter activity in cooperation with other viral activators 
like E4Orf3 and Iva2. In addition, p53 knockdown reduced late gene expression 
massively which suggests that this cellular factor plays a transient positive role in 
enhancing the production of proteins that are expressed from this newly discovered 
promoter. P53 separates from the L4 promoter when the MLTU starts being active 
(Wright and Leppard, 2013). 
Another cellular factor which plays an opposite role for that of p53 in adenovirus 
gene expression is TFII-I. This multitask transcriptional factor shows an inhibitory 
effect on adenovirus late gene expression through inhibiting the activity of the L4 
promoter. TFII-I binds to an Inr site in the promoter and this binding inhibits L4 
promoter activity; this inhibition could be neutralized with the effect of L4P viral 
activator Orf3 (Wright et al., 2015). 
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Multi-functional promyelocytic leukaemia proteins (PML) (which will be discussed 
extensively in section II), have been known for their interaction with adenovirus 
proteins. Two decades ago, the first observation that connected adenovirus 
infection with PML was published (Puvion-Dutilleul et al., 1995). In uninfected cells, 
PML protein is found mainly concentrated in spherical sub-nuclear structures that 
are now termed PML-NB (other names include PODs or ND10). At early times in 
adenovirus infection, the structure and morphology of PML remained as normal as 
in uninfected cells. Later on and at the intermediate stage of infection when viral 
DNA replication reaches its maximum levels, infection caused PML-NB re-
arrangement. The nuclear bodies were not detectable as defined structures during 
the late stage until the end of the infectious cycle. PML-NB were found to be 
targeted specifically by one of the early region products, E4Orf3. This protein when 
expressed alone, could target the PML-NB, co-localize with them and change their 
circular shape to thread-like structures known as PML tracks. E4Orf3 was not the 
only adenovirus early protein which showed an interaction with PML; the 
oncoprotein E1A also co-localizes with PML through its CR2 amino acid conserved 
region (DLXCXE), also conserved among other several viral oncogenic proteins 
(Carvalho et al., 1995). 
PML re-organization by the adenovirus E4Orf3 protein enhances many steps in the 
adenovirus life cycle. Adenoviruses defective for this protein were unable to re-
arrange the PML and their replication is significantly reduced. Those E4Orf3 
mutants failed in shutting off cellular transcription which might give a chance for 
the innate immune response to develop (Huang and Hearing, 1989). One of the six 
PML isoforms, PML-II, co-immunoprecipitated efficiently and directly with E4Orf3 
through the C-terminal residue. Mutated Orf3, which fails to interact with PML-II 
isoform is no longer able to rearrange the PML into track-like structures, hence this 
Orf3:PML-II interaction is necessary for PML arrangement (Hoppe et al., 2006). 
Although Doucas et al. (1996) showed that PML over-expression could suppress Ad 
replication, one explanation for the reason for targeting PML-II in particular by 
adenovirus proteins might be to exploit this cellular factor to improve the virus 
efficiency of virus infection. At the early stage of adenovirus infection, the trans-
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activator E1A is very active and enables the virus to start effective transcription of 
most of the other viral regions. This viral protein has been found to co-
immunoprecipitate with PML-II and interact specifically with it. This interaction 
enhanced the E1A- mediated transcription activation which means that PML-II plays 
a positive role in the adenovirus life cycle (Berscheminski et al., 2013). In fact, 
adenovirus does not only interact with PML, the major component of PML-NB, 
instead it recruits and displaces other PML-NB components to guarantee efficient 
transcriptional regulation of its own genes. Adenovirus impairs the antiviral activity 
of some cellular viral repressors such as Sp-100B and C and HMG by displacing them 
from the nuclear bodies. In contrast, it recruits and keeps the Sp100-A inside the 
residual PML-NBs in order to benefit from it as a positive transcriptional regulator 
of the viral early gene (Berscheminski et al., 2014). 
1.4 Innate immune response to adenovirus infection: How does adenovirus 
overcome interferon? 
 
The interferon response is a very well-organised innate immune response and 
according to the type of the signal transduction pathway, this response is divided 
into two types, the classical and the Toll-like receptor response. The classical 
pathway is triggered in cells that have internal compartment receptor which can 
sense the cytoplasmic components produced upon viral infection and results in IFN-
β induction through inducing the type I interferon regulatory factors such as IRF3 
and NF-kB. The other type of interferon response is mounted by plasmacytoid 
dendritic cells through either surface receptors or endosome receptors to sense the 
external or the internalised virus compartment respectively (review Haller et al., 
2006). In immune cells and early in Ad infection (2 to 6 hours), infection with 
adenovirus upregulates transcription of IRF3, ISGs (ISG56), IFN-β and 
phosphorylation of components of IFN secondary signalling pathway (STAT1/STAT2) 
(Stein and Falck-Pedersen, 2012). In permissive human cell lines such as HeLa cells, 
infection with adenovirus (dl312: which lacks the E1A coding region) increases the 
level of ISG54 and ISG56 mRNA level to comparable levels to that induced by 
interferon treatment and this increase was at the transcription level. This 
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transcriptional induction of ISGs is suppressed by E1A gene products; E1A 12S but 
not 13S in particular exerts this property (Reich et al., 1988). The detailed 
mechanism for interferon induction by adenoviruses was mainly obtained by 
analysis of the IFN response to adenovirus vectors. E1 and E3 deleted vectors 
showed dose-dependent IFN response within 6 hours of infection when the virus 
enters cells, moves to the nucleus and achieves its own effective translation. 
Adenovirus infection in HeLa cells triggered the direct primary IFN response by 
phosphorylating the IRF3 which is a significant marker for activation of the early 
recognition response. This is accompanied by an increase in STING adaptor protein 
which is degraded at later time points. The primary induction of pattern recognition 
receptor (PRR) by adenovirus vector infection in HeLa cells was accompanied with 
inducing the paracrine/autocrine signalling pathway which extended to include 
other cellular transcription factors. In Ad-infected HeLa cells, STAT1 increased also 
in a dose dependent manner, thus adenovirus infection induces both an IRF3 
primary response and IFN-β receptor (IFNR)/Jak-STAT secondary immune responses 
(Lam and Falck-Pedersen, 2014).  
Infection with human adenovirus type 5 causes a universal increase in 
monoubiquitination of H2B, this is characteristic for transcriptionally active 
chromatin. This is specific for E1A deleted viruses which unexpectedly caused such 
an increase in H2Bub at 8 hours post infection which is then massively decreased in 
wild type adenovirus infection in different cell types such as A549, murine 
embryonic fibroblasts and human diploid lung fibroblast line WI38. This H2B-ub 
increase is due to the elevated level of type interferon (IFN) as a consequence of 
adenovirus infection. This was verified by the massive increase in H2B-ub in A549 
cells treated with IFN-β which was comparable in level to that caused by infection 
with E1- deleted adenoviruses. Treatment with interferon or infection could not 
increase the H2B-ub in Vero cells which are deficient for IFN-β. Correspondingly, 
E1A blocks the increase in H2B-ub and transcription of IFN-β and interferon 
stimulated genes through its N-terminal region. It is necessary for each virus to 
overcome the interferon response especially at early stages of infection. Adenovirus 
achieves that through E1A which targets hBre1 by physical interaction with it, 
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hence disrupting the latter´s function in activating ISG transcription. E1A blocks the 
interferon response through inhibiting chromatin modification by terminating the 
existence of H2B-ub within transcriptionally active regions such as the IFN-β 
promoter region (Fonseca et al., 2012). 
Another strategy employed by Ad5 to escape the innate immune response is 
modulating the activation of NF-kB transcription by E1 region products. The E1A 
13S protein activates the transcription of cytoplasmic NF-kB that contains p65 
which is then followed by translocation to the nucleus. This function of E1A is 
antagonized by E1B 19 kDa which inhibits NF-kB activation. Those two opposite 
actions are important to keep the balance for adenovirus to circumvent the 
immune response and use the host cell as long as it can to avoid apoptosis (Schmitz 
et al., 1996). 
1.5 Effect of adenovirus infection on cellular transcription 
 
E1A can manipulate most cellular transcription through binding to the 
transcriptional adaptors CBP/p300 to which many cellular transcription factors bind 
and which are involved in the transcription of many genes. E1A binds to the 
transcription adaptive motif (TRAM) of CBP through a region which contains a small 
peptide that prevents the binding of other cellular transcription factors like P53, 
E2F and TFIIB. P53 is stabilized by a complex process that depends on interaction 
with CBPTRAM which leads to the activation of P53 dependent transcription. Wild 
type E1A abolishes P53-CBPTRAM dependent transcription activation (O'Connor et 
al., 1999). E1B55K SUMO activity is well correlated with the P53 trans-activation 
function. E1B55K sumolaytion of P53 is essential to transformation of rodent cells 
and  to induce the oncogenic growth (Wimmer et al., 2015) 
Adenovirus affects and manipulates cellular chromatin modelling through another 
early gene product, the E2A DBP. DBP interacts with and inhibits one of the SNF2 
chromatin family members Srcap (Xu et al., 2001). Another example of the viral 
control of cellular transcription is the interaction between adenovirus E4-Orf6/7 
polypeptide and the cellular factor E2F in an E1A-independent mechanism. This 
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interaction enhances the transcription activity of E2F specifically on the E2 early 
promoters and causes a substantial increase in E2 mRNA expression (Marton et al., 
1990). 
1.6 Blocking cellular translation by adenovirus 
 
The relationship between Ad5 and the cellular translation machinery evolves 
throughout infection. While the cell responds to Ad5 infection by shutting off 
cellular translation at early times in infection, this translation is shut down at later 
time points by the virus to avoid the translation of unwanted immune response 
effectors (Weitzman and Ornelles, 2005). A well distinguished harmony was 
revealed between host cellular translation and the kinetics of Ad5 infection. This 
coincidence was also accompanied by inhibition in CBP phosphorylation. The whole 
cellular translation was not affected by Ad5 infection at early time points until 12 
hours post infection when the whole translation was reduced massively and that 
went along with reduction in CBP phosphorylation which reached 20 fold less at 24 
hours post infection (Huang and Schneider, 1991). Ad5 has evolved to discriminate 
between viral and host mRNA, such that cellular translation can be shut off whilst 
carrying on its own viral translation without any delay or disturbance. Adenovirus 
achieves its own late mRNA translation through a special mechanism called 
ribosome shunting, when the 5 ́- capped mRNAs are alternatively jumping the 
ribosomal scanning. This mechanism provides a selective translation of the viral 
mRNA and not the cellular translation. The regular translation when the eIF-4 is 
abundant is achieved through  linear ribosome scanning from the 5 ́- cap, while in 
conditions when the eIF-4 is inactive or less available, adenovirus late tripartite 
leader (5  -́non coding region) preferentially uses ribosome shunting. This kind of 
translation also happens when mammalian cells experience heat shock condition, 
when the need for eIF-4 is reduced too (Yueh and Schneider, 1996). One of the 
impressive effects of adenovirus during the late phase of infection, is the de-
phosphorylation of eIF4E by physically blocking the binding of eIF4F kinase (MnK1) 
to eIF4-G without inactivating the MnK1 activity or changing the cytoplasmic 
abundance of any of the eIF4 forms. This dephosphorylation step is completely 
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responsible for preventing the translation of most of the cellular mRNA but not the 
viral late mRNA, despite adenovirus translation critically needing dephosphorylated 
eIF4-E. The virus might benefit from de-phosphorylated eIF4-E since the latter 
provide a weak interaction that is not sufficient to translate the cellular mRNA. As 
the virus uses the ribosome shunting translation pathway, the less abundant 
phosphorylated eIF4-F might be the better for such translation mechanism (Cuesta 
et al., 2000). The L4 product, 100K protein, competes with Mnk1 to bind to the 
same C-terminal region of eIF4-G, which leads to the phosphorylation of eIF4-E and 
as a result inhibition of most cellular mRNA translation (Cuesta et al., 2000). 
Section II 
1.7 PML proteins and PML NB 
1.7.1 PML gene and PML isoforms 
The promyelocytic leukaemia proteins or PML, were firstly described as a part of a 
fusion protein with retinoic acid-α receptor (RAR-α) that results from a reciprocal 
translocation, chromosome 15:17. This translocation was detected in 6 of 8 acute 
promyelocytic leukaemia patients and RAR-α was connected since that time with 
leukaemia (de Thé et al., 1991). The PML gene has nine exons that are subject to an 
array of alternative splicing during gene expression; therefore, different PML 
protein isoforms are encoded by an enormous number of PML transcripts (Fig.1.4).  
Variations in the C – terminal region or the length of the central region divide these 
PML isoforms into two groups (Fagioli et al., 1992). Individual isoforms are expected 
to have at least some discrete and unique functions. 
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Fig.1.4. Structural diagram for the principal PML isoforms. All known isoforms share the 
same N-terminal region which comprises the first six exons (1-6), while they differ in their  
central region, variably including exon 5 and in their C-termini that are responsible for the 
specific function of each. The RBCC motif consists of R:RING finger, B:B-BOX and CC:Coiled 
coil. Green N- is the nuclear signal , dark blue is the SUMO-interactive motif (SIM), and 
yellow S refers to the sumoylated Lysine resides . Number of amino acids of each isoform is 
indicated at the end of each isoform structure (Wright, 2010).  
 
1.7.2 PML proteins and PML NB function 
PML proteins are a principal component of PML nuclear bodies (PML- NB). These 
are sub-nuclear structures that play crucial roles in many cellular processes. These 
functions include: tumour suppression, hence some oncogenes developed 
mechanisms to supress PML induction as an IFN induced gene (Rego et al., 2001, 
Buonamici et al., 2005), apoptosis (through interaction of PML with p53)(Guo et al., 
2000), and DNA damage repair, when PML co-localizes with repair proteins and 
stabilizes them as a response to any damage factor (Guo et al., 2000, Xu et al., 
2003) . One of the main biological roles of PML is in the antiviral response. IFN α, β 
and γ up-regulate expression of PML proteins in different types of human cells, 
indicating that PML is  involved in the IFN response pathway (Chelbi-Alix et al., 
1995). PML-NB are disrupted by many viruses (Everett et al., 1998, Everett et al., 
2006, Everett and Orr, 2009, Sivachandran et al., 2008) and some PML-NB 
components have been shown to be antiviral. One of those proteins is Sp100 which 
was found to be essential for stabilising NB  and protecting the PML from 
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degradation by ICP0 in order to exert the expected antiviral response since the total 
knockdown of Sp100 isoforms or PML decreases the constituent ND10 proteins 
(Negorev et al., 2009). Another NB component is Daxx which mounts an antiviral 
function in cooperation with PML proteins. E4Orf3 deficient virus restores complete 
replication activity when the Daxx or PML are antagonised (Ullman and Hearing, 
2008). Another component which mediates the SUMO-1 modification of PML is the 
UBC9 that binds the PML directly or indirectly (Duprez et al., 1999). Opposite to 
Sp100, CBP is a dynamic component of NB, its accumulation is cell-specific and it 
could be stimulated to move in and out of the NB according to the stimulus 
(Boisvert et al., 2001).  
1.8 Early intrinsic and innate host response to virus infection and the role of 
PML in this response  
 
Virus infection triggers innate immune responses which are considered as the first 
line of defence that counteracts and slows down the infection before the adaptive 
immune response begins. Viral RNA and DNA and intermediate products can be 
recognized by Pattern Recognition Receptors (PRR). The latter then initiate an 
interferon (IFN) response in both the infected cells and other cells (Koyama et al., 
2008). 
Many studies have pointed to the central role of PML and PML NB in confronting 
DNA and RNA viruses. This role may be to two main reasons. Firstly, the fact that 
PML gene is up-regulated by IFN and this is associated with the increased level of 
PML proteins (Lavau et al., 1995). Secondly, to the targeting of PML and PML NB by 
many DNA and RNA viruses. Many DNA and RNA viruses cause disruption of PML 
NB when their proteins accumulate inside these bodies. This accumulation results 
in a uniform disruption of PML NB throughout the nucleus or change their 
appearance into track-like structures by a variety of mechanisms (Wilkinson et al., 
1998, Ullman et al., 2007, Everett and Chelbi-Alix, 2007). 
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1.8.1 DNA viruses 
As was mentioned earlier, many viruses target PML-NB and disrupt their structure 
in order to establish efficient replication centres. Herpes simplex virus (HSV) type 1 
immediate early protein ICP0 can disrupt the PML NB within a few hours post 
infection. ICP0 acts as a ubiquitin ligase to degrade the PML when it co-localises to 
PML-NB causing their disruption (Everett et al., 1998, Everett, 2006). PML-NB 
staining disappears at the time of maximal immediate early protein synthesis and at 
the beginning of early protein synthesis. Furthermore this disappearance is not 
accompanied by a reduction or difference in PML protein expression, in contrast, 
the PML isoforms expressed normally (Maul et al., 1993). ICP0, the first causes loss 
of high molecular weight of PML isoforms. There are two reasons for, firstly, ICP0 
migration to PML NB. Secondly, the complete C- terminal region of ICP0 containing 
HAUSP (Ubiquitin-specific protease enzyme associated with PML NB) binding and 
PML NB localisation (Everett et al., 1998). Other herpesviruses also cause PML-NB 
disruption by various mechanisms. Epstein-Barr virus achieves this through the 
interaction of EBNA1 protein with a specific PML isoform which results in PML-NB 
disruption (Sivachandran et al., 2008). Human Cytomegalovirus (HCMV) ensures 
efficient replication by altering PML NB distribution significantly in human foetal 
foreskin fibroblasts (HFFF) (Kelly et al., 1995).  A transient co-localisation has been 
revealed between PML and the IE1 protein within a few hours of HCMV infection. 
IE1 causes PML displacement from PML NB through a direct interaction with the N-
terminal RING finger domain (Ahn et al., 1998). 
Dramatic changes have been detected in the appearance of PML bodies upon Ad5 
infection and they increase in number after infection with the wild type virus 
(Doucas et al., 1996). One of Ad5 protein that arrests the innate immune response 
is the E4 orf3 protein. This protein plays a crucial role in disruption of PML-NB into 
track - like structures. Interaction between E4Orf3 and PMLII inhibits the activation 
of the IFNβ promoter (J Wright; Atwan et al., manuscript in preparation). E4Orf3 
mutants cannot establish sufficient normal replication centres when the cells are 
pre-treated with IFNs (Ullman et al., 2007) in contrast to wild type. Furthermore, 
cells pre-treated with IFN α and infected with wild type or E4Orf3 mutant did show 
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evidence of viral replication when their PML was disrupted by pre-treatment with 
shRNA. These results strongly suggest that E4Orf3 blocks an IFN- mediated antiviral 
effect via its interaction with PML II. 
1.8.2 RNA viruses 
HIV transcription depends critically on Tat protein- mediated recruitment of pTEFb 
to the transcription complex (Zhu et al., 1997, Muniz et al., 2010). Both members of 
the P-TEFb kinase complex CDK9 and cyclinT1 localize inside PML NB. The aceylated 
and the enzymatically inactive form of CDK9 interacts with PML and binds the 
integrated and transcriptionally silent HIV-1 viral genome. This suggested an 
important role for PML NB in HIV-1 repression. These observations had been 
confirmed when the PML NB were disrupted by arsenic trioxide or by PML 
knockdown: both treatments caused striking increase in viral transcription (Marini 
et al., 2011). Recently the mechanism that PML adopts to confer its antiviral 
response against retrovirus was unraveled. PML inhibits retrovirus reverse 
transcription indirectly through the stabilization of the cellular repressor Daxx 
(Dutrieux et al., 2015). 
Replication of the (-) strand RNA virus, rabies, has also been shown to be negatively 
affected by PML. CHO cells stably expressing PML III were infected or not with 
rabies virus at an M.O.I of 1. The infection resulted in an increase in PML NB size. 
Electron microscopy showed that these bodies are empty spheres in uninfected 
cells, while two days post infection they became dense.  Rabies P3 colocalizes with 
PML in the nucleus and reorganises the PML NB in increased size dots (Blondel et 
al.,2002). Rabies escapes the innate immune response through very well developed 
mechanisms to inhibit the IFN response through modulating the phosphorylation or 
the localization of IFN regulatory factors. The other way to avoid cellular resistance 
is by retaining the PML in the cytoplasm and as a consequence changing the 
structure of NB (Chelbi-Alix et al., 1998b). 
PML proteins regardless of whether they were inside the NB or not and as a part of 
their antiviral function, they exert an inhibitory effect of the multiplication of VSV 
and influenza A viruses (Chelbi-Alix et al., 1998a). Seventy hours post infection with 
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LCMV, a predominant cytoplasmic PML distribution with only minor nuclear 
staining was detected in NIH3-T3 cells. PML recovered its distribution pattern when 
the cells were incubated with heat – inactivated virus. PML colocalises with the viral 
Z protein through a direct interaction which was verified by co-
immunoprecipitation and this interaction was necessary for PML re-localization  
(Borden et al., 1998). 
1.9 Effect of PML on cellular transcription 
 
Early evidence implicating PML proteins in regulating transcription was uncovered 
by transfecting C-terminally truncated GAL4-DNA binding/PML fusion protein 
constructs in yeast and mammalian cells (Ahn et al., 1998). Unexpectedly, in yeast, 
the full length constructs which comprised the N-terminal Cys-rich region and the 
coiled coil domain showed no activity using the β-gal assay. Deleting the coiled coil 
region but keeping the RING finger plus the Cys/His region improved the 
transactivation activity of PML constructs. Making the GAL4/PML constructs even 
shorter, which kept only the intact RING finger domain of PML, still showed higher 
activity than the full length constructs but 6 fold less than those which retained the 
Cys/His neighboring region.  This means that the coiled coil region may block the 
transactivation function of intact PML. The finger domain itself plays a crucial role 
in unmasking the transactivation activity of the intact PML, since mutating the Cys 
residues within this domain significantly reduced the transactivation activity of the 
C- terminally truncated PML constructs. The transactivation unmasking property 
was found to apply also in mammalian cells such as Vero cells. Using the same 
constructs but driven by a different enhancer (SV40 enhancer derived- vector) and 
expressing them in Vero cells showed about 22 fold increase in transactivation 
activity in constructs containing the RING domain and Cys/His rich residues. Again 
mutating the RING finger domain caused a 3 fold-reduction in the transactivation 
activity. Altogether, there is enough evidence that the N-terminal region has a role 
in cellular transcription but it is masked by the α- helical coiled coil domain (Ahn et 
al., 1998). 
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1.9.1 PML proteins interact with cellular transcription factors (transcription 
enhancement) 
PML proteins have been discovered to be a positive partner for many cellular 
transcription factors and thus enhance transcription activity. CBP, a dynamic 
component of PML-NB (Boisvert et al., 2001) associates with PML-NB through 
interaction with PML. This association is located between residues 216-331 in the 
domain common to all PML and residues 331-521 in the N-terminal domain of CBP, 
PML proteins caused an increase in the transcriptional activity of CBP cofactor 
(Doucas et al., 1999). Another explanation for the reason for recruitment of CBP to 
the NB is to keep its level at a steady state inside the cells. Valproic acid, an epilepsy 
treatment medicine is used to degrade CBP through the ubiquitin proteasome 
pathway. PML-NB show ubiquitin activity and participate in degrading target 
proteins to control their levels inside the cells. This might explain why CBP is co-
localizing in PML-NB (St-Germain et al., 2008). 
PML-NB also show a critical role in tumour suppression after DNA damage by 
increasing the stability of p53. After DNA damage PML proteins are phosphorylated 
by ATR and accumulate together with Mdm2 (a negative regulator of p53 levels) in 
the nucleolus, hence stabilizing p53 by direct interaction between PML and Mdm2 
(Bernardi et al., 2004). The transactivation function of p53 is increased with the 
recruitment of p53 to the nuclear bodies by PML IV in a promoter-dependent 
manner (Fogal et al., 2000). Another function of PML proteins and in particular 
PML-IV, is increasing transcription through stabilizing p300 by protecting it from 
ubiquitin-mediated degradation (Shima et al., 2008). 
1.9.2 PML proteins interact with cellular transcription factors (transcription 
repression) 
PML proteins have also been reported to be transcriptional repressors. GAL4/PML 
fusion proteins inhibited transcription from GAL4-responsive reporter plasmids in 
HeLa and Cos1 cells (Vallian et al., 1997). Twenty-five years ago, PML protein was 
depicted as a regulator of the repressive transcriptional function of Daxx. Daxx is an 
efficient repressor of global cellular transcription: it interacts with Sumo-1-modified 
PML and is recruited to PML-NB or is recruited to condensed chromatin in PML-
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deficient cells. Movement of Daxx between the condensed chromatin and PML-NB 
reflects the variable equilibrium between the chromatin and NB and how dynamic 
is this process which is in the same time needs the accumulation of SUMO-1 
modified PML to make the basic structure and framework of NB (Ishov et al., 1999).  
The Daxx-PML interaction therefore determines the correct of this global repressor, 
keeping it mainly in the nucleus, despite its locations potential to interact with c-fos 
although a very tiny proportion of Daxx was reported in the cytoplasmic fraction. In 
the absence of any inducers of the dissociation of co-repressors, such as all-trans-
RA (atRA), Daxx can interact with the PML-RARα complex (Li et al., 2000). This 
interaction was shown in vivo but could not be confirmed in vitro since it needs 
highly sumoylated PML, or maybe other cellular factors to associate and facilitate 
this interaction. Immunofluorescent antibody staining has shown a specific co-
localization between Daxx and PML in different tumour cell lines such as HeLa and 
A549 in addition to normal human fibroblasts. Using reporter gene assays, the 
ability of PML to inhibit the Daxx repression function in HEK293 cells was measured. 
Compared to samples which were transfected with GAL4- DNA Binding Domain 
(DBD) alone, reporter gene expression was greatly reduced when cells were 
transfected with GAL4-Daxx, and this reduction was rescued in a dose-dependent 
manner by co-expression of increasing doses of full length PML VI plasmid (Li et al., 
2000). This isoform of PML at least is therefore a negative regulator of Daxx 
repression and its interaction with Daxx may be important for mounting a potent 
anti-viral response against the invading viruses as it will permit the up-regulation of 
antiviral response genes.  
Many DNA virus proteins, such as Ad5 E4Orf3, disrupt the PML-NB and such 
disruption is well-correlated with blocking the innate immune response. E4Orf3-
deleted viruses do not replicate as well as wild type, but their replication can 
rescued by a reduction in PML and Daxx using knockdown approaches (Ullman and 
Hearing, 2008). Another example that reveals the involvement of PML in regulating 
cellular transcription in eukaryotic cells is the interaction with the specificity protein 
1 (SP1). In vitro co-immunoprecipitation assays showed that SP1 and PML interact 
directly through the C- terminal DNA binding site of Sp1 and the coiled coil regions 
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of Sp1 and PML. The physiological significance of such an interaction was 
demonstrated as an effect of PML on SP1 – dependent gene transcription of genes 
such as epidermal growth factor receptor (EGFR). In other words, PML represses 
the transcription of EGFR by inhibiting EGFR’sSp1-dependent activity.PML inhibits 
transcription from the EGFR promoter through disrupting the DNA binding activity 
of SP1 and thus PML plays a negative role in regulating the transcriptional activity of 
the EGFR gene (Vallian et al., 1998a). 
1.10 Roles of PML in interferon responses 
 
PML proteins have been implicated in the effective mounting of both type I and 
type II IFN responses. It was found that PML plays a positive role in regulating the 
interferon-γ response. Overexpressing the nuclear but not the cytoplasmic PML 
isoforms caused significant increases in IFN-γ-induced STAT1 phosphorylation and 
STAT1 DNA binding activity. These effects were reversed by transient siRNA 
interference of PML. An analogous effect was seen in mouse embryo fibroblasts 
(MEF), PML(-/-) MEF cells showed a decreased IFN-γ response compared to 
PML(+/+) cells (El Bougrini et al., 2011). 
Similarly, for the type I interferon response, permanent PML knockdown in human 
fibroblast cells (having lentiviral shRNA transducedtion) showed less efficient IFN-
stimulated gene (ISG) response compared to the control cells; similar results were 
obtained with the transient siRNA knockdown. This deficiency in interferon 
response was restored with the re-expression of the most abundant PML isoform. 
PML increased the level of ISGs through a significant increase in the active form of 
STAT1 and a slight increase in STAT2. This increase in STAT1 and STAT2 expression 
arose from a direct association of PML with STAT1 and STAT2 promoters which was 
accompanied by an increase in ISG promoter activity (Kim and Ahn, 2015). 
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1.10.1 PML-II regulates the type I interferon response 
The involvement of PML in the type I IFN response was further confirmed by a 
recent report (Chen et al., 2015). Here, PML-II isoform specifically regulated the 
type I interferon response in multiple cell types. PML-II depletion by transient 
knockdown caused substantial reductions in IFN-β reporter gene activity and IFN-β 
mRNA expression measured by RT-qPCR, following stimulation with poly I:C. This 
effect was specific to PML-II as PML-V transient knockdown showed no such 
reduction. PML-II effect was mediated through both the IRF3 and NF-kB regulatory 
elements of the IFN-β promoter and the major part of that effect seemed to be 
inside the nucleus since the activation and nuclear translocation of these 
previously-described cytoplasmic transcription factors was affected only slightly by 
PML-II removal. In the same way, expression of ISGs following IFN-α treatment was 
also specifically impaired by PML-II depletion. Poly I:C stimulation normally causes 
an association between IRF3 and NF-kB with CBP recruitment to the IFN-β promoter 
which is known to be important for gene activity (Merika et al., 1998). This 
association was massively reduced when PML-II mRNA expression was transiently 
blocked in HEK293 cells. Furthermore, CBP-STAT1 binding was reduced by 62% 
compared to the control. Those results implicate PML-II in the stability of binding of 
different transcription factors to CBP. Using Chromatin immunoprecipitation, IRF3, 
NF-kB and CBP recruitment to IFN-β promoter was greatly impaired when PML-II 
was depleted under stimulation conditions, and this depletion similarly reduced the 
binding of STAT to ISGs promoters which means that PML-II is necessary for the 
assembly of ISGF3 to ISRE promoters. Mutational analyses showed that PML-II 
regulates IFN-β expression through its unique C-terminal region as binding to both 
STAT1 and IFN-β was impaired by two mutants in that region (Chen et al., 2015). 
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1.11 Effect of PML proteins on general cellular translation 
 
PML proteins show very specific binding to eIF4E, which is necessary for the 
translation of most of cellular mRNA and hence acts to repress translation. This 
binding was verified by specific pull-down of PML-RBB-GST which was also 
accompanied by conformational rearrangement upon binding to eIF4E. PML 
regulates eIF4E using a different binding site at the dorsal surface of eIF4E rather 
than the sites that are normally used by other regulators like eIF4G (Volpon et al., 
2010). 
Mutation of the PML-RING finger reduced the binding toeIF4E and also caused a 
substantial reduction in repression of cellular translation. This indicates that 
translation repression requires the fully intact RING domain of PML and its specific 
interaction with eIF4E since reduced translation did not result from the expected E3 
ubiquitination activity of RING containing proteins like PML. PML binding to eIF4E 
reduced its interaction with the 5’ cap structure of mRNA. Depending on 
fluorescence that was emitted from tryptophan, the fluorescence increased in 
dose-dependent manner with the increasing m7GpppG. Adding PML to the mixture 
reduced the eIF4E activity by two-fold by reducing the fluorescence of tryptophan. 
The reduction was similar to that caused by mutating eIF4E and it was rescued 
when wild type PML was replaced by site I mutated PML (Kentsis et al., 2001). 
1.12 PML and Stress  
 
Morphological changes have been detected in PML-NB when cells were exposed to 
various kinds of environmental and viral protein – induced stress. Heat shock, 
exposure to Cd2+ and Ad5 E1A protein expression all lead to the reversible 
formation of PML microstructures as PML bodies regained their original sizes after 
removal of stress (Eskiw et al., 2003). SUMO-1, a ubiquitin-like protein that is post-
translationally attached to PML and other proteins in PML- NB, is a key regulator of 
PML body integrity; its over-expression prevents stress-induced disassembly of PML 
bodies (Eskiw et al., 2003). Despite the similarity in recovery time of PML-NB after 
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heat shock or sub-lethal concentrations of Cd2, each condition makes a different 
impact on proteins release from PML NB. Upon heat shock, Daxx and SP100 are 
released from the PML NB, while Cd+2releases additional proteins from PML-NB 
including PML itself. This release could be blocked by inhibiting activation of p38 
mitogen-activated protein (MAP) kinase or extracellular signal – regulated kinases 
(ERK1/2). In contrast, heat shock induced desumoylation of PML and release of 
other proteins and PML was unaffected by these inhibitors (Nefkens et al., 2003). 
P53 is a central regulator of cell response to stress damage. PML III and IV interact 
directly through their C terminal regions with the RING finger of the Murine double 
minute (Mdm2) - a cellular negative regulator of p53 levels, during cellular stress 
and DNA damage. Over-expression of PML also recruits Mdm2 to the PML-NB 
following treatment with ultraviolet light, a DNA damaging treatment destruction of 
PML NB architecture and increased nucleoplasmic PML staining was also detected 
(Kurki et al., 2003). In response to double strand break (DSB) induction by ionising 
radiation or chemicals, PML- NB increased in number simultaneously with an 
increase in γH2AX (histone protein) phosphorylation, a signature for a cellular DNA 
repair response. PML-NB numbers reached their peak coinciding with the highest 
levels of phosphorylated γH2AX (Dellaire et al., 2006). 
Oxidative stress also affects PML- NB. Upon oxidative stress, sumoylated Bach2 (a 
member of the BTB- basic region leucine zipper factor family) is recruited to PML 
bodies and forms nuclear foci associated with PML. Bach2 recruitment causes a 
repression in the transcription activity of PML (Tashiro et al., 2004). Antioxidants 
such as sulphoraphane  particularly target the distribution of PML inside cells in 
order to regulate the transactivation function of the cellular transcription factor, 
nuclear factor erythroid 2- related factor (Nrf2). Nrf2 binds to antioxidant response 
elements (AREs) in promoters in order to promote the cyto-protective response 
against accumulated reactive oxygen species (ROS), which suggests a role for PML 
in controlling the anti-oxidative response through regulating Nrf2 activity (Sahin et 
al., 2014). 
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Finally, after transfection of plasmid DNAs in HeLa cells, the number of NB 
increased two- fold, whereas parallel treatment in HEK293 cells did not cause any 
increase in PML NB number as this cell line shows a deficient response to lethal and 
sub-lethal ionizing radiation doses. However, stress evoked by transfection 
preserves NB cargos of associated proteins like SP100, Daxx and SUMO because 
they still co-localise to NB. IL-6 and IL-8 treatment induced NB numbers, and in 
addition, IL-6 redistributed NB  to the nucleoplasm (Laredj et al., 2008). 
Upon UV irradiation, PML regulates apoptosis in a p53-independent manner. 
Furthermore, there is functional crosstalk between PML and c-jun. This was 
observed when a dominant negative mutant of c-jun caused a reduction in cell 
death upon UV radiation. This reduction was also significantly reduced in PML -/- 
cells. PML- NB components re-localise in micro speckles upon UV-radiation in 60% 
of MEF cells in a p53 – independent manner. PML NB re-localisation may be 
triggered by different signals or posttranslational activation (Salomoni et al., 2005). 
Non- irradiated 293-T cells showed co-localisation of PML and hcds/chk2 (DNA 
damage checkpoint kinase) in PML-NB and co-immunoprecipitation showed that 
there is interaction between Hcds1/chk2 and PML III. This interaction decreased 
after irradiation. Radiation did not affect the level of these two proteins and kinase 
activity was required for the separation of hcds1/chk2 from PML within the NB 
after DNA damage. Hcds1/chk2 phosphorylates PML at Ser 117 and this 
phosphorylation is important for apoptosis-induction after gamma irradiation (Yang 
et al., 2002). 
In conclusion, different kinds of stresses cause the PML or PML-NB to respond in 
different ways. The response is often reflected in morphological changes in PML-NB 
appearance when they form micro speckles or an increase in their numbers and is 
associated with the release of PML protein partners or the recruitment of others 
also changes in their sumoylation. PML and PML-NB react to any abnormal 
condition that the cell experiences. This response might help the cells to overcome 
or to survive such conditions as moderate stress, and when the stress ends these 
nuclear structures go back their original morphology and structure.  
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Section III: Stress responses 
1.13 Heat Shock Response  
1.13.1 Mechanism of heat shock response 
 
Stress responses are specific protective mechanisms that are elicited in the cell in 
response to abnormal conditions and are characterized by stress protein synthesis 
(Liang et al., 2011, Kultz, 2003). The nucleus undergoes dynamic changes upon 
exposure to abnormal conditions. A stress response includes different cellular 
activities incorporating re-localization of factors and induction of heat shock gene 
transcription. There is also cross-talk between different stresses. The purpose of 
stress response is to retain the normal function of cellular components and allow a 
return to unction once the source of stress is removed (Cotto et al., 1997, Saydam 
et al., 2003). 
Heat shock stress causes a global change in cellular activities in both the nucleus 
and the  cytoplasm; the underlying reason for such global response is to help the 
cell to overcome this abnormal condition. When cells sense any elevation in 
temperature in their environment they start a highly organised and conservative 
heat shock response. In mammalian cells, there are three heat shock factors which 
trigger the heat shock response, hsf1, hsf2 and hsf4 with no very distinct role for 
the last two factors reviewed by Sonna et al., (2002). Heat shock increases the 
transcription of a set of heat shock family genes (Table 1.1), which are also induced 
by other kinds of stress. Heat shock factor 1 (hsf1) is the transcription factor which 
regulates the production of heat shock family proteins. Cells that are deprived of 
hsf1 are still able to produce the hsps constitutively but are not able to initiate a 
proper heat shock response. This steady state level of hsps, that is continually 
produced without any heat stimulus, cannot provide the cell with cyto-protection 
or thermo-tolerance, which suggests that hsps produced under heat shock show 
different functions than those produced under normal conditions (McMillan et al., 
1998). 
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Table1.1. A list of the known human heat-shock family genes (Sonna et al., 2002) 
Family Gene Symbol Gene Name 
Chromosome 
Location  
Small 
HSPs HSPE1 Heat shock 10-kDa protein 1 (chaperonin 10) 2q33.1  
 
HSPB1 Heat shock 27-kDa protein 1 7q11.23  
 
HSPB2 Heat shock 27-kDa protein 2 11q22-q23  
 
HSPB3 Heat shock 27-kDa protein 3 5q11.2 
 
HSPB7 Heat shock 27-kDa protein 7 (cardiovascular) 1p36.23-p34.3  
 
HSPB9 Small heat shock protein B9 17q21.2  
 
CRYAB Crystallin, alpha B 11q22.3-q23.1  
HSP32 HMOX1 Heme oxygenase-1 22q13.1 
HSP40 DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 9p13-p12  
 
DNAJA2 DnaJ (Hsp40) homolog, subfamily A, member 2 16q11.1-q11.2  
 
DNAJA3 DnaJ (Hsp40) homolog, subfamily A, member 3 16p13.3  
 
DNAJA4 DnaJ (Hsp40) homolog, subfamily A, member 4 15q24.1  
 
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 19p13.2 
 
DNAJB2 DnaJ (Hsp40) homolog, subfamily B, member 2 2q32-q34  
 
DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 1p22.3  
 
DNAJB5 DnaJ (Hsp40) homolog, subfamily B, member 5 9p12  
 
DNAJB6 DnaJ (Hsp40) homolog, subfamily B, member 6 11q24.3  
 
DNAJB9 DnaJ (Hsp40) homolog, subfamily B, member 9 7q31  
 
DNAJB11 DnaJ (Hsp40) homolog, subfamily B, member 11 3q28  
 
DNAJB12 DnaJ (Hsp40) homolog, subfamily B, member 12 10q22.1  
 
DNAJC3 DnaJ (Hsp40) homolog, subfamily C, member 3 13q32  
 
DNAJC4 DnaJ (Hsp40) homolog, subfamily C, member 4 11q13  
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DNAJC6 DnaJ (Hsp40) homolog, subfamily C, member 6 1pter-q31.3  
 
DNAJC7 DnaJ (Hsp40) homolog, subfamily C, member 7 17q11.2  
 
DNAJC8 DnaJ (Hsp40) homolog, subfamily C, member 8 1p35.3 
HSP47 SERPINH1 Serine (or cysteine) proteinase inhibitor, clade H, member 1 11  
 
SERPINH2 Serine (or cysteine) proteinase inhibitor, clade H, member 2 11q13.5 
HSP56 FKBP5 FK506-binding protein 5 (HSP56) 6p21.3-21.2 
HSP60 HSPD1 Heat shock 60-kDa protein 1 (chaperonin) 12q13.2  
HSP70 HSPA1A Heat shock 70-kDa protein 1A 6p21.3  
 
HSPA1B Heat shock 70-kDa protein 1B 6p21.3  
 
HSPA1L Heat shock 70-kDa protein-like 1 6p21.3  
 
HSPA2 Heat shock 70-kDa protein 2 14q24.1 
 
HSPA3 Heat shock 70-kDa protein 3 21 
 
HSPA5 
Heat shock 70-kDa protein 5 (glucose-regulated protein, 78-kDa; 
grp78; BiP) 9q33-q34.1  
 
HSPA6 Heat shock 70-kDa protein 6 (HSP70B′) 1cen-qter  
 
HSPA7 Heat shock 70-kDa protein 7 (HSP70B) 1q23.1  
 
HSPA8 Heat shock 70-kDa protein 8 (HSC70) 11q23.3-q25  
 
HSPA9A Heat shock 70-kDa protein 9A (mortalin-1) Unknown  
 
HSPA9B Heat shock 70-kDa protein 9B (mortalin-2) 5q31.1  
HSP90 HSPCA Heat shock 90-kDa protein 1, alpha 1q21.2-q22  
 
HSPCB Heat shock 90-kDa protein 1, beta 6p12  
 
TRAP1 Heat shock protein 75 16p13.3  
HSP110 
HSP105A; 
HSP105B Heat shock 105-kDa protein 13q12.3  
 
APG-1 Heat shock 110-kDa protein; osmotic stress protein 94 4q28  
 
HSPA4; APG-2 Heat shock 70-kDa protein 4 (heat shock protein apg-2) 5q31.1-q31.2 
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Heat shock responses are graded in response to elevated temperature and have 
most often been studied in the context of the acute response to short term 
exposure of cells to temperatures that are not survivable in the long term. 
However, even exposure to mildly elevated temperature induces the response. 
HeLa cells  heat shocked for 60 minutes at 42  ̊C showed consistent co-localization 
between hsf1-containing nuclear granules and SUMO-1 and a subset of those 
granules showed a significant co-localization with PML in PML-NB (Hong et al., 
2001). In addition, it was found that hsf1 in heat shocked samples was modified by 
SUMO1 at lysine 298 which showed a strong homology with the modification site of 
PML by SUMO, which suggests a possible relationship between hsf1 and PML (Hong 
et al., 2001).  SUMO-1 modified hsf2 was found to co-localize with PML in PML-NB 
and this interaction could be important to bring hsf2 close to other transcription 
factors that are important to its function to sequester it in order to regulation its 
function (Goodson et al., 2001). 
 
 
 
 
Ubiquitins UBB Ubiquitin B 17p12-p11.2 
 
UBC Ubiquitin C 12q24.3 
 
UBD Di-ubiquitin 6p21.3  
 
UBF-fl Ubiquitin UBF-fl 19q13.43  
Other HSPABP1; ST13 
Suppression of tumorigenicity 13 (colon carcinoma); HSP70-
interacting protein 22q13.2  
 
TOR1B Torsin family 1, member B (torsin B) 9q34  
 
TRA1 Tumor rejection antigen 1 (gp96) 12q24.2-q24.3 
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1.13.2 Transcriptional effect of heat shock 
 
Heat shock transcription activation affects the entire transcription machinery inside 
the stressed cells. This effect is represented by changes in  the subcellular 
distribution of transcription factors or changes in their expression level or 
transcriptional activity (Sonna et al., 2002). The heat shock transcription response 
requires an interaction between the stimulated hsf1 and upstream heat shock 
elements (HSE) in target promoters. Whether or not this activation needs any 
protein synthesis is determined by the extent of the elevated temperature. When 
the cells are heat shocked to extremely high temperature, hsf1-directed 
transcription happens without any need for protein synthesis, while the protein 
synthesis becomes a necessity when cells are exposed to mild elevation in 
environmental temperature (Zimarino and Wu, 1987). In fact hsf-dependent 
transcription is controlled and repressed by certain chaperones such as hsp70 and 
hdj1. Both endogenous and co-expressed GAL4-hsf1 transcription activation was 
reduced by those two chaperones and this was at a transcriptional level as the 
phosphorylation of hsf1 and DNA-binding activity were not affected by hsp70 
expression. Heat shock gene expression is auto-regulated by hsp70 in unstressed 
conditions due to the association of hsp70 with the hsf1-transactivation domain 
(Shi et al., 1998). Serine-hyperphosphorylated hsf1 is necessary for the transcription 
activation in the nucleus and this needs heat shock inducer to greater competent 
hsf1 (Cotto et al., 1996). 
Within a few minutes post heat shock or any other physiological kind of stress, hsf1 
which is normally found in a monomeric inactive state in the cytoplasm and nucleus 
at unstressed conditions, assembles into a trimeric state, acquires DNA binding 
activity and condenses in the nucleus (Fig1.5). Both immunofluorescence and 
fractionation protein analysis of cell fractionation showed clear localisation of hsf1 
to the nucleus shortly after heat shock which coincides with phosphorylation of 
hsf1 and acquisition of DNA binding activity in different types of mammalian cells. 
Human-specific cellular distribution of hsf1 was verified in HeLa cells and several 
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other human cell lines. In HeLa, but not in mouse 3T3 cells, hsf1 is organised in 
distinctive bright speckles inside the nucleus shortly after heat shock (Sarge et al., 
1993). 
This leads to a rapid and highly regulated activation of the heat shock gene 
response via the interaction of hsf1 with the heat shock elements in the 5’- flanking 
sequence in heat shock responsive genes. Prolonged exposure to mild heat 
elevation might attenuate the heat shock transcriptional response by converting 
the hsf1 trimers to monomers and re-localising them to the cytoplasm, mediated by 
the increased level of hsp70 as discussed above. In addition, inhibitors of protein 
synthesis attenuate the heat shock response to the mild heat shock which suggests 
that the aggregation of folding intermediates or misfolded proteins could be a 
trigger for initiation of heat shock transcription activation (Morimoto, 1993). 
 
 
Fig.1.5. HSF1 trimerisation. The left  structure shows the monomeric cytoplasmic form of 
hsf1 at attenuation. Upon heat shock the hsf1 trimerizes and moves to the nucleus to start 
the transcription of the global heat shock (Liou, 2010) 
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1.13.3 How do molecular chaperons help the cell to overcome stress? 
 
Mechanisms that explain the protective effect of hsp proteins or what are called 
sometimes chaperones are still not well understood. Over a wide array of 
temperatures ranging from 22 to 41 ̊C, hsp70 is one of the most dominant hsps; it 
can assist the cell under stress conditions by refolding the affected proteins to a 
native state in the presence of ATP. In contrast, hsp 90 has a different role that is 
summarized by saying that it keeps the non- native protein in a steady folding state. 
It has been noticed that unfolded β-galactosidase can recover its activity rapidly 
after different time periods of pre-incubation with hsp90 even in the absence of 
ATP (Freeman and Morimoto, 1996). 
1.13.4 The protective effect of heat shock 
  
Thermo tolerance, the state established in response to conditioning with heat 
stress, could have a protective effect against different kinds of stresses. In mitosis, 
pre-exposure to high temperature for a few minutes protects against heat-induced 
mitotic division error. The underlying reason for that is the conscription of hsp70, 
which is one of three HSPs that increase after thermo-tolerance is established, to 
the mitotic centrosomes (Hut et al., 2005).  Stable expression of human hsp70 
made rodent cells resistant to thermal stress even when its ATP binding site was 
deleted (Li et al., 1992). Pre-adapting HT22 mouse hippocampal cells by three days 
treatment with low concentrations of H2O2 protected them against the damaging 
effect of more extreme oxidative stress. hsp70 is implicated in this protection since 
this protection was abolished when the cells were treated with quercetin which is 
an hsp synthesis inhibitor (Khomenko et al., 2007). 
Lipopolysaccharide (LPS) –induced apoptosis was mitigated by overexpression of 
hsp70 in human peritoneal mesothelial cell line (HMrSV5). There is evidence linking 
this cyto-protection effect of hsp70 with its ability to amplify LPS-stimulated 
autophagy (Li et al., 2011b, Li et al., 2011a). Another protective role of this protein 
has been revealed in transgenic mice +hsp72 (which constitutively express hsp72 
from multiple organs such as brain, heart, liver, spleen, lung, kidney, skeletal 
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muscle, and tail). The pre-exposure of such mice to 40  ̊C for 60 minutes reduced 
heat-stroke induced hyperthermia, circulatory shock and cerebral ischaemic injury 
(Lee et al., 2006). Similarly, exposing Caenorhabditis elegans to a mild elevation in 
temperature protected them against heat stroke and heat induced necrosis. This 
protection was mainly achieved by hsf1 which induces several HSP genes including 
hsp16.1, hsp16.41 and DNJ-19 (hsp70) regulator (Kourtis et al., 2012). 
1.13.5 Effect of heat shock on NF-kB responses 
 
Exposing brain cells to 41 ̊C or 20 minutes was sufficient to induce hsp70 to 
significant levels after 22 hours. Pre-treatment with mild heat shock reduced NOS2 
(reactive oxygen product induced by NO synthetase2) positive staining in most of 
the brain areas of the treated animal by 90%. Reduced NOS2 staining was 
accompanied by reduced NF-kB levels through increasing the expression of IkB-α 
protein (Heneka et al., 2000). Another route could be exploited by hsp70 to inhibit 
NF-kB activation through physical binding with TRAF-6, which facilitates the 
ubiquitination of the latter and results in inhibiting LPS-induced NF-kB activation 
(Chen et al., 2006). However, other heat shock family members show a completely 
opposite effect on NF-kB transcription activation. hsp25 or what is known as hspb1 
increases the activation of NF-kB through promoting of the degradation of Ikb, 
which is accompanied by an increase in NF-kB-responsive gene products TNF-α and 
interleukin 1 beta (Yi et al., 2002). Heat shock protein 27 (Hsp27) regulates NF-kB 
mediated transcription since siRNA interfering with hsp27 mRNA caused a 
substantial reduction in and hence in nuclear NF-kB IKK activity (Guo et al., 2009). 
1.14 Viral infection and heat shock response  
 
According to the notion that viral infection is another kind of stress, there are many 
studies that have analysed the relationship between the response to infection and 
the induction of heat shock proteins. The yield of Influenza virus titre was 
significantly reduced at 8 hrs post infection when the cells were previously treated 
with Prostaglandin A PGA1 (which induces the level of hsp70). This is also observed 
in vivo; viral titres in lungs of infected mice treated with TAT-HSP70 (a form which 
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can enter cells) were substantially reduced in comparison with the controls. It is 
believed that HSP70 interferes with viral transcription and replication due to 
translocation of HSP70 from the cytoplasm to the nucleus in the infected cell which 
associates with the viral RNA and disrupt its binding to the viral RNA polymerase (Li 
et al., 2011a) 
Another example of the inhibitory effect of heat shock on the outcome of viral 
infection is the blocking effect of accumulated HSPs (90,72 and 70KDa 
polypeptides) on late HSV gene expression. In human neuroblastoma IMR32 cells 
which were grown at 40 ̊C, expression of ICP5 (a viral late polypeptide) was 
obstructed in contrast to the early-expressed genes that were not affected. A 
plausible explanation here could be a defect in switching from the synthesis of the 
early to the late polypeptides (Yura et al., 1987). Transfection of hsp70- vector 
plasmids in  HeLa cells also inhibited the cellular arrest that is induced by HIV 
infection, (Iordanskiy et al., 2004). 
On the other hand, some viruses may benefit from HSP expression. HSP40 and 
HSP70 knockdown decreased viral protein accumulation in hepatitis C virus HCV -
infected cells. This suggests a potential role of these two HSPs proteins in 
translation levels mediated by the virus by the viral IREs. This was further confirmed 
when the cells were treated with quercetin which showed a significant reduction in 
virus production which was attributed in partial to reduction of HSP40 and HSP70 
(Gonzalez et al., 2009). 
1.14.1 Heat shock restricts virus infection in Drosophila 
Infecting Drosophila S2 cells with Drosophila C virus (DCV) stimulates the stress 
response at 8 and 24 hours post infection. Six heat shock gene products were 
significantly up-regulated upon infection including Hsp70Abm Hsp70Ba, Hsp22, 
Hsp23, Hsp26, Hsp27. Transcription CHIP enrichment prediction showed substantial 
enrichment of the transcription factor HSF binding motif at the up-regulated gene 
promoters. Both RNA viruses like DCV and DNA viruses like DCV iridescent 6(IIV-6) 
virus caused increases in hsp70m, Hsp23 and Hsp26 8-48 hours post infection. 
Deficient replication of RNA and DNA viruses when the heat shock response was 
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impaired was verified by infection of S2 cells with UV-in activated virus. (Merkling 
et al., 2015). 
1.14.2 Heat shock and adenovirus  
Heat shock responses to adenovirus infection could be beneficial for viral 
replication. Some adenovirus proteins, like Gam1 from an avian adenovirus, trigger 
and re-localize of hsp40 and hsp70 upon infection to ensure a successful DNA 
replication. Deleting Gam1 in some adenovirus mutant causes impairment in 
adenovirus replication and this defect was rescued partially by re-expression of 
hsp40 (Glotzer et al., 2000). Ad5 infection alters the cellular transcriptional 
machinery by activating or repressing certain cellular factors in a way that enables 
the virus to establish a successful infection. One of the earliest discovered cellular 
proteins that is activated by Ad5 is hsp70, which is induced at the transcriptional 
level.  HSP70 mRNA increased specifically with infection and in a regulated manner. 
Ad5 infection increased cytoplasmic hsp70 mRNA very significantly, with levels 
reaching about 100 times those before infection at 7.5 hours post infection. The 
increase declined after 13 hours post-infection. E1A protein played major role in 
increasing hsp70 mRNA  level since the E1A-deleted virus (dl312) caused only a 
modest increase in hsp70 mRNA level similar to that for mock-infected cells and 
much less than the wild type (Kao and Nevins, 1983). 
To summarize, stress responses are protective mechanisms which induce many 
drastic events like relocalization of some proteins. There is a cross – talk between 
different response mechanisms. These responses affect viral infection due to their 
interaction with the IFN- based immune response through a complex mechanism 
which is important in controlling IFN induction and also through a direct effects on 
virus replication. PML NB and PML proteins have pivotal roles in many cellular 
activities, like tumour suppression, apoptosis, DNA repair and antiviral response. 
Stress-induced disassembly of PML NB is a characteristic feature of the latter 
response to different kinds of stresses. This change is accompanied by release of 
many proteins (including the PML itself) and recruitment of others.  
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Disruption of PML NB by many DNA and RNA viruses and the fact that the PML 
proteins are up-regulated by IFN which is also mounted by the stress response 
motivated us to start this project. For the purpose of this project, the most suitable 
type of stress for study was heat shock. This was because heat shock is reversible 
and the recovery starts once the normal temperature returns. Cd2+shock is also 
reversible but the time of recovery is indeterminate.The time-determined 
reversible changes due to heat shock were very important for our experiments 
since we wished to test the sensitivity of the surviving cells to virus infection. 
1.15 Aim of Study 
Adenovirus infection, PML and PML-NB, and heat shock are interconnected, with 
the cellular response to adenovirus infection and heat shock having many shared 
features. Both kinds of effectors, infection and heat stress greatly affect the cellular 
transcription machinery in order to enable the cell to survive and not to enter 
apoptosis. If the cell survives then the virus can take advantage of several cellular 
factors to finish the infectious cycle inside the affected cell and produce progeny 
that can infect the neighbouring ones. The heat shock response achieves different 
goals from assisting the cell to survive since it is for keeping cellular proteins in their 
native form, degrading the affected proteins to avoid any persistent damage to the 
cell or the whole tissue. PML partners for example Daxx either dissociated or 
recruited to the NB upon stress, the same proteins whose antiviral activity is 
antagonized by adenovirus E1b55k (Schreiner et al., 2010). PML or PML-NB and the 
heat shock response are well connected with the innate immune response, this is 
another shared feature between both types of stress, which suggests that they 
might have direct cooperation in triggering the antiviral immune response.  
Aim 1: To investigate the effect of mild heat shock conditioning of HeLa cells on 
PML and PML-NB and on the outcome of adenovirus infection. This was evaluated 
qualitatively and quantitatively using different approaches in comparison with the 
control infected samples. 
Aim 2: To investigate the role of PML and the specific isoform PML-II in changing 
the outcome of adenovirus infection in normal and stressed conditions, using a 
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persistent PML or PML-II knockdown system to be established using lentiviral 
expression of shRNA.  
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    Chapter 2: Materials and Methods 
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2.1 Materials 
All reagents, prepared or manufactured plasmids, cell types and competent cells 
that were utilised in this study are listed below: 
Table 
 2.1 List of cell lines, their description and source 
 
Table 2.2 List of viruses  
Virus Description Source and references 
Wt300 Wild type Ad5 (Jones and Shenk, 
1978) 
(Jones and Shenk, 1978) 
E4orf3 Implanting  of E4 frame-shift 
(300 backbone)    
(Huang and Hearing, 1989) 
Table 2.3 Restriction enzymes  
 
 
 
 
Cell type Description Source and suppliers 
HEK293 Embryonic Kidney immortalized with 
adenovirus type 5- express E1A and 
E1B proteins 
Supplied by Dr. Keith 
Leppard, University of 
Warwick  
(Graham et al., 1977) 
HeLa Human cervical cancer cells provided by Prof. M.A. 
McCrae, University of 
Warwick 
MRC5 Normal diploid human lung fibroblasts   
ATCC No. 
HB-8117TM 
Hybridoma cells produce anti-Ad5 
hexon antibodies 
Provided by Dr. Hans-
Gerhard Burgert. 
293T cells HEK293 cells; transformed with SV40 to 
increase protein production 
 
Restriction enzymes Description 
AgeI Promega 
EcoRI Fermentas 
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Table 2.4 Bacterial cells  
 
Table 2.5 Plasmids  
 
Table 2.6 PLKO. Sequencing primers 
Primers Sequence Source 
PLKO.1 A GACTATCATATGCTTACCGT Addgene 
PLKO.1 B CTTTCCCCTGCACTGTACC This study 
PLKO.1 C GCTATTATGTCTACTATTC This study 
 
 
 
Competent cells Description 
DH5α supE44,    lacU169(ϕlacZ    M15), hsdR17, recA1, 
gyrA96, thi-1, relA1 
Plasmid Description and sources 
PLKO.1  Shuttling plasmid with ampicillin bacterial resistance 
and puromycin as selective marker for production of 
recombinant lentivirus, (with cloning site 5 AgeI and 3 
EcoRI and a stuffer insert of 1900bp.(Addgene) 
psPAX2 Packaging plasmids, contains a robust CAG promoter 
to express packaging proteins for PLKO.1(Addgene) 
pMD2 Envelope plasmid for PLKO.1 packaging (Addgene) 
PGEM-T  PGEM R-T Easy Vector  Promega 
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Table 2.7 ShRNA constructs 
shRNA 
functional 
products 
Sense 5 Antisense 3 Description 
PML-II CATCCTGCCCAGCTGCAAATT TTTGCAGCTGGGCAGGATGTT Specific sequence targets PML-II within 
exon 7b (Wright, 2010) 
Exon3 GAGCTCAAGTGCGACATCATT TGATGTCGCACTTGAGCTCTT Targets all PML isoforms (Wright, 2010) 
Scrambled 
DNA 
GAGCCGGACGCCAAAGAAATT TTTCTTTGGCGTCCGGCTCTT Control shRNA with no target effect of any  
human gene (Wright, 2010) 
GFP GCAAGCTGACCCTGAAGTTCAT ATGAACTTCAGGGTCAGCTTGC Dr. Kirsten Bentley  
 
Table 2.8 SiRNA 
Target Sense 5 Antisense 3 Description 
HSP70 -- --  Targets HSPA1 and HSPB1 (Ambion) 
IRF3 UGGAUGAGUUACUGGGUAATT UUACCCAGUAACUCAUCCAGA  Targets IRF3, gene ID = 3661 (QIAGEN) 
STAT1 GAAAGAGCUUGACAGUAAATT UUUACUGUCAAGCUCUUUCTG Targets STAT1 gene ID = 6772 (QIAGEN) 
PML-II CAUCCUGCCCAGCUGCAAAUU UUUGCAGCUGGGCAGGAUGUU Targets exon  7b (Wright, 2010)  
Scramble siRNA “A” GAGCCCGGACGCCAAAGAAAUU UUUCUUUGGCGUCCGGCUCUU Control siRNA with no target effect of any  
human gene (Wright, 2010) 
Scramble siRNA “B” ACGCGAAUAGCGAGCAAGCUU GCUUGCUCGCUAUUCGCGUUU (Chen, 2014) 
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Table 2.9 PCR and qPCR primers 
Primer Forward Reverse Description 
genomic 
GAPDH 
CCCCACACACATGCACTTACC CCTAGTCCCAGGGCTTTGATT (Krog et al., 2007) 
PML-II AGGCAGAGGAACGCGTTGT GGCTCCATGCACGAGTTTTC (Chen, 2014) 
PML Exon3 ACTGCCGAGGATGTTCCAAG TCCTGTCGCTGCTGGATCTC This study 
IL-6 AAAGAGGCACTGGCAGAAAA TTTCACCAGGCAAGTCTCCT (Chen, 2014) 
ISG56 GCCATTTTCTTTGCTTCCCCTA TGCCCTTTTGTAGCCTCCTTG (Chen, 2014) 
GAPDH GGTCGGAGTCAACGGATTT CCAGCATCGCCCCACTTG (Vestergaard et al., 2011) 
Β-Actin AAAGACCTGTACGCCAACAC GTCATACTCCTGCTTGCTGAT (Shi et al., 2010) 
18S ACGCTGAGCCAGTCAGTGTA CTTAGAGGGACAAGTGGCG (Menager et al., 2009) 
HSP70 AGGCCAACAAGATCACCATC TCGTCCTCCGCTTGTACTT (Tanaka et al., 2007) 
HSPA1A GCCGAGAAGGACGAGTTTGA TCCGCTGATGATGGGGTTAC www.rtprimerdb.org 
HSPA1B AGGCCAACAAGATCACCATC TCGTCCTCCGCTTTGTACTT www.rtprimerdb.org 
Hsp705 GGCCGCACGTGGAATG ACCTCCAATATCAACTTGAATGTATGG www.rtprimerdb.org 
HSP706 GCCCTTCAGAGATGAACTTT TGTTAAAGTGCCACACAAGT www.rtprimerdb.org 
HSP27 AAGCTAGCCACGCAGTCCAA CGACTCGAAGGTGACTGGGA (Wang et al., 2013) 
Daxx TCTACAACTTTGGCTGTCACCTC GTCTCTTCTGTCTCTCGCCCT (Pan et al., 2013) 
hexon CGCTGGACATGACTTTTGAG GAACGGTGTGCGCAGGTA (Schreiner et al., 2013) 
E1A GTGCCCCATTAAACCAGTTG GGCGTTTACAGCTCAAGTCC (Schreiner et al., 2013) 
 
52 
 
Table 2.10 primary antibodies  
Antibody Description Dilution Sources 
and 
suppliers 
Western blotting Immunofluorescence FACS  
Viral proteins 
Rat-anti E4Orf3 
monoclonal 
Detects E4Orf3 
expression 
1/500 -- -- (Nevels et 
al., 1999) 
Mouse anti-
E1B55kmonoclonal  
Detects E1B55K 
expression 
1/250 -- -- (Sarnow et 
al., 1982b) 
Mouse anti DBP Detects Ad5 DNA 
binding protein 
1/10000  1/5 (Reich et 
al., 1983) 
Mouse anti-Hexon 
monoclonal antibodies 
2Hx-2 IgG2a 
Adenovirus group 
specific antigen  
-- No dilution  No dilution Provided by 
Dr. Hans-
Gerhard 
Burgert 
Rabbit poly clonal anti-
late (AdJLB1) 
Detects all Ad5 late 
gene expression 
1/10000 -- 1/500 (Farley et 
al., 2004) 
Cellular proteins 
Anti-Hsp70 Rabbit polyclonal 1/50000 1/300 -- StressMarq 
(SPC-
103C/D) 
anti- IRF3 Rabbit polyclonal 1/1000 -- -- Santa Cruz 
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(SC-9082X) 
Anti PML Detect total PML 
(Rabbit polyclonal) 
1/50000 1/500 -- (Xu et al., 
2003) 
Anti- PML-II Detect PML-II(Rabbit 
anti-peptide) 
1/50000 1/500 -- (Xu et al., 
2003) 
Anti- PML-V Detect PML-V(Rabbit 
anti-peptide) 
1/50000 -- -- (Xu et al., 
2003) 
Mouse anti- GAPDH Mouse GAPDH( 
monoclonal Detect) 
1/50000 -- -- MA5-15738 
Anti-STAT1 Detects STAT1 (Rabbit 
polyclonal) 
1/1000 -- -- Santa Cruz 
(SC-346) 
Anti-Sp1 polyclonal Ads 1/1000 -- -- Santa Cruz 
(SC-59x) 
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Table 2.11 Secondary antibodies 
Antibody Description Dilution Supplier 
Western blotting Immunofluorescence FACS 
Goat anti-Mouse IgG Horse Radish 
peroxidase conjugate 
1/10000 -- -- Sigma 
Goat anti- Rabbit IgG Horse Radish 
peroxidase conjugate 
1/20000 - 100000 
 
-- -- Santa Cruz (SC-2054) 
Goat anti Rat IgG 
 
Horse Radish 
peroxidase conjugate 
1/5000 -- -- Chemicon 
International 
Goat anti- Rabbit 
IgG(H+L) 
AlexaFluor 
488(conjugate) 
 
-- 1/500 1/50 Life Technology 
Goat anti- Rabbit 
IgG(H+L) 
AlexaFluor 594 
(conjugate) 
 
-- 1/500 -- Life Technology 
Goat anti- Mouse IgG 
(H+L) 
AlexaFluor 
488(conjugate) 
 
-- 1/500 1/50 Life Technology 
Donkey anti-Goat IgG Horse Radish 
peroxidase conjugate 
1/10K -- -- -- 
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2.12 A list of reagents  
 
 
 
Reagent Supplier 
Dulbecco's modiﬁed Eagle's medium(DMEM 1X) Gibco 
Fetal bovine serum (FBS) Sigma                             
Roswell Park Memorial Institute (RPMI) Gibco 
Minimum Essential Medium(MEM) Gibco 
Puromycin dihydrochloride Sigma 
QNZ, 6-Amino-4(-4-Phenoxyphenylethylamino)quinazolin Santa Cruz 
Recombinant Human Tumor necrosis factor (TNF-α) 
Lyophilised 
Invitrogen 
 Interferon-α (IFN-α) PbI interferon 
source 
Lipofectamine 2000 (LF2000) Invitogen 
TransITR LT1 transfection reagent (LT1) Mirus 
Dimethyl Sulfoxide(DMSO) Sigma 
GenEluteTM Mammalian Total RNA  Miniprep kit                                                                                                                                                    Sigma
SV Total RNA Isolation System Promega 
GenEluteTM Mammalian Total DNA  Miniprep Kit                                                                                                                                                    Sigma 
GoScriptTM Reverse Transcription System  Promega 
QIAquickR PCR Ourification kit QIAGEN 
QIAprep Spin Miniprep Kit Using a Microcentrifuge QIAGEN 
GeneJET Gel Extraction Kit Thermo Scientific 
Gene detecting primers Sigma 
Brilliant III Ultra-Fast SYBR Green qPCR Master Mix with Low 
Rox 
Agilent 
DNase treatment kit Promega 
100bp DNA Ladder Promega 
1kb DNA ladder Promega 
PageRuler Plus Prestained Protein Ladder Thermo Scientific 
Super Signal R West Femto Maximum Sensitivity Substrate Thermo Scientific 
Nitrocellulose Blotting Membrane  GE Health 
 Care Amersham 
Flow Cytometer Tubes  Elkay 
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2.2 Methods  
2.2.1 Routine cell maintenance 
 
Immortalised human tumour cell lines: human embryonic kidneys (HEK293), 
HEK293 transformed with T large antigen (293T) and human cervical cancer cells 
(Hela) were grown at 37  ̊C, 5% CO2 in a humidified atmosphere in Dulbecco
’s 
Modified Eagle Medium (DMEM) supplemented with 10% new born bovine or 10% 
fetal bovine serum (FBS). MRC5 cells were maintained in 10% FCS Eagle´s Minimal 
Essential Medium (MEM) provided with 2mM L- glutamine and 1% non- essential 
amino acids. For routine work, they were seeded at a ratio of 1:5, 1:6 and 1:8 
respectively. For experimental purposes cells were seeded at different densities 
according to the size of culture that was required. In general, 90 mm dishes were 
used for routine passaging (twice a week). Routine cell culture was achieved in an 
aseptic environment. At the time of confluence, cells were washed once with 3 ml 
versene (0.02% EDTA in PBS), then cells were incubated with 2.5 ml versene 
containing 0.02% (v/v) of 0.25 mg/ml trypsin and left for 3 minutes. The cells then 
collected by centrifugation and re-suspended in a suitable medium according to the 
ratios above. Transduced HeLa cells, were periodically “each 3 days” exposed to 
puromycin selection and for each experiment the cells were released for 3 days 
prior any kind of treatment. 
2.2.1.1 Long term storage of cells 
The cells were plated in the routine way, two days later the sub-confluent dishes 
were washed, trypsinised and cells collected. The cell pellet was re-suspended in 2 
ml 90% (v/v) FBS and 10% (v/v) dimethylsulphoxide DMSO. The suspensions were 
distributed in small vials as 1 or 2 ml in each. The vials were kept in ice for 20 
minutes then they transferred to -80 ̊C freezers for 16 hours and finally relocated to 
the liquid nitrogen freezers. For 2-Hx2 hybridoma cells, they were frozen in 10% 
DMSO,30% FBS, 60% RPMI.  
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2.2.1.2 Making competent cells 
DH5α cells were grown overnight at 37 ̊C in 5 ml LB broth culture ( no antibiotics), 
Two ml of that culture was used to inoculate a culture size of 100 ml LB broth. The 
cells were left to grow at 37 ̊C at 200 rpm shaking and samples were taken every 20 
minutes to measure the optical density till it reached to 0.39 after about 2-3 hours. 
The cells were left on ice for 5 minutes, then a pellet of the bacterial cells was 
collected by centrifugation at 4  ̊C, 6000 rpm for 10 minutes in Eppendorf centrifuge 
5810. The pellet was re-suspended in 2/5 volume of Transformation Buffer I (TFBI), 
which consists of 10 mM RbCl2, 30 mM potassium acetate, 10 mM CaCl2, 50 mM 
MnCl2 15% (v/v) glycerol, and left on ice for 5 minutes and then collected by 
centrifugation as before. Transformation Buffer II (TFBII);75 mM CaCl2, 10 mM 
RbCl2, 10 mM3-N morpholinopropanesulfonic acid ( MOPS) and 15 (v/v) glycerol 
with a pH of 6.5 was pre-chilled for 15 minutes in ice and 4 ml was added to the 
bacterial pellet and the mixture was incubated for 2 hours on ice. A 200 µl aliquot 
of the cell suspension was added to each sterile Eppendorf tubes and moved to -80 ̊
C freezers for long term storage.  
Transfection   
Cells were plated at 1×105/ml in 12- or 24-well plates 24 hours prior to liposome-
mediated transfection. For plasmid DNA transfection each 1µg of DNA was 
prepared in 50 or 100 µl (24- well or 12- well plate)of pre-warmed serum free 
OptiMEM. An equal volume of the same medium was prepared containing 2µl of 
LT1 transfection reagent. The DNA and LT1 were mixed and left for 20 minutes at 
room temperature. The transfection mixture was added to each well slowly and 
drop by drop covering all the surface area of the culture. The cells were incubated 
for 24 hours (24 or 48 hours for lentiviral production).   
Each 125 pmol of siRNA was transfected with 1.2 µl Lipofectamine2000 transfection 
reagent. The siRNA was prepared in 50 or 100 µl of OptiMEM depending on the 
culture size (0.5 ml or 1 ml respectively), then mixed with the appropriate volume 
of LF2000 which was also prepared in an equal volume of OptiMEM for 20 minutes. 
The combination was dropped gently and evenly on cells that were then re-
incubated again for 48 hours followed by different kinds of treatments. 
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2.2.1.3 Cell culture treatment 
Cells were treated with 1000 U/ml with IFN-α for 24 hours prior infection. To 
stimulate NF-kB activity, cells were treated with 100 ng/ml of TNF-α for 1 hour. In 
order to block the NF-kB signalling pathway, cells were treated with 10µM N4-[2-(4-
phenoxyphenyl)ethyl]-4,6-quinazolinediamine (QNZ) for 45 minutes. To study heat 
stress, cells were grown in 35 mm dishes and plated at  106 cell/dish  After 24 hours 
cells were exposed to 40˚ C and individual cultures harvested at 30 minute intervals. 
Then the temperature was shifted again to 37̊C and further samples were 
harvested.  
 
2.2.2 Generation of PML shRNA cell lines    
2.2.2.1 Generation of PML shRNA lentiviral constructs 
PLKO.1TRC cloning vector (Addgene) was used to produce lentiviral particles 
following the Addgene protocol. ShRNA-coding sequences for insertion into the 
vector were purchased as pairs of complementary oligonucleotides each having the 
form:5´CCGG- sense-CTCGAG- antisense-TTTTTG 3´(forward) with the sense and 
antisense elements of each oligonucleotide being as described; and 5´ 
AATTCAAAAA- sense- CTCGAG- antisense 3´ (reverse). The forward and reverse 
oligos were annealed to give dsDNA with overhangs compatible with AgeI and 
EcoRI-cut DNA by mixing 5 µl of each with 5 µl of 10x NEB buffer 2 and the volume 
completed to 50 µl using ddH2O. The mixture was incubated at 95 ̊C for 4 min at 
70 ̊C for 10 min followed by a slow cooling to room temperature for 5 hrs. 
PLKO.1 vector digestion was achieved using AgeI and EcoRI, 6 µl of the vector 
digested firstly withAgeI, for 2 hrs at 37C purified using QIAquick PCR extraction kit, 
and then secondly digested with EcoRI in each case using manufacturer´s 
recommendations. The double digested vector was then electrophoresed on a 0.8% 
agarose 1x TBE gel and purified using Thermo scientific gel extraction kit according 
to the manufacturer’s instructions. Ligation was performed by mixing 60 ng of the 
double digested PLKO.1 TRC vector with either diluted or ten- fold diluted of the 
annealed shRNA oligos and 4 µl of 5xNEB T4 DNA ligase buffer,1 µl of NEB T4 DNA 
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ligase was added and the volume was completed to 20 µl with ddH2O. The mixture 
was incubated overnight at 16  ̊C. Two microliters of each ligation mixture were 
mixed with 25 µl of competent DH5-α E. coli, plated out on LB agar containing 100 
µg/ml ampicillin and incubated for 16 hrs at 34 ̊C. The selected colonies were grown 
in 5 ml of LB broth containing 100µg/ml ampicillin for 16hrs at 37 ̊C. The plasmids 
were purified using QIAprep Spin MiniprepKit and sent for sequencing at GATC 
Biotech using PLKO.1 TRC vector primers. Another pair of reverse primers was 
designed to overcome the difficulty in sequencing through the secondary structure 
of the shRNA-encoding DNA hairpin.  
2.2.2.2 Preparing Lentiviral particles  
HEK-293T cells were counted and seeded at a density of 7×105 in 3ml in 60mm 
dishes overnight. Growing cells were transfected for 15 hrs with 1 µg of each 
PLKO.1 sh plasmid (Addgene) mixed with 750ng of psPAX2 packaging plasmid 
(Addgene) and 250 ng of pMD2 envelope plasmid (Addgene) usingTransi LT-1 
(Mirus) in a ratio of 2 µl of LT-1 to 1 µg of DNA, 80 µl of LT-1  in OPTI-MEM was 
added to the 20 µl plasmid mixture, incubated for 20 minutes at room temperature 
and then added to HEK-293T cells gently and dispersed evenly throughout the 
plate. The plates were incubated for 15 hrs. The transfection reagents were 
removed and replaced with fresh DMEM with 10% FBS and left at 37 ̊C for 24 hours. 
The medium was harvested as a lentivirus stock, stored at 4 ̊C and new fresh 
medium was added to the same plates and the cells were left for another 24 hours 
before harvesting the medium again. Both harvests were mixed and centrifuged at 
1250 rpm for 5 min to remove any cells from the lentiviral suspension. For long 
term storage the lentivirus was kept at -20 ̊C.  
2.2.2.3 Lentiviral transfection and selection 
Prior to attempts to transduce cells, the intended target cells (HeLa) were tested for 
their puromycin sensitivity, cells were plated out at a density of 1×105/ml in 35 mm 
dishes and incubated for 24 hrs at 37 ̊C. Puromycin was prepared in a wide range of 
concentrations (1 µg/ml to 10 µg/ml) and each concentration was added to a 
different plate and the level of killing was monitored every day. For transduction 
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HeLa cells were plated at a density of 4×105/ ml in a 6- well plate, 24 hrs later cells 
were infected with 0.1, 0.5 and 1ml of the prepared lentiviral particles and  
incubated at 37 ̊C for 24 hrs. The medium was replaced with DMEM plus 10% FBS 
containing the pre-determined concentration of puromycin. Death was monitored 
every day. Efficiency of knockdown in puromycin-resistant cell population was 
analysed by RT-qPCR, western blotting and confocal imaging at 3, 9 and 14 days 
post transduction. 
2.2.3 RNA and DNA analyses 
2.2.3.1 DNA isolation 
Mammalian DNA samples were extracted by a column based purification technique 
which was provided by Sigma-Aldrich GenEluteTM Mammalian Genomic DNA 
Miniprep Kit (G1N70). DNA samples were extracted by following the manufacturer’s 
instructions and the eluted DNA was stored at -20 ̊C. Viral and cellular gene 
expression and viral DNA copy number were quantified by RT-qPCR assay using the 
specific primers for each target gene. 
2.2.3.2 RNA extraction 
Acquiring the total cellular RNA in all experiments relied on using the purification 
columns kits provided by Sigma-Aldrich (GenEluteTM Mammalian RNA Miniprep Kit 
(RTN70) or Promega (SV Total RNA Isolation System (z3100). Purification steps were 
accomplished according to the manufacturer’s instructions; the purified eluted RNA 
was immediately DNase-treated and converted to the complementary DNA by 
reverse transcription as described below. 
2.2.3.3 Routine DNaseI treatment 
Using the Promega reagent kit, a 10 µl reaction was prepared by mixing 200ng of 
the extracted RNA with 1 µl of DNaseI and 1 µl of DNase buffer and the volume 
adjusted to 10 µl with sterile water. The reaction was incubated for 30 minutes at 
37  ̊C and then stopped by adding 1 µl of DNase stop solution and incubated for 10 
minutes at 65  ̊C. 
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2.2.3.4 Reverse transcription reaction 
The DNase treated RNA samples were reverse transcribed to complementary DNA 
using GoScriptTM reverse transcription System A5000. Mixed oligo-dT and random 
hexamers were used as primers for first strand cDNA synthesis according to the 
manufacturer´s protocol. The thermal cycle of the reverse transcription was as 
follow: 
Step Temperature Period of time (minutes) 
Annealling 25 ̊C 5 
Extension 42 ̊C 60 
Reverse transcriptase 
Inactivation 
70 ̊C 15 
 
2.2.3.5 Real Time Quantitative Polymerase Chain reaction 
The reaction was prepared containing 0.1 µl of 20µM Forward and Reverse primers 
(Table 2.9), 10 µl of SYBR Green  reaction mix and 0.3 µl ROX (1:500 dilution) or 
SYBR green pre- mixed with low Rox as a reference dye(Agilent).  For DNA copy 
number analysis 1 ng and 5ng of total DNA were used per reaction for Ad5 and 
GAPDH plasmids respectively. For early and late viral and cellular gene expression, 
cDNA samples were uses as templates at concentrations of 5 to 10 ng/ well. All 
qPCR experiments were performed on a Stratagene MX3005P light cycler (Agilent 
Technologies) using the following cycling conditions: 95  ̊C for 3 mins, then cycles of 
1 min at 95 ̊C, 30 sec at 55 ̊C and 30 sec at 95 ̊C. Cycle threshold and baseline values 
were determined using the machine software and all PCR products were subjected 
to dissociation curve analysis to ensure primer specificity. Viral and cellular gene 
expression were calculated as ∆ Cts by subtracting house-keeping gene Ct values 
while viral DNA copy number was quantified from standard curves of viral genome 
and GAPDH plasmids, the latter to quantify cellular DNA as an internal control (see 
below). 
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2.2.3.6 Construction of GAPDH DNA plasmid 
HeLa cells were used as a source of genomic GAPDH DNA for PCR amplification. 
Genomic GAPDH was amplified using GAPDH genomic specific primers to give a 97 
bp product. The reaction was performed using an Eppendorf Master Cycler 
Gradient Thermo-cycler and Taq DNA polymerase. The concentration of the 
template was adjusted to 50 ng/µl and mixed with 1 µl of 20mM of forward and 
reverse primers and dNTPs. MgCl2 was added at a concentration of 50mM. The 
volume was completed to 50 µl. The reaction was set as follow: 94 C̊ for 3.5 
minutes, 30 sec at 60 ̊C and 7 minutes at 70 ̊C. The amplified gene was then de-
contaminated by QIAquick PCR purification kit and according to the manufacturer´s 
directions. The PCR product was ligated to pGEMT using 2X rapid ligation buffer 
(PGEM R-T Easy Vector Promega) at a ratio of 3:1 insert to vector in a total volume 
of 10 µl, according to the manufacturer’s instructions. Half of this was used to 
transform 100 µl of E. coli competent DH5α cells as described in section 2 and 
plated on. XGAL/IPTG LB ampicillin plates prepared by mixing 40 µl of 20mg/ml 
XGAL with 40 µl of 100mM IPTG and spreading the mixture on the surface of the 
sterile LB-amp agar plates. Potential insert-containing colonies (white) were grown 
in 5 ml of LB broth containing 100µg/ml ampicillin for 16hrs at 37C. The plasmids 
were purified using QIAprep Spin Miniprep Kit and sent to GATC Biotech to 
determine correct DNA sequence. 
2.2.4 Qualitative and quantitative assays of proteins 
2.2.4.1 Cells extraction and Western-blotting  
Total cell extracts were made by lysing cell monolayers in 1x sample buffer (1x SB) 
which was prepared from a stock of Laemmli sample buffer2x ( 4 ml of 10% SDS, 2 
ml of 20% glycerol, 1.2 ml of 1 M Tris-HCl pH 6.8 2.8 ml of H2O and 0.02% w/v of 
bromophenol blue). Samples were boiled for 10 minutes and loaded onto 8%, 10% 
or 12% polyacrylamide gels and electrophoresed at 70 V for 3.5 hours. Proteins 
were then transferred to nitrocellulose membrane (10 cim ×7 cim) at 0.35 A for 1.5 
h (or 0.08 A overnight) in a cold room. After blocking for 1h at room temperature or 
overnight at 4 ̊C with 2% blocking reagent in PBS/0.05% Tween 20 (PBS-T), 
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membranes were incubated with the appropriate antibodies (Table 2.10) for 1 h. 
Membranes were washed 7 times for 13 minutes with PBS-T, then incubated with 
the appropriate secondary antibodies (Table 2.11). Finally, the reaction was 
detected by ECLTM Advance reagent according to the manufacturer’s instructions 
by exposure to Fuji Super RX X-Ray film. Different loading controls were used in this 
study. Depending on the molecular mass of the protein (GAPDH, β-actin or α- 
tubulin) the loading control was either acquired by cutting the lower part of the 
same membrane or loading the same samples on a different gel.  
2.2.4.2 Western blotting stripping  
Nitrocellulose membranes which were previously probed to evaluate the 
expression of certain genes were used again to display expression of other genes by 
stripping and re-probing. The membranes were stripped with 50 ml reagent 
consisting of 2% SDS, 62.5 mM Tris-HCl pH 6.8 and the last component is 350 µl of 
β-mercaptoethanol, all those contents were mixed together and the volume was 
adjusted to 50 ml by distilled water. The solution was pre-warmed for 10 minutes at 
50  ̊C and then added to the membranes and warmed again for 15 minutes at 50  ̊C. 
The membranes were washed 3 times for 15 minutes with PBS-T, then re-blocked 
and probed using the same steps of membrane blotting as the first time.  
2.2.4.3 Cellular fractionation  
To prepare separate cytoplasmic and nuclear extracts, cells were washed once with 
pre-chilled PBS, scraped and collected in 1.5 ml microfuge tubes by centrifugation 
at 1300 rpm for 3 minutes. Cells were lysed using lysis buffer (10mM NaCl, 1.5 mM 
MgCl2, 10 mM Tris-HCl pH 7.5, 0.67% NP40).  The suspension was left in ice for 10 
minutes and followed by separating the nuclei from cytoplasm by centrifugation at 
1500 rpm for 3 minutes at 4 ̊C; cytoplasm (supernatant) and nucleus (pellet) 
samples then were mixed with 1xSB. 
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2.2.4.4 Confocal Immunofluorescence   
Cells were plated at 2×105 /well or 1×105/ well culture in 12- well containing sterile 
coverslips to analyse the outcome of infection and effect of knockdown 
experiments respectively. At the end of the experiments, cells were fixed with 
10% formalin and permeabilised with 0.5% NP40 in PBS with washing after each 
step. Blocking was achieved by 1% bovine serum albumin (BSA) in PBS for 45 
minutes. After 3 washes with PBS, appropriate dilutions primary antibodies (Table 
2.10) were added and left for 45 minutes. After further washes, the primary 
antibodies were replaced with diluted 250 µl of Alexafluor 488 or 594-labelled 
secondary antibodies (Table 2.11) for 45 minutes. Coverslips were washed twice 
with PBS. Cells were washed for a third time with  PBS included 1 µg/ml DAPI for 5 
minutes. Coverslips were mounted with Vectasheld mounting medium. The images 
were taken as single optical section by a Leica SP2 or Leica SP5 system and Leica 
software.  
 
2.2.4.5 Fluorescence- Activated Cell Sorting (FACS analysis) 
HeLa Cells were seeded at a density of 0.8×106 or 2.2×106 per dish in 60 and 100 
mm2  dishes respectively; 24 hours later cells were heat shocked or not and then 
infected  with Ad5 wt300 at a multiplicity of infection (m.o.i) of 5 or 10 fluorescence 
foci units (f.f.u.) per cell. Cells were then washed once with pre-warmed PBS. The 
cells were then trypsinized, re-suspended in 10 ml DMEM 10% FBS, then pelleted 
by centrifugation at 1280 rpm for 7 minutes, supernatant was removed to leave a 
final volume of 0.5 ml, 8 ml of PBS was added and the cells were gently re-
suspended. Then the cells were pelleted by centrifugation for 7 min at 1280 rpm 
and re-suspended in 450µl or 810µl of PBS for 60 mm2 and 100 mm2 dishes 
respectively. Cells were fixed by adding by formaldehyde to give a final 
concentration of 4% and left to incubate at room temperature for 20 minutes  with 
vortexing each 5 mins, then cells were incubated with 600/900 µl of  50 mM NH4CL 
for 30 minutes at room temperature. PBS (500 or 900 µl) was then added to the 
tubes followed by centrifugation for 3 min at 3000 rpm. The pelleted cells were 
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permeabilized with 500 or 900 µl of 0.5% NP40 for 10 minutes, then were 
centrifuged 3 minutes at 3000 rpm and blocked with 1% BSA  in PBS for 45 minutes. 
To analyse for specific antigens, they were re-suspended to a concentration of 
1.67×107/ ml in FACS Buffer (PBS containing 3% FBS and 0.07% NaN3 ). Anti- Hexon 
monoclonal, anti-late polyclonal and DBP monoclonal antibodies (Table 2.10) were 
used in a 96- well plates; 100 µl of Abs were mixed with 30 µl of the fixed cells and 
left for 45 minutes at 4 ˚C. Cells were then removed by centrifugation of the plate 
and washed twice with FACS buffer. The process was then repeated with 
appropriate AlexaFluor 488- labelled secondary antibodies (Table 2.11). Cells were 
recovered by plate centrifugation and washed three times with FACS buffer. 
2.2.4.6 FACS Analysis 
Stained cells were re-suspended in 100 µl of FACS buffer and transferred to FACS 
tubes containing 300 µl of FACS buffer. The suspension was mixed by pipetting and 
the readings were acquired by FACSCAN (BECTON DICKINSON) and data were 
analysed by WinMDI software. 
2.2.5 Virus titration 
 
Ad5 wt300 was titered by counting DBP a fluorescence-positive cells as Flourescent 
Focus Assay (FFA). HeLa cells were plated at 1 ×105/ well in 24- well plates for 24 
hours. The virus to be titred was prepared in serial ten-fold dilution (10-1 to 10-10) in 
serum-free DMEM free serum. The medium was removed from the cells in each 
well and 50 µl of each dilution was added to the cells in duplicate. Cells were 
incubated with the virus for 1 hour, then the virus was discarded and the cells were 
covered again with a fresh DMEM 10% FBS and incubated for 16 hours. Cells were 
then fixed and stained with anti-DBP antibodies and AlexaFluor 4888 secondary 
antibody as for confocal microscopy. The DBP foci were counted using UV- 
microscopy. 
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Chapter 3:  Characterising PML Kd and PML-II Kd 
cells 
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3.1 Introduction 
PML and PML-NB display an antiviral function against wide range of viral infections, 
for example decreased human foamy virus (HFV) and rabies gene expression and 
replication have been found following PML and PML-IV overexpression in different 
cell lines (Regad, 2001a, Blondel et al., 2010). Also permanent removal of PML 
results in increased replication and gene expression in HSV and HCMV infections 
(Everett et al., 2006, Tavalai et al., 2006). In a broader aspect, this function has been 
verified even in immune cells when HIV proviruses were reactivated in about 90% 
of latently infected primary CD4+ T- cells with stable shRNA PML knockdown (Lusic 
et al., 2013). In addition, PML has been described as an enhancer of HPV mRNA 
transcription  (Day et al., 2004). This project is concerned with the role of PML and 
PML-II in Ad5 infection, for which there is already evidence to correlate viral 
infection and PML proteins. Adenovirus infection causes PML reorganisation into 
track-like structures and this has been particularly attributed to a direct interaction 
between Ad5 E4Orf3 protein and the PML-II isoforms (Carvalho et al., 1995, Hoppe 
et al., 2006). In addition, the viral E1A oncoprotein co-localises to PML through its 
conserved CR2 amino acid domain that is homologous to sequences found in other 
oncogenic viral proteins (Carvalho et al., 1995). 
It seems that Adenovirus interaction with PML and in particular PML-II is of a 
distinctive importance and the latter in particular has been suggested to play a 
decisive role. Hence, there are good reasons to investigate the role of PML and 
PML-II in the adenovirus life cycle. To facilitate this, a permanent PML knockdown 
system was established as described in this Chapter. This would generate consistent 
conditions among different experiments. Other important reasons for establishing 
this system include the ease and cheapness of achieving quantitative analyses in 
cell populations using FACS assays and the saving of  time from avoiding the 48 
hour incubation for the transient knockdown. The technique that was employed to 
meet the requirements for permanent knockdown was shRNA that targets the gene 
of interest, delivered using lentiviral vectors to infect and select the target cells. 
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3.2 Isolation and characterisation of PML- Knockdown cells 
The early attempts that were achieved in this work to transiently knock down total 
PML or the PML-II isoform specifically created many variations among the individual 
experiments, especially when applying heat stress (chapter 5). The ultimate aim 
was to quantify the outcome of infection in the presence and absence of PML or 
PML-II at both the normal temperature and after mild heat shock. Hence, growing 
large size cultures which show consistent knockdown throughout the culture was 
critical to achieve this and transient knockdown was not appropriate. 
The shRNA interfering technique was the robust approach chosen to meet the 
above goals. This technique is characterised by the ability to transduce both 
dividing and non- dividing cells, and express the designed shRNA by stable 
integration of the sequence into the cellular genome, based on puromycin 
resistance which allows selection to differentiate transduced from non- transduced 
cells (Naldini et al., 1996, Zufferey et al., 1997). The shuttling plasmid expresses the 
cloned shRNA from  an RNA polymerase III (POL III) promoter derived from the U6 
gene and terminates with the Pol III signal of a 5T repeat sequence cloned at the U6 
5’ end (Stewart et al., 2003).  
The shRNAs which were made in this study were designed to mimic siRNA 
templates that were designed by Wright (2010). It is well known that the PML gene 
is an alternatively spliced human gene; it consists of 9 exons which encode for 
different nuclear and cytoplasmic PML protein isoforms (PML I to PML VII) (Jensen, 
2001). Total PML mRNA was targeted by a 21 nucleotide fragment which hybridises 
to exon3 RNA, common to all human PML mRNAs (Fig 3.1). PML-II mRNA expression 
was interfered by a siRNA fragment which uniquely targeted exon 7b (Fig 3.1). The 
efficiency of those siRNAs has already been verified by (Wright, 2010)) proving their 
ability to deplete total and PML-II transcripts. 
69 
 
 
Fig.3.1. A schematic diagram illustrates PML gene structure and targets of siRNA 
interference. A. The PML gene cartoon which shows (1-6) shared exons among PML I to 
PML V with recognised protein elements RING (R), B-boxes (B1,B2) and coiled coil (CC) 
known collectively as the RBCC motif. Nuclear localisation signal (NLS), SUMO modification 
site (S). B. Exon3 siRNA sketch targets all PML mRNA. C. PML-II siRNA that was designed to 
target exon 7b, the unique identifier of PML-II mRNA. 
 
The plan was to permanently knock down PML or PML II using lentiviral 
transduction of shRNA constructs and to explore the outcome of infection in HeLa 
cells that lack PML or PML-II compared to HeLa cells in control and stressed 
conditions. The system in general includes ligating the shRNA constructs as cDNAs 
with the plasmid vector (PLKO.1). The control constructs were either scrambled 
(Ctrl.DNA –shRNA) which do not interfere with any human sequences, verified using 
Ambion siRNA target finder (Wright, 2010), shRNA for GFP constructs or PLKO.1 
empty vector. Then, the recombinant PMLKO TRC.1 was transfected with the 
second generation packaging vector psPAX2 and the second generation envelope 
vector pMD2.G, encoding the vesicular stomatitis virus (VSV) G protein, into 293T 
cell to produce the lentiviral particles and these particles were used to infect target 
HeLa cells.  
HeLa cells were chosen to be the target of the lentiviral transduction for two main 
reasons. Firstly, those cells are amenable for human adenovirus type 5 infection. 
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Secondly, HeLa cells show a good infectivity level using HIV lentiviral particles; they 
display a 60% transduction efficiency when they are challenged with those vectors 
at MOI of 1 (Ikeda et al., 2002). The physical and functional knockdown in these 
cells was investigated at both RNA and protein levels using RT-qPCR, WB and IF. 
3.2.1 Constructing the shRNA- PLKO.1 plasmids 
 
The U6 human promoter which is transcribed by RNA polymerase III is a feature of 
the cloning vector PLKO.1 (Kunkel et al., 1986). This short small nuclear RNA 
promoter in all kinds of human cells provides substantial expression of short hairpin 
RNA transcripts which consist of 2x 19 nucleotides with an intermediate loop and 
4U overhangs at the antisense strands (Paul et al., 2002). Another important 
feature of this promoter which facilitates the transcription of short hairpin small 
interfering RNA sequences is the lack of the non- coding DNA sequences or what is 
called intragenic sequences, which is unusual for the promoters that are 
transcribed by Pol III. This characteristic feature is crucial for the purpose of 
transcribing the desired gene as the promoter will drive expressing of the shRNA 
rather than its own intragenic sequences (Das et al., 1988, Kunkel and Pederson, 
1989). U6- driven-shRNAs exhibit substantial and specific knockdown of the target 
gene, in addition to which when they are delivered into cells they form duplexes 
and are thus well protected from intracellular nucleases (Miyagishi and Taira, 
2002). 
3.2.2 Digestion of PLKO.1 TRC cloning vector and construction of  shRNA –
PLKO.1 recombinant vectors 
 
The two restriction enzyme sites AgeI and EcoRI were the target sites where the 
shuttle vector PLKO.1 TRC was double digested. The puromycin resistance property 
allows a positive selection for the transduced cells (Fig.3.2.A). The constructs were 
ordered with CCGG  at the sense end and TTTTTG  at the antisense end, with a short 
sequence (CTCGAG) separating the sense and anti-sense elements (Fig.32.B). 
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Fig.3.2 PLKO.1 TRC vector diagram and sequence – definite knockdown of PML-II, EXON3 and scrambled DNA. A. Cartoon presentation of PLKO.1 TRC 
cloning vector with its genetic properties. Those characters are mainly; the human U6 promoter to operate the shRNA transcription via RNA polymerase III;  
the Amp and Puro resistance genes to allow  successful selection in bacterial cells and mammalian cells correspondingly. B. Upper diagram : the stem loop 
which incorporates the specific sense and anti-sense RNA . The lower panel : the knockdown- specific sequences; top, PML-II shRNA; middle, total PML, 
bottom, control DNA sequence (Wright 2010) 
5’ PML-II shRNA 5-CCGG CATCCTGCCCAGCTGCAAATT CTGAG TTTGCAGCTGGGCAGGATGTT TTTTTG-3’ 
5’ EXON-3 shRNA 5-CCGG GAGCTCAAGTGCGACATCATT CTGAG TGATGTCGCACTTGAGCTCTT TTTTTG-3’ 
5’ Scrambled.DNA5-CCGG GAGCCGGACGCCAAAGAAATT CTGAG TTTCTTTGGCGTCCGGCTCTT TTTTTG-3’ 
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Following AgeI digestion the product was extracted using PCR extraction kit then 
was digested again with EcoRI (Fig.3.3.A). The second digestion was to remove the 
stuffer and leaving the blunt ends which would facilitates ligating the shRNA 
constructs into the blunt ends. Two bands were visualised by UV light, the small and 
large bands were very well distinguished from each other and from the undigested 
plasmid which appeared as one big smear. The larger one (7kb) was removed and 
then was ligated with annealed oligonucleotides and used to transform DH5α E. 
coli. Positive clones containing PML-II shRNA, exon-3 shRNA and Ctrl. Potentially 
positive shRNA plasmids were identified by size in agarose gel (about 9 kb) and 
confirmed by DNA sequence using PLKO.1 TRC vector primers (Fig.3.3.B and C). 
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Fig.3.3. Agarose gel electrophoresis of the intact, double digested and recombinant 
PLKO.1 cloning vector. A. lanes 1 and 2 are the linearized  PLKO.1 two separate double 
digestion reactions with AgeI and EcoRI, lane 3: the whole circular PLKO.1  plasmid, markers 
indicated are 1.5 and 0.5 kb. B. From left to right: 1kb ladder, the undigested PLKO.1, the 
large segment of double digested PLKO.1, 1 and 2 positive selected clones and lane 3 is the 
PML-II shRNA clone. C. From left to right: 1 kb ladder; 1 and 2 uncut plasmid; 3, 4, 5 and 6 
are different positive selected clones, 7 and 8 are Exon3 and Ctrl. shRNA clones 
respectively.    
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3.2.3 Characterising Exon 3 stable knockdown cells 
 
In order to determine the concentration of puromycin that would give effective 
selection, standard HeLa cells were plated and exposed to an increasing dose of 
puromycin (1 to 10 µg/ml), the percentage of killing was monitored each 24 hours. 
The minimal killing concentration was 3µg/ml as it was the dose that killed the cells 
within 2 days. This concentration was adopted as the standard to differentiate the 
lentiviral infected (transduced) cells from the un-transduced cells for all the 
upcoming experiments. Samples were collected at 3, 9 and 14 days after 
transduction with PML, PML-II and Ctrl shRNAs to analyse the efficiency of 
knockdown by RT-qPCR and western blotting. The 3 day analysis didn’t show any 
physical or functional sign of PML removal as the mRNA and protein accumulation 
was equal in the exon3 and the Ctrl. DNA transduced cells (data not shown). 
However, quantitative RNA analysis by RT-qPCR after 9 days of selection showed 
more or less 80 % reduction in the total PML mRNA level (Fig.3.4A). Another control 
cell line was constructed by transducing the target HeLa cells with an shRNA 
targeting an irrelevant  gene (GFP) and the knockdown effect analysis was repeated 
with the newly selected cells and at the same time points after selection, when the 
knockdown started to emerge. PML expression was knocked down to about 50% in 
PML Kd cells compared to the new control cells (Fig 3.4. B). 
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Fig.3.4. Characterising the physical removal of PML RNA in PML Kd cells in comparison 
with Ctrl.DNA and GFP Kd control cells by RTqPCR. PML Kd, Ctrl.DNA and GFP Kd cells 
were seeded at a density of 1×10
5
 /ml for 24 hours. RNA samples were extracted from each 
cell type, total PML mRNA was quantified by RT-qPCR using 10 ng/well of complementary 
analysed DNA (cDNA) as a template. Data were calculated by the ∆∆Ct method, using 
GAPDH as internal control, and then normalised to the control cell value. All PCR products 
were subjected to dissociation curve analysis to ensure primer specificity. A. Total PML 
depletion in PML Kd in comparison with Ctrl.DNA control cells. B.  Total PML removal in 
PML Kd in comparison to GFP Kd control cells. 
 
3.2.3.1 PML depletion affects the NF-kB signalling pathway 
Treating cells with TNF-α can induce the NF-kB signalling pathway and IL-6 mRNA 
expression (Kurokouchi et al., 1998). That means NF-kB induction by TNF-α 
treatment could induce IL-6 expression and other cytokines in the cells, thus 
removing total PML would decrease the expression of IL-6 which is one of the 
functional effects of removing total PML proteins. To analyse the functional effect 
of PML removal on the response to TNF-α treatment, PMLKd and Ctrl.DNA cells 
were treated with 100 ng/ ml of TNF-α for 1 hour, then the effects of PML removal 
was determined by comparing the level of IL-6 by RT-qPCR. As expected the level of 
IL-6 mRNA was reduced significantly in PML Kd in comparison with Ctrl.DNA (Fig 
3.5.A)  
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The level of NF-kB response has been also measured in comparison with a different 
control cell line, GFP Kd. This control cell line was made by using the same lentiviral 
transduction approach to express an shRNA targeting GFP. There was a drastic 
decrease in IL-6 mRNA expression in PML Kd cells at both stimulated and un-
stimulated levels (Fig.3.5.B). 
 
Fig.3.5. Characterising the functional effect of removal of PML on NF-kB. PML Kd  , 
Ctrl.DNA and GFP Kd cells were seeded at a density of 1×10
5
 /ml for 24 hours. Prior to 
harvesting RNA samples, cells were treated with 100ng /ml of TNF-α for 1 hour . RNA 
samples were extracted from each cell type, total IL-6 mRNA was quantified by RT-qPCR 
using 10 ng/well of complementary DNA (cDNA) as a template. Data were analysed by the 
∆∆Ct method, using β-actin as the internal control. All PCR products were subjected to 
dissociation curve analysis to ensure primer specificity A. IL-6 mRNA level in PML Kd  in 
comparison with Ctrl.DNA control cells; the values were normalised to the control cells. B. 
IL-6 mRNA level in PML Kd in comparison to GFP Kd control cells; values were normalised to 
the unstimulated GFPKd cells value. 
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3.2.3.2 Total PML protein expression was affected by exon3 permanent 
knockdown 
At the protein level and to further confirm the removal of total PML proteins, two 
weeks post puromycin selection PML Kd and Ctrl.DNA cells were either lysed for 
WB or  stained to visualise the PML by IF techniques. WB analysis showed a level of 
reduction in expression of all PML-related bands, however this was not dramatic 
(Fig.3.6.A). The knockdown affected all the PML isoforms to some extent. The effect 
was weakest on the major PML band (PMLI/II) which is around 130 kDa and 
increased in strength with the lower molecular PML isoforms, including smallest 
one (around 55 kDa), which is believed to be a PML-II related band. This could be 
expected as the 130 kDa bands are the most abundant ones and they are expressed 
higher level than the rest of the PML isoforms. PML-I in particular is the most 
abundant and conserved isoform which might be essential for PML’s various 
functions in the cell (Condemine et al., 2006). This is consistent with a study by 
(Chang et al., 2013), who showed a significant level of total PML knockdown using 
two different siRNAs when they normalised their data to the loading control. 
However one siRNA showed efficient knockdown though a significant level of 
detectable PML expression. The other possible reason here is the single target 
shRNA within exon 3 region was used rather than a pool of sequences, this could 
possibly give less efficient binding. Many companies recommend using more than 
one target within the same gene sequence to PML mRNA ensure an effective 
reduction in the target gene mRNA (Smith, 2006). Levels of RNA and proteins in the 
cells were previously considered as reflective of each other.  However, recently 
using proteomic and next generation sequencing techniques, it has been found that 
there can be a big difference in the ratio of RNA and protein levels inside the cells. 
One reason for that is the half- life of mRNA and protein may be totally different as 
the latter is typically 5 times more stable than the RNA. Although there is a high 
correlation between mRNA and protein levels, on average there are approximate 
2800 times more protein copies than its corresponding transcripts. The average 
rate of translation in mammalian cells also exceeds the rate of mRNA synthesis. It 
has been found that a protein is translated at a rate of 140 per mRNA per hour 
while mRNA is transcribed in a rate of two molecules per hour in cells 
78 
 
(Schwanhausser et al., 2013). However, confocal imaging of a population of PML Kd 
and Ctrl.DNA cells showed a relatively efficient decrease and diffuse staining of PML 
proteins inside the nucleus (Fig.3.6.B). The number of PML –NB was apparently 
greater, brighter and well distinguished in the Ctrl.DNA cell compared to the PML 
Kd cells.   
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Fig 3.6. Characterising the removal of PML at the protein level. A. PML Kd  and Ctrl.DNA cells were seeded at a density of 1×105 /ml for 24 hours. Protein 
samples were collected by 1xSB, total PML proteins were probed using specific anti-PML antisera. The protein sizes were indicated relying on migrating 
known- molecular sizes protein (kDa) on the left. B. PML Kd and Ctrl.DNA cells were grown at a density of 2.5×105 /ml for 24 hours, fixed with 10 % 
formaldehyde and then stained with anti-PML polyclonal antibodies (primary) and detected with Alexafluor 594 goat anti-rabbit IgG (H+L) (red). Nuclei 
(blue) were visualised with DAPI. Images were taken by confocal immunofluorescence microscopy; those shown are representative of around 8 photos 
taken for each field. 
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3.2.3 Characterising stable PML-II knockdown cells 
In parallel with the creation of PML Kd cells, experiments were also done to 
generate and to characterise the depletion of PML-II from HeLa cells. Cells were 
infected with shPML-II lentiviral particles for 24 hour and then subjected to 
puromycin selection. The same selective concentration of puromycin was applied to 
select PML-II Kd cells. The analyses of effectiveness of knockdown were 
accomplished at the same time interval (3, 9 and 14 days) post selection when 
samples were collected for both RNA and protein analysis. The best RNA physical 
and functional knockdown was again at 9 days while the protein effect was 
detected at 14 days post selection. PML-II expression level showed an 
approximately 60% decrease in comparison with its level in Ctrl.DNA cells 
(Fig.3.7.A). This level of decline in PML-II expression was very consistent with the 
results that were obtained from the transient knockdown in human lung fibroblast 
cells (MRC5), using the same sequence of shRNA as used in siRNA for transient 
knockdown to interfere with PML-II expression (Fig.3.7.B). This constancy in level of 
knockdown between two different cell lines validates the knockdown effect in the 
newly constructed PML-II Kd cells.  As a consequence of that reduction in PML-II 
expression, the NF-kB activity was diminished to about 10% of its normal level. This 
was evaluated by measuring IL-6 after stimulating the cells with 100ng/ml TNF-α for 
1 hour (Fig.3.7C).  
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Fig.3.7. Characterising the physical and functional effect of PML-II removal quantitatively 
by Real Time qPCR. PML-II kd, Ctrl.DNA and MRC5 cells were seeded at a density of 1×10
5
 
/ml for 24 hours. In characterising the knockdown effect on NF-kB signalling pathway, prior 
to harvest RNA samples, cells were treated with 100ng /ml of TNF-α for 1 hour to quantify 
IL-6 mRNA. RNA samples were extracted from each cell type, total PML-II and IL-6 mRNA 
were quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. 
Data were presented by the ∆∆Ct method and then normalised to the control cell value. All 
PCR products were subjected to dissociation curve analysis to ensure primer specificity. A. 
PML-II mRNA level in PML-II Kd in comparison with Ctrl.DNA control cells, data were 
normalised to GAPDH. B. Transient knockdown in MRC5 cells, PML-II level in MRC cells in 
comparison to siC, data were normalised to 18S RNA as internal control. C. IL-6 mRNA 
expression in PML-II Kd and Ctrl.DNA and results were normalised to GAPDH. 
 
To further confirm the RNA quantitation data, PML-II protein expression in PML-II 
Kd cells was measured by western blotting and IF techniques. Consistent with the 
RNA data there was an obvious reduction in a PML-II related protein band by 
Western blotting (Fig.3.8.A) and the appearance of bright stained nuclear PML- foci, 
detected by PML-II specific antibody, was also reduced (Fig.3.8.B).  
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Fig 3.8. Characterising PML-II removal at the protein level. A. PML-II Kd  and Ctrl.DNA cells were seeded at a density of 1×105 /ml for 24 hours. A. Total 
protein extracts were prepared and analysed by Western blotting using specific anti-PML peptide antisera. The positions to which proteins of known 
molecular mass migrated are indicated on the left (kDa). B. PML Kd and Ctrl.DNA” cells were grown at a density of of 2.5×105 for 24 hours  and then 
processed for immunofluorescence using anti-PML polyclonal antibodies and Alexafluor 594 goat anti-rabbit IgG (H+L) (red). Nuclei (blue) were visualised 
with DAPI. Images were taken by confocal immunofluorescence microscopy an average of 8 photos were taken for each field.  
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3.2.3.1 Effect of PML-II depletion on type I interferon 
 
It is well known that PML is an IFN- up-regulated gene. Type I and type II IFN 
treatment increases the mRNA and protein level of PML in HeLa S3 cells after 2 
hours of treatment. This augmentation has been detected at the transcriptional 
level and is regulated by the transcription factor ISGF3 (Grotzinger et al., 1996). 
Actually this transcriptional connection between IFN and PML expression is of 
special importance in achieving the antiviral response that is exhibited by PML. PML 
physically fixes the HFV-trans-activator in a way that blocks the latter from binding 
with the viral DNA, here reducing viral replication. A similar decrease in HFV 
replication could be obtained only by treating the cells with IFN but not in PML-null 
cells, which emphasizes the role of PML in the IFN antiviral function  (Regad, 
2001b). Very recent data have established a role for PML proteins in IFN 
transcription. PML- null human fibroblast cells show down-regulated ISGs 
expression when pre-treated with IFN-β or UV attenuated HCMV (Kim and Ahn, 
2015). Among PML isoforms, PML-II has a role in the reduced transcription in a type 
I interferon response. It was displayed that this isoform particularly participated in 
the active binding of NF-kB, STAT1 and CBP with IRF3 to the IFN-β promoter (Chen 
et al., 2015). Hence PML-II Kd cells should show a decrease in ISG56 expression and 
in order to verify this, both PML-II kd and Ctrl.DNA cells were plated for 24 hours 
and stimulated with 1 µg of Poly I:C to increase the level of interferon in both types 
of cells. As expected, the level of ISG56 mRNA, one of the Interferon stimulated 
genes (ISGs), was reduced to about 50% in PML-II Kd cells in comparison with the 
control cells (Fig.3.9). 
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Fig.3.9. ISG56 mRNA level in PML-II Kd and Ctrl.DNA cells. PML-II Kd and Ctrl.DNA cells 
were seeded at a density of 1×105 /ml for 24 hours. Cells were treated with 1µg/ml of Poly 
I:C for 16 hours. RNA samples were extracted from each cell type, total  ISG mRNA was 
quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data 
were presented by the ∆∆Ct method and then normalised to the control cell value. All PCR 
products were subjected to dissociation curve analysis to ensure primer specificity. Results 
were normalised to GAPDH as an internal control.  
To summarize, and from all RNA and protein analyses that were accomplished, PML 
Kd  and PML-II Kd cells exhibited a good level of physical and functional knockdown 
of the target genes. This was the base to start in the next part of work by 
investigating the sensitivity of these cells to be infected by adenovirus. 
3.3 Assessing Ad5 wt300 infection in the presence and absence of PML  
A key objective was to study the effect of PML depletion on Ad5 infection. All the 
cells (PML Kd, PML-II kd and Ctrl.DNA) were plated out, infected with wt300 for 20 
hours with multiplicity of infection of 5 and analysed for the outcome of the 
infection. Unexpectedly, since this moi is sufficient to infect standard HeLa cells 
efficiently, the Ctrl.DNA cells showed no sign of infection while the other two cell 
types showed an acceptable level of infection. Hexon, which is the main late 
structural viral protein, was completely absent from the Ctrl.DNA  sample while it 
was expressed well in PML-II Kd cells and to a lesser extent in PML Kd cells 
(Fig.3.10.A). On the other hand GAPDH, which was the loading control in this 
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experiment, was expressed from all samples indicating that the deficiency in 
expression was particular to the viral proteins not because of an error in loading 
process or less protein in this particular harvest. This situation suggested increasing 
the moi to 50 to boost the level of infection and in fact this high dosage did infect 
the cells to a level that could be acceptable to compare the outcome of the 
infection among cells (data not shown). However, this high level of infection could 
also interfere with the accuracy of the analyses as many phenomena could 
disappear or be altered with the high dose of particles that the cell would receive. 
The overall conclusion from this was that the Ctrl.DNA cells were not amenable to 
be the control cell line with which to compare the outcome of infection. 
After the discovery of  gene silencing by siRNA or shRNA there were many 
publications that pointed to siRNA or shRNA interference with different cellular 
pathways and in particular the innate immune response. Some siRNAs and gene-
target shRNAs could increase the innate immune response to similar levels as the 
stimulation with poly I:C does. It has been proved in certain kinds of cells like 
porcine fetal fibroblasts that the scrambled siRNA and shRNA increased the 
expression of IFN-β and 2'-5'-oligoadenylate synthetase 1 (OAS1) to about 10 to 15 
times more in quantitative PCR assay respectively (Stewart et al., 2003). To 
investigate the possibility of Ctrl.DNA cell having a high level innate immune 
response they were stimulated with 1µg/ml of Poly I:C for 16 hours in comparison 
with standard HeLa cells then the level of ISG-56 was quantified by RT-qPCR. It was 
obvious that the innate immune response was nearly twice higher in Ctrl.DNA cells 
compared to the standard HeLa cells (Fig3.10.B). This could be a reason for the poor 
infectivity of the Ctrl.DNA cells as the interferon response is mainly mounted by the 
cells to suppress the viral infection. 
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Fig.3.10. Evaluating the infectivity level of the transduced cells and level of interferon 
stimulated cells in control cell lines. A. Western blotting analysis of Adenovirus late gene 
expression in PML-II Kd, PML Kd and Ctrl.DNA cells. Cells were seeded at a density of 1×10
5
 
/ml for 24 hours, infected with wt300 at moi=5 and protein samples were collected with 
1SD Laemmli buffer. Samples were probed with anti- late adenovirus polyclonal antisera 
from which the hexon while GAPDH is shown below as a loading control. B. ISG56 
expression in PML-II kd and Ctrl.DNA cells.  Prior to collecting samples, cells were treated 
with 1µg/ml poly I:C for 16 hours. RNA samples were extracted from each cell type, total 
PML-II and IL-6 mRNA were quantified by RT-qPCR using 10 ng/well of complementary DNA 
(cDNA) as a template. Data were presented by the ∆∆Ct method and then normalised to 
the control cell value. All PCR products were subjected to dissociation curve analysis to 
ensure primer specificity. A. PML-II mRNA level in PML-II Kd in comparison with Ctrl.DNA 
control cells, data were normalised to GAPDH. 
 
This poor infectivity of Ctrl.DNA cells was the reason to start to make new control 
cell lines which could show a comparable level of infection to the standard HeLa 
cells, in order to allow a study of the role of PML and PML-II in the viral life cycle 
under normal and stress conditions. GFP Kd and EV cells were made using the GFP 
shRNA insert and the empty PLKO.1 vector respectively.  
The level of late viral gene expression was compared in those three control cell 
lines with moi of 5. The two new control cell types showed good levels of late viral 
protein while Ctrl.DNA cells didn’t show any late protein expression (Fig.3.11.A). 
Whilst late protein was detected in both GFP Kd and EV cells, expression was 
greater in GFP Kd cells. To determine which of these cell types matched best the 
infectivity of standard HeLa cells, viral gene expression was compared in standard 
HeLa, GFP Kd and EV vector. As expected, GFP Kd and EV cells showed an 
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acceptable level of infection (Fig.3.11.B). Although EV cells showed roughly similar 
expression in standard HeLa cells, GFP Kd cells showed more late gene expression 
(Fig.3.11.C). Finally, to assess relative growth ability the different cell lines were 
counted frequently and both EV and HeLa cells showed faster level of growth than 
all the rest cell types despite HeLa cells showed the quickest growth rate among 
them. However, PML-II Kd in particular had showed the slowest level of division 
although the cells appearing healthy (Fig.3.11.C and D). In a separate experiment 
and in the context of optimising the conditions before starting in the next stage of 
work, for the purposes of transient knockdown of other genes, two control siRNAs 
were evaluated in their ability to trigger the NF-KB signalling pathway in EV cells.  
The basal level of IL-6 was measured in EV RNAs, which were left without treatment 
or treated with siC1 or siC2 for 48 hours. It was clear that siC1, the sequence of 
which was used in making Ctrl.DNA cells, has the ability to trigger NF-kB activity 
compared to the other control and the untreated samples (Fig.3.11.E). 
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Fig.3.11.Comparing the viral late gene expression in control cell lines. A. Ad5 wt300 late 
gene expression in Ctrl.DNA EV and GFP Kd
 
cells. Cells were seeded at a density of 1×10
5
 
/ml for 24 hours, infected with wt300 at moi=5 and protein samples were collected with 
1xSB Laemmli buffer. Samples were probed with anti- late adenovirus polyclonal antisera. 
The “upper” hexon and fiber expression while “lower” is GAPDH expression and a loading 
control.B. Ad5 wt300 late gene expression in  EV, GFP Kd and standard HeLa cells PML-II Kd, 
EV and Hela morphology under microscopy. C. PML-II Kd, EV Hela cells morphology under 
microscopy. D. Average of PML-II, EV and HeLa cell growth over repeated experiments. E. 
Levels of IL-6 mRNA in EV cells which were transfected with two types of scrambled DNA C1 
and C2. 
3.4 Evaluation of PML-II Kd cells in comparison with GFPKd and EV 
control cells  
To evaluate the state of PML knockdown in PML-II Kd cells in comparison with the 
newly selected control cells, PML-II and IL-6 mRNA expression were evaluated in 
PML-II Kd, GFP Kd and EV cells. Consistent with the previous analyses PML-II Kd cells 
again showed physical loss of PML-II and its functional effects. The knockdown 
efficiency was about 60%  and 50% in  comparison with GFP Kd and EV cell lines  
respectively (Fig.3.12.A&B) but the functional effect  in comparison with the EV was 
not as strong as when PML-II kd was compared to the Ctrl.DNA  and GFP Kd cells   
(Fig3.12.C&D and Fig.3.7.C). 
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Fig.3.12. Characterising the physical and the functional effect of PML-II removal I in PML-
II Kd cells in comparison with the GFP and EV cells. PML-II Kd, GFP Kd
 
and EV cells were 
seeded at a density of 1×10
5
 /ml for 24 hours. For characterising the effect on NF-kB 
signalling pathway, prior to harvest RNA samples, cells were treated with 100ng /ml of TNF-
α for 1 hour. RNA samples were extracted from each cell type, total PML-II and IL-6 mRNA 
were quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. 
Data were analysed by the ∆∆Ct method and then normalised to the control cell value. All 
PCR products were subjected to dissociation curve analysis to ensure primer specificity. 
A&B. PML-II expression in PML-II Kd, GFP Kd
 
and EV. C&D. IL-6 expression in PML-II Kd, GFP 
Kd
 
and EV. Data normalised to GAPDH in case of GFP Kd
 
and to β-Actin in case of EV cells as 
house-keeping genes. Data show a significant decrease in PML-II mRNA and IL-6 mRNA in 
PML-II Kd cells (*P<0.05, n=3). 
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The most likely explanation for the difference in effect is the difference in the 
number of passages between those two analyses. The first analysis with GFP cells 
was achieved many passages earlier than the other one with EV, alongside the 
same PML-II Kd cell batch. This could create a difference in the knockdown 
efficiency in terms of knockdown itself or the functionality of it. In general, cells 
may gradually lose the knockdown with increasing number of passages. Cells were 
selected as a mixed population and not as single clones, and with this type of 
selection and especially if the down-regulated gene causes growth defects (in this 
case the PML-II Kd cells showed typically a 30-40% slower growth rate, then the 
knockdown cells will be easily outgrown by any cells that evolve to lose knock-down 
whilst retaining puromycin resistance. Within the same heterogeneous population 
it is possible to find cells which show the antibiotic resistance but no functional 
shRNA expression as the promoters that drive the two characters are not firmly 
linked (Schuck et al., 2004). 
As was mentioned before, transient PML-II removal substantially decreased the 
IFN-β response (Chen et al., 2015). The level of interferon response in PML-II Kd 
cells in both mock and infected conditions was therefore measured. As expected, 
the PML-II Kd cells showed a lower basal level of ISG56 mRNA in comparison with 
the EV cells and at two time points, 8 and 20 hours post infection with HAdv5 
wt300, PML-II Kd cells displayed a deficient interferon response (Fig.3.13). 
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Fig. 3.13. ISG56 expression level in mock and infected PML-II Kd and EV. RNA samples were extracted from each cell type, total  ISG56 and IL-6 mRNA were 
quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were analysed by the ∆∆Ct method and then normalised to the 
control cell value. All PCR products were subjected to dissociation curve analysis to ensure primer specificity.A.  ISG56 in PML-II Kd mock infected and EV.B. 
ISG56 mRNA levels in PML-II Kd and EV 8 hours post infection. C. ISG56 mRNA levels in PML-II Kd and EV 20 hours post infection.  
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3.5 HSP70 expression in all cell lines 
 
HSP70 is one of the heat shock protein family which is induced under different 
chemical or physiological stresses. HSP70 helps in folding the mis-folded proteins 
that arise. One of the early observations that were made about the profile of gene 
expression in PML-II Kd cells was the elevated level of hsp70 (Fig.3.14 A&B). 
 
Fig.3.14. HSP70 expression in PML-II Kd, HeLa, Ctrl.DNA and EV cell lines. PML-II Kd, HeLa, 
Ctrl.DNA and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours. RNA samples 
were extracted from each cell type, total PML-II and IL-6 mRNA were quantified by RT-qPCR 
using 10 ng/well of complementary DNA (cDNA) as a template. Data were presented by the 
∆∆Ct method and then normalised to the control cell value. All PCR products were 
subjected to dissociation curve analysis to ensure primer specificity. A. HSP70 expression in 
PML-II Kd HeLa and Ctrl.DNA, data were normalised to GAPDH as an internal control. B. 
HSP70 expression in PML-II Kd and EV cells, data were normalised to 18S RNA. Primers are 
specifically detecting the heat shock 70 kDa 1A/1B. Data shows significant increase in hsp70 
mRNA in PML-II Kd cells (*P<0.05,n=3). 
 
This increase was specific for the hsp70 protein and its related isoforms, highly heat 
shock inducible genes HSPA1A/1B, that were not distinguished by qPCR primer pair 
used, since other members of HSP70 (HSPA) family, A5 and A6 were not induced by 
absence of PML-II and neither was a member of another HSP family, HSP60. Using 
primers that distinguished HSPA1A and HSPA1B, it was clear that the induction by 
PML-II loss was highly specific for HSPA1B. However, in Ad5 wt300 infected PML-II 
Kd cells for 20 hours and at moi of 5, PML-II Kd cells showed again significant 
elevated levels of HSP70 and HSP70A1B was expressed much higher than the other 
two tested isoforms of HSP70 (Fig.3.15B). Presenting the data as fold induction of 
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each hsp70 isoform in PML-II Kd and EV cells showed that hsp70A1b had the 
highest level of induction in PMl-II Kd cells compared to its level in the control cells. 
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Fig.3.15. Expression of heat shock mRNAs in PML-II Kd and EV cell. PML-II Kd, and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours. RNA samples 
were extracted from each cell type, total PML-II and IL-6 mRNA were quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. 
Data were presented by the ∆∆Ct method and then normalised to the control cell value. All PCR products were subjected to dissociation curve analysis to 
ensure primer specificity. A. HSPA/B1, HSPA1A, HSPA1B and HSP60 expression in un-infected cell Data were normalised to GAPDH. B. HSPA/B1, HSPA1A, 
HSPA1B and HSP5 in RNA  from cells infected for 20 hours with wt300 at moi of 5, data were normalised to β-actin. C. Fold change induction of the increase 
in each gene in PML-II Kd / EV cells. 
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Levels of HSP70 vary according to the cell line under the study. HeLa cells have 
more expression of hsp70 than many other cells under induced or un-induced 
conditions except HEK 293 (Imperiale et al., 1984) which expresses even more 
hsp70 due to that fact that they were immortalised by adenovirus E1A which is a 
known inducer of HSP70 transcription (Nevins, 1982). This level of un-induced 
hsp70 is controlled by the stage of the cell cycle which is also well reflected in 
adenovirus gene expression. For example in mouse F9 teratocarcinoma cell line (F9 
stem cells), upon differentiation the cells restrict E1A expression which is 
accompanied by shut off  hsp70 expression (Imperiale et al., 1984). Another study 
which showed the induction of hsp70 by Ad5 infection of HeLa cells, showed a high 
level of 70K heat shock protein which was induced in harmony with the expression 
of E1A since it disappeared in E1A-deficient Ad5 mutant dl312 – infected HeLa cell. 
The increased hsp70 reached up to 100 fold greater levels than its level pre-
infection, while it increased only two fold in the absence of E1A expression. This 
hsp70 induction was at the transcriptional level and was controlled by E1A (Kao and 
Nevins, 1983, Nevins, 1981) 
A possible explanation of the elevated levels of hsp70 is the chaperone function of 
PML and HSP70. In mouse embryonic stem cells (ES) it has been found the PML 
represents the required platform to enable the DAXX /α-thalassemia mental 
retardation X-linked (ATRX) complex to function in maintaining telomere chromatin 
integrity. Simply, PML achieves that via being the physical podium where all the 
proteins that are involved in histone methylation form (Chang et al., 2013). As a 
way to compensate that deficiency in chaperone function inside the cells in which 
total PML is removed, the cell starts to up-regulate hsp70 expression because of the 
importance of the latter in preserving the correct function of the telomeres. Hsp70 
and co-chaperone protein CHIP ( C- terminus of HSC interaction protein) bind to 
hTERT( human telomerase reverse transcriptase) to ubquitinate it and thus direct 
its proteasomal degradation (Lee et al., 2010). 
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3.6 PML- II stable knockdown in 293 HEK cells 
In a trial to transduce another cell line with lentiviral shRNA vectors, Human 
Embryonic Kidney (HEK) 293 cells were chosen as the target for PML-II removal. 
This transduction was accomplished mainly to further confirm the effect of PML-II 
on the innate immune response. The same PML-II shRNA lentivirus transduction as 
applied to HeLa cells was used here. The 5- day analysis of the knockdown and its 
functional consequences showed a substantial decrease in PML-II mRNA, reaching  
about 90% (Fig.3.16 A ), accompanied by a similar reduction in interferon response  
which is represented by a decrease in ISG56 mRNA (Fig.3.16.B). Thus lentiviral 
shRNA transduction can successfully disrupt PML-II function in multiple cell types. 
This could be a good reason to generalize the role of PML-II in the innate immune 
response and to conclude the real function of this gene in the adenovirus life cycle.  
 
 
Fig.3.16. PML-II and ISG56 expression in 293PML-II Kd and 293Ctrl.DNA cells. 293PML-II 
Kd and Ctrl.DNA 293 cells were seeded at a density of 1×10
5
 /ml for 24 hours. RNA samples 
were extracted from each cell type, total  PML-II and ISG56 mRNA were quantified by RT-
qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were analysed 
by the ∆∆Ct method and then normalised to the control cell value. All PCR products were 
subjected to dissociation curve analysis to ensure primer specificity and normalised to 
GAPDH as house-keeping gene. A. PML-II expression. B. ISG56 expression  
 
 As this study is concerned with defining the role of PML-II in the Ad5 life cycle, HEK 
293 cells were excluded from this study despite the fact they support Ad growth 
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efficiently. HEK293 cells are immortalised by the Ad5 E1A oncoprotein which has a 
critical role in viral early and late gene expression and might therefore compromise 
the results.  Thus the next part of this work will focus on using HeLa cells are fully 
competent cells in supporting Ad5 infection.   
3.7 Discussion 
Lentiviral shRNA transduction which was employed in this study has allowed 
establishment of the HeLa cells in which  target genes (PML and PML-II) were 
permanently knocked down. This means that the main goal of this part of the 
project was achieved. The stable PML-II Kd and PML Kd, with EV cells, as control 
cells are suitable and completely amenable to analyse the outcome of Ad5 infection 
and to define the suggested role of PML and PML-II in virus life cycle. The 
knockdown system and its significant functional effects on the innate immune 
response was efficient and it was used in the transient knockdown in HeLa cells and 
in other tumour and normal cells like HEK293 and MRC5 cells which have been  
tested in this study or in different projects by other current and previous members 
in the group. 
The more profitable aspects from this kind of knockdown alongside its functional 
effects is the consistency over different experiments. Treating a bulk of cells which 
display the same knockdown characteristics reduced the probability of transient 
knockdown failure in one experiment as compared to another one. In addition, the 
experiments were achieved in less time (2 days quicker) than the transient 
knockdown. In addition as this project includes working with stress, this system 
reduced the consequences that could arise from adding the transient knockdown 
reagents (siRNA and lipofectamine) to the cells which is another kind of stress 
(Fig.3.11 D&E). Finally, and in order to attain quantitative data, it was easier to grow 
the cells to any culture size to analyse quantitatively by FACS. 
Experience from working with such kinds of cells and knockdown system suggested 
many considerations and further steps which should be incorporated during 
experiments. An important observation was that knockdown cells grew at a slower 
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rate than the control cells. This is possible and expected as many genes are 
important for cell growth, division and proliferation and PML in particular interacts 
with other proteins which are important in cellular proliferation. In order to make a 
fair comparison in all analyses it was necessary to compare an equal number of 
knockdown and control cells. In each single experiment, knockdown and control 
cells were counted at the day of plating out, then at infection and harvesting and 
the number of viral particles used for infection corrected according to the number 
of cells in each sample, measured in parallel wells that were made for purposes of 
counting only. Slower growth was a source of another critical consideration, the 
gradual loss of knockdown efficiency over number of passages. Over a wide range 
of selection experiments it was noticed that the knockdown starts to weaken over a 
number of passages that ranged from 10 to 22, with some exceptions which 
showed shorter or longer duration of sustained knockdown. This might depend on 
the percentages of the transduced cells that show a real functional knockdown in a 
bulk of selected cells, or could be attributed to the amount of the viruses that the 
cells were infected with. As mentioned before, removing PML-II caused a slowdown 
of growth in the knockdown cells and this resulted in a reduced number of cells that 
showed a real functional knockdown compared to those that displayed puromycin 
resistance only. 
Shown below (Fig.3.17) is an example of this gradual decline in the knockdown 
phenotype of cells were selected on 22/02/2015 and grown until 18/05/2015.  This 
bulk of selected cell showed 70% knockdown at the first analysis after puromycin 
selection. Gradually, the efficiency of knockdown started to drop over time and 
reached 30% after 8 weeks since the first selection. This weakening was well 
reflected in the biological effect and also in terms of the effects of the knockdown 
genes in the virus life cycle. This situation was the reason to establish a periodic 
knockdown analysis at the RNA level to make sure that there was a reasonable 
knockdown at the time of doing any experiment. 
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Fig.3.17. PML-II expression in PML-II Kd and EV cells over 8 weeks. Cells were seeded at a 
density of 1×10
5
 /ml for 24 hours. RNA samples were extracted from each cell type, total 
PML-II were quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a 
template. Data were analysed by the ∆∆Ct method and then normalised to the control cell 
value. All PCR products were subjected to dissociation curve analysis to ensure primer 
specificity and normalised to GAPDH as house-keeping gene.  
 
In order to keep the work continuously effective and to provide a good platform to 
do the corresponding analyses, large amounts of the shRNA-lentivral particles were 
prepared as stock and when the level of knockdown started to decline a new 
parallel selection was made. This substantial supply of shRNA-lentiviral selection 
was not only required because of the declining level of knockdown during passage 
but also to avoid the sudden loss of knockdown for some batches of cells when they 
were grown after storage in liquid nitrogen.  
In general, freshly selected knockdown cells did not readily show the knockdown 
effect; it seems they need time to build up and express the shRNA to produce its 
effect and in this study the time required was about 9 days. Also the cells needed to 
be released from puromycin selection at least 24 hours before doing any biological 
experiment with them. The best results were obtained by releasing cells for 3 days 
before infecting, or transfecting cells or applying any other biological treatment. It 
is worth mentioning here that these cells were very sensitive to even mild changes 
in their environment. Thus, it was necessary to keep the conditions stable as much 
as it is possible. 
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As controls are critical for any biological experiment, the challenge was to choose 
the right control cell type for comparison with PML-depleted cells. The required 
control was required to behave very similarly to the standard HeLa cells while at  
the same time they are genetically modified. In this project, empty vector cells, 
which were made from filling the overhangs in PLKO.1 vector, were the best choice 
as they showed closer growth rate and comparable level of virus infection to HeLa 
cells. 
Despite all these difficulties which were mentioned earlier, the substantial 
biological effect of the knockdown of PML that arose from heterogeneous 
population of selected cells was very convincing and provided a solid start for 
verifying the role of PML-II in the Ad5 life cycle at both normal and stressed 
conditions. 
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Chapter4: Role of PML-II in the adenovirus life 
cycle at 37  ̊C 
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4.1 Introduction 
PML-II is a human PML isoform, the unique part of which is encoded by exon 7b, 
with a molecular weight around 130 kDa. PML-II contributes to PML-NBs but has a 
very distinctive pattern of localisation inside the nucleus when it is overexpressed, 
being relocated in the area very close to the inner nuclear membrane. PML-II has 
been found to play  an important role in the cellular immune response as its 
removal by siRNA interference reduces the IFN-β levels produced in response to 
stimuli (Chen et al., 2015). It was also shown that this particular isoform restricts 
the growth of some viruses. For example, PML-II overexpression inhibits adeno-
associated virus (AAV) transduction about 5 fold in comparison with the other 
overexpressed PML isoforms which succeeded in reducing this transduction only 2 
fold (Mitchell et al., 2014).  
In another example, PML-II and PML-I overexpression in PML-depleted cells can 
restrict ICP0-null mutant HSV replication efficiency. ICP0 is the viral protein that 
disrupts PML function and ICP0-null mutant HSV plaque formation was increased 
significantly in PML-depleted cells and overexpressing PML-I and PML-II reduced 
plaque formation to 50%. This suggests that PML-II might interact with other 
cellular repressive factors to prevent infected cells from entering the lytic cycle 
(Cuchet et al., 2011). Another interesting observation linking PML-II with antiviral 
effects is that HSV specifically down regulates its expression. After 3 hours of HSV 
infection, it was noted that the levels of PML-II mRNA and protein foci were 
reduced. This reduction was occurred in parallel with increased retention of PML 
intron 7a in mRNA. This change switches the encoded protein isoform from PML-II 
to PML-V (Nojima et al., 2009). This effect was attributed to the expression of ICP27 
which works as an alternative splicing regulator. This alteration in PML splicing 
pattern is of crucial importance in ensuring a successful viral infection especially 
since ICP27 is an immediate early protein and this could be a strategy developed by 
the virus to overcome the immediate innate immune response and interferon 
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response (Nojima et al., 2009). This proposal is supported by the fact that the PML-
II isoform is necessary to induce the interferon response (Chen et al., 2015). 
4.1.1 PML-II and Adenovirus infection 
 
There is a clear evidence for a link between Ad5 infection and expression of the 
PML-II isoform. It is well-known that Ad5 infection causes disruption in PML –NB 
morphology as they redistribute into thread- like structures rather than spherical or 
dot shapes upon infection (Carvalho et al., 1995). This interaction was found to be 
specific for the PML-II isoform and is achieved by one of the early viral products E4 
Orf3. This interaction between the viral and cellular proteins is direct and critical to 
change the PML-NB morphology since mutating the Orf3 caused a failure in Orf3-
PML-II interaction and PML rearrangement (Hoppe et al., 2006). Overexpressing 
PML-II ∆RBCC truncated mutants increased interferon promoter activity, which is 
reduced again when Orf3 protein is overexpressed ( Wight, 2010). This suggests 
that Ad5 overcomes the innate immune response by expressing Orf3 protein which 
decreases the IFN response that is mounted by PML-II related isoforms (Wright, 
2010)This suggests a negative role for the PML-II isoform in the Ad5 life cycle. 
In contrast, it was found that PML-II plays a positive role in Ad5 early transcription. 
E1A-13S was selectively bound to the PML-II isoform resulting in augmented E1A-
mediated transcriptional activation. Virus growth was also enhanced in PML-null 
cells by expressing PML-II, suggesting a positive role for PML-II during the early viral 
life cycle (Berscheminski et al., 2013). 
4.1.2 Aim of work described in this chapter 
 
PML-II has a positive role in the innate immune response represented by its 
regulation of interferon and NF-kB responses. PML-II is specifically disrupted and 
antagonized by Ad5 E4Orf3, an example of targeting PML-NB by various viruses This 
suggests that PML-II should be a negative regulator of adenovirus growth. On the 
other hand the augmented E1A transcriptional activation and Ad5 replication with 
the re-expression of PML-II in PML-null cells points to how viruses might benefit 
from the proteins that are involved in the immune response to promote their own 
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transcription and replication. These apparently conflicting possibilities motivated us 
to analyse the effect of PML-II in Ad5 gene expression and replication. 
Work descibed in the previous chapter established a very convenient system in 
which to study the role of PML-II in the Ad5 life cycle. Well characterised PML-II 
depleted and suitable control cell lines that provided reliable and persistent 
physical and functional knockdown provided useful reagents with which to study to 
the role of PML-II in the progress of adenovirus infection.  
The experimental design was to infect the knockdown and control cells with 
Ad5wt300 at moi of 5 for 20 hours. The cells were then harvested and RNA and 
proteins analysed by RT-qPCR, Western blotting and FACS. Virus replication was 
assay was by infecting the knockdown and control cells for different time intervals 
(24 and 48 hours), samples were harvested and infectious virus titres determined 
by the fluorescent focus assay (FFA). In transient knockdown experiments, the same 
systems of infection and analyses were used except 48 hours of IRF3 or hsp70 
knockdown were performed prior to infection. 
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4.2 The role of PML-II in the Ad life cycle 
4.2.1 Effect of transient removal of PML-II on adenovirus gene expression 
and genomic copy number 
 
In order to investigate the specific role of PML-II in the Ad5 life cycle, a pilot study 
was carried out using PML-II or Ctrl siRNAs for transient knockdown in standard 
HeLa cells. Cells were plated for 24 hours and transfected with PML-II siRNA or siC 
for 48 hours before Ad5 wt300 infection for 20 hours at moi of 5. It is clear that 
PML-II knockdown augmented hexon mRNA expression by approximately 2- fold in 
comparison with cells transfected with siRNA control (Fig.4.1A). A similar effect was 
noticed in Ad5 genomic copy number per cell.  There was a 3-fold increase in Ad5 
genomic copies following PML-II knockdown compared with the control sample 
(Fig.4.1B). 
Fig.4.1. Ad5 late expression and genome replication. Standard HeLa cells were seeded at a 
density of 1×10
5
 /ml for 24 hours in 24-well cultures. Cells were transfected with 125 pmol 
of either PML-II siRNA or siC for 48 hour then samples were infected with Ad5 wt300 at moi 
of 5 for 20 hours. RNA or DNA samples were extracted from each sample. Total hexon 
mRNA was quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a 
template. Ad5 genomic copy number was calculated from standard curves of Ad5 and  
genomic GAPDH plasmids made by 10 fold serial dilutions and then normalised to the 
control sample value. mRNA data were calculated by the ∆∆Ct method, using β-actin as 
internal control. All PCR products were subjected to dissociation curve analysis to ensure 
primer specificity. A. Hexon mRNA expression in PML-II depleted and control samples. B. 
Ad5 relative copy number in PML-II depleted and control samples. 
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Adenovirus gene expression and replication in stable PML-II knockdown cells 
One of the main goals of making permanent PML-II knockdown cells was to 
extensively explore the role of PML-II in the Ad5 life cycle and how infection 
progressed in the presence or absence of PML-II under normal and stress 
conditions (stress conditions will be discussed in the next chapter). Cells were 
plated for 24 hours at 37  ̊C and infected with Ad5wt300 at moi of 5 and samples 
were harvested for either RNA or protein analysis. Compared to different control 
cell lines, early and late Ad5 gene expression was significantly elevated in PML-II Kd 
cells than in control cells. The increase in late gene expression was more drastic 
than the early gene expression; it was about 7- fold greater compared to the GFPKd 
control and more than 30-fold when compared to the Ctrl.DNA cells (Fig.4.2B). On 
the other hand, the increase in E1A expression was not as big as for hexon; it 
displayed 3 and 9 times more expression compared to GFP Kd and Ctrl.DNA cells 
respectively (Fig.4.2A). In Chapter 3, EV cells showed Ad5 infection characteristics 
that were most similar to standard HeLa cells among the three potential control cell 
lines available for comparison with PML-II Kd cells. Using EV cells as control, the 
results were very consistent with the previous comparison. Hexon mRNA 
expression was about 5-fold greater in PML-II Kd cells in comparison to the EV cells 
(Fig.4.2C). Protein analysis verified the RNA analysis; it was clear that there was 
more DNA binding protein (DBP), E1B55K and hexon protein in PML-II Kd cells when 
compared to the EV cells (Fig.4.2D). 
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Fig.4.2 Ad5 gene expression in PML-II knockdown and control cell lines. PML-II Kd, GFP Kd, 
Ctrl.DNA and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours. Cultures were 
infected with Ad5 wt300 at moi of 5 for 20 hours. RNA samples were extracted from each 
cell type, viral gene expression was quantified by RT-qPCR using 10 ng/well of 
complementary DNA (cDNA) as a template. Data were calculated by the ∆∆Ct method, 
using 18S RNA as internal control, and then normalised to the control cell value. All PCR 
products were subjected to dissociation curve analysis to ensure primer specificity. A. E1A 
RNA expression in PML-II Kd, GFP Kd and Ctrl.DNA control cells. B.  Hexon RNA expression 
in PML-II Kd, GFP Kd and Ctrl.DNA control cells. C. Hexon RNA expression in PML-II Kd and 
EV cells. D. For WB analysis, samples were harvested with 1xSB, the membranes were 
blotted against the appropriate Abs: (anti-DBP mouse monoclonal Abs (upper panel), anti-
E1B55K mouse monoclonal Abs (second panel), anti-late polyclonal rabbit Abs (third panel) 
and anti-GAPDH mouse monoclonal Abs (bottom panel). Data show a significant increase in 
hexon expression in PML-II Kd cells (*P<0.05, n=3). 
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4.2.2 Ad5 gene expression at different time points post infection 
 
With the intention of investigating the progress of the Ad5 infection in the presence 
or absence of PML-II, cells were subjected to Ad5 infection at moi of 5, and samples 
were harvested at different time intervals (6, 12, 18 and 24 hours) post infection. At 
all these time points, protein samples were harvested from both PML-II Kd and EV 
cells and the were analysed for early and late gene expression. Over the time 
course, there was an evidently greater increase in early and late viral proteins in 
PML-II Kd cells than the EV cell in all time intervals, having accounted for loading 
differences (GAPDH), both for E1B 55K (Fig.4.3A) and for late gene products, at 18 h 
and 24 when late protein begin to accumulate (Fig.4.3B). However, the difference 
appeared more significant for late than early proteins. These findings are consistent 
with the results of infection following transient knockdown. In conclusion, it is clear 
that PML-II plays a negative role in the progress of Ad5 infection. 
 
 
 
 
 
 
 
109 
 
 
Fig.4.3. Ad5 gene expression in PML-II knockdown and control cell lines. PML-II Kd and EV 
cells were seeded at a density of 1×10
5
 /ml for 24 hours. Cells were infected with Ad5 
wt300 at moi of 5 for 24 hours. Protein samples were harvested for WB analysis at the 
times indicated, analysed by SDS-PAGE and western blotting. The membranes were probed 
with the appropriate Abs. A. anti-E1B55K mouse monoclonal abs; B. Anti-late polyclonal 
rabbit Abs; C. Anti-GAPDH mouse monoclonal Abs. The last two samples at 24 hours were 
diluted 100 times relative to the others as the expression was very high and as a 
consequence, the GAPDH band was very faint for those two samples in particular. 
4.2.3 Quantitative estimation of early and late gene expression in PML-II Kd 
and EV cells 
All the previous RNA or protein analyses showed more viral gene expression in 
PML-II kd cells compared to different control cell lines. This increase could be 
attributed to an increase in the number of cells that showed viral gene expression 
or to the same numbers of cells showing more gene expression within the same 
population of cells or in comparison with other cell types. In order to make a 
quantitation that could count the number of cells that expressed early and late Ad5 
proteins and to give an idea about the intensity of expression of  a given protein in 
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the population of positive cells, we used FACS for that purpose. Using this 
technique it was possible to distiguish the percentage of positive (infected) cells 
from the negative uninfected cells in each sample, which allows a fair comparison 
by obtaining the fraction of infected cells in each culture. At the same time and 
within a population of positive cells it was possible to detect the amount of each 
viral protein by measuring the intensity of the mean of fluorescence (MFI). Cells 
were plated for 24 hours and infected with Ad5wt300 at moi of 5 and samples were 
fixed and stained to measure the DBP and hexon expression in PML-II Kd and EV 
cells. The results further confirmed the previous RNA/protein analyses through 
showing more or less 100% increase in the population of cells that showed late Ad5 
protein expression (Fig.4.4B, the black curves) PML-II Kd cells showing 26.53% late 
expressing cells compared to only 13.58% in EV cells. The MFI of hexon expression 
within the positive cells was also higher in PML-II Kd cells, 1493.45 compared to its 
value in EV cells which was 965.16 (Fig 4.4B). However, and consistent with the 
previous results, the DBP fluoresence was only slightly higher in PML-II Kd cells 
compared to the EV cells. The percentage of cells that showed DBP positive staining 
was 50.79% in PML-II Kd cells in comparison with 44.1% in EV cells. A greater 
difference was noticed in the MFI of DBP between the two types of cells,PML-II Kd 
cells showed an MFI value of 1636.79 while EV cells showed 1160 (Fig 4.4.A).This 
increase is likely to reflect largely the continuing expression of DBP in the late 
phase. To summarise, it is clear that both the proportion of infected cells and the 
intensity of viral gene expression was higher in PML-II Kd cells that the EV cells, 
particularily in the late phase. 
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Fig.4.4 FACS analysis of early and late gene expression in PML-II Kd and EV cells. Cells 
were plated at a density of 0.8×10
6
 or 2.2×10
6
 per dish in 60 and 100 mm
2
 dishes 
respectively for 24 hours. Cells were infected at moi of 5 with Ad5wt300 for 20 hours. Cells 
were then fixed, permeabilized and stained with either anti-DBP monoclonal Abs or anti-
hexon monoclonal Abs as primary antibodies, followed by Alexa-Fluor 488 Gt anti-Mouse 
Abs staining. A. DBP fluorescence in PML-II Kd cells (left) in EV cells (right). B. Hexon 
fluorescence in PML-II Kd cells (left) in EV cells (right). The grey curves represent the mock 
infected cells (background) while the black curves represent the infected cells. 
  
4.2.4 Virus yield in PML-II Kd and EV cells 
Differences in viral gene expression may or may not be translated into effects on 
the yield of infection progeny. To determine whether loss of PML-II affected the 
virus yield, PML-II Kd and EV cells were infected with Ad5wt300 at moi of 5 for 24 
and 48 hours, total cell cultures were harvested and freeze-thaw extracts titered on 
HeLa cells by fluorescence focus assay. There was a noticeable increase of about 3-
fold in virus yield in PML-II Kd when compared with control cells at both time points 
(Fig 4.5A&B). 
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Fig.4.5. Ad5 yield in PML-II Kd and EV cells. PML-II Kd and EV cells were plated at a density 
of 1×10
5
 /ml for 24 hours, infected at moi of 5 with Ad5wt300 for 24 and 48 hours. Samples 
were harvested and subjected to freeze-thaw cycles to release virus and then serial 
dilutions were prepared from each sample and used to infect standard HeLa cells  for 16 
hours. Cells were fixed and stained using anti-DBP monoclonal antibodies as primary Abs 
and 488 Alexafluor goat anti mouse Abs as secondary antibodies. Samples were examined 
using UV- microscopy and DBP foci were by eye. Numbers from duplicate cultures were 
averaged and divided by cell numbers in the producedr culture, then normalised to the 
yield in EV cells. A. Virus yield at 24 hours. B. Virus yield at 48 hours. 
As an overall conclusion, it is clear that PML-II  has a negative impact on Ad5 gene 
expression and virus replication. This could be related to the fact that this protein in 
particular is antiviral, either in promoting the IFN-β response or other functions, 
and although it is targeted by E4Orf3 in a way that could result in blocking its 
specific function, this may not completely abrogate its negative effect (Hoppe et al., 
2006, Chen et al., 2015). Inhibiting the innate immune response may facilitate the 
virus’s mission in establishing efficient replication and the progress of infection. 
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4.3 Mechanisms underlying the increased Ad5 gene expression and 
replication in the absence of PML-II 
4.3.1 Decreased level of Interferon response 
 
PML-II is known to facilitate a robust IFN response and at the same time it is 
upregulated significantly from basal level with stimulation by IFN-α or β (Der et al., 
1998, Chen et al., 2015). Hence, the straightforward mechanism that could be 
proposed here is that the reduced level of IFN response in PML-II Kd cells allows 
Ad5 to grow better, even though Ad5 expresses E4Orf3 that presumably inhibits 
this factor. To test this, the idea was to block the interferon response before Ad5 
infection in both PML-II Kd and EV cells by another means, then to compare the 
outcome of Ad5 infection. IRF3 is a transcriptional factor that is retained in an 
inactive form in the cytoplasm due to a constitutive nuclear export signal. When a 
cell senses a pathogen, IRF3 becomes activated and is transported to the nucleus 
where it starts its transcription function in triggering the type I interferon response 
(Yoneyama et al., 1998). Adenovirus infection in particular induces interferon type I 
in an IRF3-dependent manner soon after infection which results in a direct 
stimulation of ISG56 and other ISGs (Stein and Falck-Pedersen, 2012). 
IRF3 siRNA treatment was optimised by using a series of concentrations: 31.25, 62.5 
and 125 pmol (data not shown); the best concentration was 62.5 pmol which 
showed about 50% reduction in ISG56 mRNA (Fig4.6A) which was used later as the 
standard for IRF3 knockdown experiments.  
To confirm the functional effect of IRF3 knockdown EV cells were treated with 
control or IRF3 siRNA, stimulated with poly I:C and ISG56 mRNA was quantified as 
one of the directly IRF3-stimulated genes (Grandvaux et al., 2002). In both poly I:C 
stimulated and un-stimulated cells, IRF3 knockdown caused the IFN response to 
decline to about 50 and 40% respectively (Fig.4.6B). IRF3 knockdown did not block 
the response completely, either because IRF3 loss was not complete or because 
there is another transcription factor, NF-kB, that is also activated and contributes to 
the IFN response within this same classical induction pathway (Haller et al., 2006) 
114 
 
Next, the effect of IRF3 knockdown on Ad5 infection was tested. PML-II Kd and EV 
cells were transfected with IRF3 siRNA or siC for 48 hours, then infected with 
Ad5wt300 for 20 hours. Late viral proteins  was analysed and compared in both cell 
lines (Fig.4.6C). The level of late viral  proteins was considerably greater inPML-II Kd 
cells than in EV cells when treated with siC, which is consistent with results that 
were obtained in these cells without siRNA treatment. IRF3 knockdown in PML-II Kd 
cells had no effect on the already high level of hexon being expressed. This reflects 
the fact that the interferon response is already strongly inhibited in these cells 
through the absence of PML-II. 
In EV cells the effect of IRF3 knockdown was to increase hexon expression 
somewhat compared to the control. Significantly though, this hexon expression was 
still substantially lower than was observed in PML-II kd cells (Fig 4.6C). Thus, 
blocking of type I interferon responses by IRF3 knockdown in EV cells does not 
make them equivalent to PML-II Kd cells in terms of their hexon expression. This 
sort of effect suggests that there might be other mechanisms in addition to loss of 
the IFN response that contribute to increased viral gene expression in PML-II Kd 
cells. 
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Fig.4.6. Ad5 late gene expression in PML-II Kd and EV cell lines with or without IRF3 
knockdown. PML-II Kd and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours in 
24-well cultures.  A. IRF3 expression in PML-II Kd and EV cells. Cells were transfected with 
62.5 pmol of either IRF3 siRNA or siC for 48 hours. Cultures were harvested for SDS-PAGE 
analysis and membranes were reacted with rabbit polyclonal anti- IRF3 Abs. B. ISG56 mRNA 
in EV cells with or without stimulation. Cells were transfected with 62.5 pmol of either IRF3 
siRNA or siC for 48 hours then either stimulated with poly I:C for 16 hours  or left without 
treatment. Total ISG56 mRNA was quantified by RT-qPCR using 10 ng/well of 
complementary DNA (cDNA) as a template. Data were presented by the ∆∆Ct method, 
using β-actin as an internal control. All PCR products were subjected to dissociation curve 
analysis to ensure primer specificity. C. Ad5 hexon expression in PML-II Kd and EV cells. 
Cells were transfected with 62.5 pmol of either IRF3 siRNA or siC for 48 hours, then 
infected with Ad5 at moi of 5 for 20 hours. Cultures were harvested for SDS-PAGE analysis 
and membranes were probed with polyclonal anti-late rabbit Abs or monoclonal anti-
GAPDH mouse Abs. 
 
To reach to a final conclusion about the effect of IFN response on Ad5 infection and 
because of the clear relationship between PML-II, IFN and E4Orf3 (Chen et al., 2015, 
Ullman et al., 2007), infection was evaluted in PML-II Kd and EV cells in the 
presence and absence of E4Orf3 with and without IFN treatment. The idea was that 
E4Orf3 deletion, as it counteracts the interferon antiviral effect, would make the 
mutant virus more sensitive to interferon treatment than the wild type, especially 
in the EV cells where the level of interferon response would be normal. PML-II Kd 
and EV cells were both treated with 1000 U/ml of IFN-α for 24 hours prior to 
116 
 
infection with Ad5wt300 or inOrf3 viruses at a moi of 5 for 20 hours. In essence, 
there was a clear increase in late viral gene expression in PML-II Kd cells for both 
viruses compared with the EV cells, this is consistent with all previous results as 
PML-II plays a negative role in the Ad5 life cycle (Fig.4.7A). The inOrf3 mutant 
displayed less gene expression in EV cells than the wild type and this is also 
expected as it lacks E4Orf3, the protein that compromises the interferon activity 
(Fig.4.7A). The wt300 was affected to a lesser extent with the interferon treatment 
than the mutant in both cell lines despite it was more striking in EV cells which is 
also the expected scenario as the control cells express more interferon than PML-II 
Kd cells (Fig4.7B). The IFN treatment had more effect on the mutant virus in both 
cell lines, especially in the control cells and it showed a more significant effect than 
the wild type as shown by the hexon band quantitation (Fig.4.7B). Hence, the 
mutant showed a greater level of late gene expression in PML-II Kd cells despite the 
interferon treatment because these cells are deficient in the interferon response 
due to the lack of PML-II protein. As an overall conclusion from this part of the 
work, the mutant was more vulnerable to the interferon treatment in the EV cells 
than in PML-II Kd cell, which suggests that the E4Orf3-PML-II interaction is 
necessary to overcome the antiviral functionof interferon since the mutant was 
affected to a lesser extent when the interferon responsewas low due to PML-II 
removal. 
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Fig.4.7. Late gene expression in PML-II Kd and EV cells with and without IFN type I 
treatment. A. PML-II Kd and EV cells were plated for 24 hours, treated  or not with 1000 U 
of IFN -α for another 24 hours (+I,-) and infected with either wt300 or InOrf3 mutant at moi 
of 5 for 20 hours. Protein samples were harvested for WB analysis; the membranes were 
probed with polyclonal anti-late rabbit Abs or monoclonal anti-GAPDH mouse Abs. B. 
Hexon band density. The upper main band with a molecular weight of about 100 kDa was 
quantified using Quantity one software to compare its intensity in all 8 samples. The 
background of the negative film was subtracted and then the results were normalised to 
the related GAPDH bands, and then further normalised to the value for wt300 in EV cells 
with no treatment 
4.3.2 Role of heat shock protein 70 (hsp70) in adenovirus gene expression 
during PML-II knockdown 
 
It was mentioned in Chapter 3 that the level of hsp70 expression was significantly 
higher in PML-II Kd cells than in any of the control cell lines or standard Hela cells. 
In addition, hsp70 is signficantly induced during adenovirus infection (Kao and 
Nevins, 1983, Nevins, 1982) which suggests that it might be beneficial to the 
infection, since Ad5 down-regulates many host genes that are inhibitory (Dorn et 
al., 2005). It was therefore tested whether the increase in hsp70 levels in PML-II Kd 
cells was correlated with an increase in hexon expression in these cells. The aim 
was to do parallel transient knockdown of hsp70 by siRNA in both PML-II Kd and EV 
cells to investigate late gene expression in the presence and absence of hsp70. Cells 
were transfected with hsp70 siRNA or siC for 48 hours and infected with Ad5wt300 
at a moi of 5 for 20 hours.  The level of hexon mRNA expression, encoding the 
major late adenoviral structural protein, was significantly reduced following hsp70 
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knockdown in PML-II Kd cells, reducing it to more or less the same level seen in EV 
cells in the presence of hsp70 (Fig4.8A). Hsp70 knockdown also further reduced the 
already low level of hexon expression in EV cells. To further confirm the RNA 
results, protein analysis was carried out to compare the DBP and hexon expression 
by Ad5wt300 with or without hsp70, applying the same conditions as in Fig.4.8A in 
PML-II Kd cells. Consistent with the RNA analysis, removing hsp70 reduced to some 
extent the DBP expression compared to the siC sample (Fig.4.8B). A greater effect 
was detected on the level of hexon protein which was reduced to a very low level in 
comparison with the siC sample (Fig.4.8C). The overall conclusion is that the 
elevated  hsp70 level in PML-II Kd cells is a significant factor in enhancing Ad5 
infection in these cells.  
 
Fig.4.8. Hsp70 effects on Ad5 hexon expression. PML-II Kd and EV cells were seeded at a 
density of 1×10
5
 /ml for 24 hours. Cultures were transfected with hsp70 siRNA or siC for 48 
hours then infected with Ad5 wt300 at moi of 5 for 20 hours. A. RNA samples were 
extracted from each cell type, hexon mRNA expression was quantified by RT-qPCR using 10 
ng/well of complementary DNA (cDNA) as a template. Data were calculated by the ∆∆Ct 
method, using β-actin as internal control, and then normalised to the control cell value (siC 
sample). All PCR products were subjected to dissociation curve analysis to ensure primer 
specificity. B &C. Protein samples were harvested for WB analysis, the membranes were 
probed with monoclonal anti-DBP mouse Abs, anti-late polyclonal rabbit Abs or anti-
GAPDH mouse monoclonal. B. DBP expression C. Late protein expression. 
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4.3.2.1 HSP70 and the NF-kB signalling pathway 
NF-kB is a transcription factor which is retained in the cytoplasm by IkBα until it is 
activated by certain stimuli, which lead to phosphorylation and ubiquitination of  
IkBα.These modifications lead to IkBα degradation by the 26S proteasome (Chen et 
al., 1995). Hsp70 within the cell was found to preferentially bind the IkB kinase IKKγ, 
preventing NF-kB activation and thus abolishing its anti-apoptotic function (Ran et 
al., 2004). However hsp72 or hsp70A1A secreted from cells or applied externally 
could induce the NF-kB transactivation and binding to DNA via TLR signaling (Chase 
et al., 2007).  
Many facts were associated with this part of work. First of all, the elevated level of 
hsp70 in PML-II Kd cells, secondly the down-regulating effect of hsp70 on NF-kB 
signaling(Cao et al., 2012, Ran et al., 2004, Senf et al., 2008) and finally the low level 
of NF-kB response in PML-II Kd cells which was monitored by measuring the basal 
and inducible levels of IL-6 mRNA. Thus, the idea was to test whether the reduced 
level of hexon expression obtained following hsp70 removal belongs to the effects 
of the latter on TNF-α induced NF-kB activation during Ad5 infection, since NF-kB is 
generally thought to be inhibitory to virus replication (Brown et al., 2003). TNF-α 
potentially stimulates NF-kB signalling and hence it was expected to oppose the 
effect of any hsp70 inhibition of the pathway. 
Before starting the extensive experiment it was necessary  first to determine the 
effect of TNF-α treatment on Ad5 gene expression at both RNA and protein levels. 
EV cells were transfected with hsp70 siRNA or siC for 48 hours and parallel samples 
were treated with 50ng/ml of TNF-α for 1 hour prior to infection with Ad5 wt300 
for 20 hours at moi of 5. Surprisingly, the overall effect of TNF-α treatment was an 
increase in hexon mRNA expression (Fig.4.9A). 
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Fig.4.9. Ad5 hexon expression in PML-II Kd cells and EV cells with or without TNF-α 
treatment. PML-II Kd and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours. A. 
Cultures of EV cells were transfected with hsp70 siRNA or siC for 48 hours and either 
treated with 50 ng/ml of TNF-α for 1 hour or not prior to infection. All samples were then 
infected with Ad5wt300 at moi of 5 for 20 hours. RNA samples were extracted from each 
cell type, hexon mRNA expression was quantified by RT-qPCR using 10 ng/well of 
complementary DNA (cDNA) as a template. Data were calculated by the ∆∆Ct method, 
using β-actin as internal control, and then normalised to the control cell value (siC sample). 
All PCR products were subjected to dissociation curve analysis to ensure primer specificity. 
The white bars are the non- treated samples while the black bars are the TNF-α treated 
samples. B. Cultures of PML-II Kd and EV cells were treated or not with 50 ng/ml of TNF-α 
for 1 hour prior to infection. Protein samples were harvested for WB analysis, the 
membranes were probed with polyclonal anti-late rabbit Abs or monoclonal anti-GAPDH 
mouse Abs. 
 
At the protein level, without hsp70 transient knockdown, the result was consistent 
with the RNA experiment; TNF-α treated samples in both cell lines showed more 
late proten expression than in untreated samples (Fig.4.9B). Thus although hsp70 
interacts with NEMO to prevent NF-kB activation, which was reduced in PML-II Kd 
cells (Ran et al., 2004), the hypothesized role of hsp70 in downregulating the TNF-α 
induced NF-kB activation was excluded as the effect of TNF-α treatment on 
infection was totally the opposite of expectation.  
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Effect of NF-kB blocking on Ad5 protein expression 
As a further test of the role of NF-kB activation in the adenovirus life cycle, the NF-
kB signalling pathway was abolished with the inhibitor QNZ. This chemical inhibits 
NF-kB activation and TNF-α production in Jurkat cells with an IC50 of 2nM and 3 nM 
respectively (Tobe et al., 2003). PML-II Kd cells and EV cells were either treated with 
10µM of QNZ for 45 minutes or left without treatment  then infected with Ad5 at 
moi of 5 for 20 hours. NF-kB blockage by QNZ decreased the viral late gene 
expression in both cell lines (Fig.4.10). This is in agreement with the effect of TNF-α 
(Fig.4.9A&B): both treatments demonstrate a positive role of NF-kB activation in 
adenovirus gene expression.These results suggest that the high hsp70 in PML-II Kd 
cells must favour Ad5 infection through mechanisms other than inhibiting the NF-
kB pathway.  
 
 
 
Fig.4.10. Late Ad5 gene expression in PML-II  Kd and EV cells with blockage of the NF-kB 
signalling pathway. PML-II Kd and EV cells were plated for 24 hours, cultures were treated 
with QNZ  for 45 minutes or not and infected with Ad5 wt300 at moi of 5 for 20 hours. 
Samples were collected for Western blott analysis, the membranes were probed with 
polyclonal anti-late rabbit Abs or monoclonal anti-GAPDH mouse Abs.  
122 
 
 
In the light of these results it is not possible to conclude that  increased expression 
of hsp70 caused an increase in Ad5 gene expression through down-regulating TNF-
α induced NF-kB activation. The results shown in figures 4.9 and 4.10 all come 
together to suggest a positive role of NF-kB in the adenovirus life cycle and hence 
enhancing its gene expression. The fact that there was an increase in the level of 
late viral gene expression with TNF-α treatment in EV cells or with NF-kB blocking in 
PML-II Kd and EV cells possibly indicates that the virus can benefit from the 
interaction with the innate immune response for its own transcription and 
replication. This is surprising given the virus encodes E3 functions that inhibit TNF-α 
signaling (Gooding et al., 1990), however the negative effect of TNF-α may only be 
manifest in vivo in the presence of a functional immune response. The virus might 
have evolved a mechanism by which it could take advantages from the cellular 
immune response, hence it can augment its own gene expression. This is actually 
consistent with a study performed by Korner et al., (1992). This study showed that 
treating 293 HEK cells with low doses of TNF-α for a short time increased the 
expression of E3/19K mRNA and protein which led to a reduction in HLA molecules 
on the cell surface (Korner et al., 1992). During adenovirus infection, the effect of 
TNF-α could be shifted to be through stimulating expression of the viral proteins 
that might neutralize the lytic effect of TNF-α which was used to treat the cells, as 
in this experiment, or the TNF-α that is already induces because of adenovirus 
infection (Pahl et al., 1996). 
4.3.2.2 How does hsp70 affect Ad5 replication? 
Within a short time post adenovirus infection, or upon heat shock or when the cell 
enters S phase, hsp70 is transported to the peri-nuclear and nuclear areas. This is 
probably as a part of hsp70 function in stabilising and re-folding abnormal or 
unfamiliar proteins. It was also found that hsp70 associates with the hexon of 
incoming virus particles (Milarski and Morimoto, 1986, Niewiarowska et al., 
1992).Therefore, it was  considered whether a part of the benefit to Ad5 of high 
hsp70 might relate to the localisation of late proteins. Cells were transfected with 
hsp70 siRNA or siC and then infected with Ad5wt300 for 16 hours. The cells were 
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lysed and the cytoplasmic and nuclear fractions were separated from each other. 
The general effect of hsp70 removal on the late gene expression seen earlier was 
replicated here since the hsp70 knockdown samples showed fainter hexon protein 
bands (Fig.4.11A). The hexon protein was found in reduced levels in the nuclear 
fraction, this conclusion was supported by band quantitation when the data were 
normalised to the internal cytoplasmic and nuclear loading controls. In contrast, 
hsp70 removal had little effect on DBP levels or distribution (Fig4.11B). GAPDH and 
Sp1, known cytoplasmic and nuclear proteins serve to show effective and 
equivalent fractionation between the two cell types. 
 
 
Fig.4.11. Cytoplasmic and nuclear distribution of hexon in correlation with hsp70 
knockdown. PML-II Kd cells were plated for 24 hours at a density of 1×10
5
 /ml, transfected 
with either hsp70 or siC for 48 hours, then infected with Ad5wt300 at moi of 5 for 16 hours. 
Cells were collected, lysed and cytoplasmic and nuclear fractions were separated and then 
lysed with 1x SB buffer, WB membranes were blotted against anti-late polyclonal rabbit 
Abs, anti-GAPDH or anti-Sp1 mouse monoclonal Abs. A. WB analysis. B. Hexon band 
quantitation from panel A, data were normalised to the cytoplasmic and nuclear proteins, 
GAPDH and Sp1. 
 
This reduction in hexon movement into the nucleus as a result of hsp70 removal 
could be explained if absence of the latter prevents viral assembly. It is well-known 
that adenovirus assembly happens in the nucleus where the viral genome is 
replicating. So the removal of hsp70 might cause a defect in the assembly process. 
More plausibly, hsp70 promotes either trimerization of hexon polypeptides in the 
cytoplasm (which also needs L4 100K) or the association of hexon trimers with the 
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viral protein pVI, which is needed for their nuclear import (Matthews and Russell, 
1995, Wodrich et al., 2003). These effects of hsp70 cannot however explain its 
significant effect on the level of late protein synthesis. 
4.3.2.3 Effect of hsp70 on type I interferon response 
It has been found that the removal of the highly expressed hsp70 during Dengue 
virus infection could increase the type I interferon response (Padwad et al., 2010). 
In order to investigate any broader effect of hsp70 on cellular cytokine expression, 
the idea was to analyse how hsp70 could affect the level of type I interferon 
response in mock and Ad5wt300 infected cells. PML-II Kd or EV cells were 
transfected with hsp70 siRNA or siC and then infected with Ad5wt300 for 20 hours 
or left as mock. In mock infected cells, PML-II cells showed much lower ISG56 
expression than the EV cells (Fig.4.12A) which is very consistent with what was 
noticed before regarding the functional effect of PML-II isoform removal(Chen et 
al., 2015). Interference with hsp70 expression by siRNA increased the level of IGS56 
expression in both cell lines with a noticeably greater increase in the control EV 
cells (Fig.4.12A). In a separate experiment with infected EV cells, the trend was 
similar since hsp70 removal strongly augmented the ISG56 expression (Fig.4.12B).  
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Fig.4.12 ISG56 expression in PML-II Kd and control cell lines with or without hsp70 
knockdown. PML-II Kd and EV cells were seeded at a density of 1×10
5
 /ml for 24 hours. 
Samples were transfected with hsp70 siRNA or siC for 48 hours. Samples were either 
infected with Ad5 wt300 at moi of 5 for 20 hours B or left as mock A. RNA samples were 
extracted from each, and ISG56 mRNA expression was quantified by RT-qPCR using 10 
ng/well of complementary DNA (cDNA) as a template. Data were calculated by the ∆∆Ct 
method, using GAPDH or 18S RNA as internal controls, and then normalised to the siC-
treated PML-II Kd value A. or the siC-treated EV value B. All PCR products were subjected to 
dissociation curve analysis to ensure primer specificity. Data show significant increase with 
hsp70 removal (*P<0.05, n=2).  
 
This result agrees with the study of  Padwad et al., (2010), in which Dengue 
infection triggered high level of hsp70 expression, and viral replication was reduced 
significantly with hsp70 knockdown associated with an increased level of IFN-α and 
protein kinase R (PKR) expression. Another possibilty which could be suggested in 
that context is that the infection-induced type I interferon might suppress hsp70 
expression. In Human T-Cell Leukemia virus type 1 (HTLV-I) infected primary cord 
blood –derived mononuclear cells, it was noted that viral infection could also 
increases hsp70 expression which could persist for at least 4 weeks. This increase in 
hsp70 expression was totally suppressed by treatment with IFN (D'Onofrio et al., 
1993). In the present study, the decreased level of interferon response in PML-II Kd 
cells could result in an increased level of hsp70 expression as a consequence, and 
because of the importance of hsp70 in enhancing viral gene expression, there was 
much more viral gene expression in those knockdown cells. Consequently with 
hsp70 removal viral gene expression was diminshed significantly and thus the 
antiviral response which is represented by the interferon response would dominate 
again. 
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4.4 Ad5 gene expression in PML-Kd cells  
Having shown the negative effect of PML-II on Ad5 infection, it was important to 
test whether the presence or absence of other PML isoforms modified the effect of 
PML-II, in order to investigate the role of total PML in the adenovirus life cycle, PML 
Kd and control cells were infected at moi of 5 for 20 hours. Samples were harvested 
for either RNA or protein analysis. PML and PML-II mRNA was reduced in PML Kd 
cells compared to the control cell line (Fig.4.13A). The functional knockdown was 
significant since the interferon response, measured by ISG56 mRNA levels, was 
reduced to about 50% in PML Kd cells in comparison with the GFPKd and Ctrl.DNA 
cells (Fig.4.13A). In terms of the progress of adenovirus infection, it was obvious 
that hexon mRNA expression was significantly higher in PML Kd cells than in the 
control cells (Fig.4.13.C).  
 
Fig.4.13. Late Ad5 gene expression in the presence and absence of total PML. PML Kd, 
Ctrl.DNA and GFP Kd cells were seeded at a density of 1×10
5
 cell/ml for 24 hours. Cultures 
were left as mock for PML and ISG56 levels or infected with Ad5 wt300 at moi of 5 for 20 
hours to detect hexon mRNA. RNA samples were extracted from each cell type, and mRNAs 
were quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. 
Data were analysed by the ∆∆Ct method, using GAPDH  or 18S RNA as internal control, and 
then normalised to the control cell value. All PCR products were subjected to dissociation 
curve analysis to ensure primer specificity. A. Total PML and PML-II mRNA depletion in PML 
Kd in comparison with Ctrl.DNA cells: black bars- exon3 specific primers (total PML); grey 
bars –PML-II specific primers. B.  ISG56 mRNA in  PML Kd in comparison to GFP Kd  and 
Ctrl.DNA cells. C. Hexon mRNA expression in PML Kd in comparison to GFP Kd  and Ctrl.DNA 
cells infected with Ad5wt300.  
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To confirm this effect, early and late viral protein expression were evaluated by 
western blotting. DBP expression was slightly increased in PML Kd cells compared 
with its level in Ctrl.DNA cells (Fig.4.14.A). Late proteins, which are represented by 
the major protein, hexon, and the vertex protein, penton, were expressed to 
significantly higher levels in PML Kd cells in comparison with the control cells 
(Fig.4.14.B). When the multiplicity of infection was increased to 50 to increase the 
infectability of Ctrl.DNA cells, the same trend of change in DBP expression was 
noticed (Fig.4.14.C). However, although protein expression had increased to some 
extent in PML Kd cells, it was not as dramatic as when analysed at a moi of 5 
(Fig.4.14.D). This may be explained as high multiplicity of infection can 
overcome/overwhelm cellular defects. This could be related to the fact that 
adenovirus infection alters the distribution and morphology of PML-NB. At the later 
stage of Ad5 infection and when mature viruses started to be synthesized, the PML 
started to disappear from the NB bodies and inter-chromatin granule-associated 
zones where it was located initially in mock or early infected nuclei. In fact, this may 
suggest that this virus targets those proteins to abolish their antiviral function as 
they are interferon up-regulated proteins (Puvion-Dutilleul et al., 1995). 
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Fig.4.14. Late Ad5 gene expression in the presence and absence of all PML isoforms. PML 
Kd and Ctrl.DNA cells were plated  at density of 1×10
5
 cell/ml for 24 hours then either left 
as mock  or infected with Ad5wt300 for 20 hours  at moi of 5 or 50. Cultures were 
harvested for WB analysis with 1xSD buffer and blotted with either monoclonal anti DBP- 
antibodies, polyclonal anti- late antibodies or monoclonal anti-GAPDH mouse monoclonal 
Ab. A. DBP expression at moi of 5. B. Late gene expression at moi of 5. C. DBP expression at 
moi of 50. D. Late gene expression at moi of 50.   
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4.4.1 Quantitative analysis of early gene expression in PML Kd and Ctrl.DNA 
cells 
In order to quantify early gene expression in PML Kd and Ctrl.DNA cells, FACS 
analysis was used. Cells were plated for 24 hours, infected with Ad5 at moi of 5 and 
samples were fixed and stained to measure DBP expression in both cell types. 
Consistent with the RNA and protein results, FACS analysis showed a small increase 
in DBP expression in PML Kd cells compared to Ctrl.DNA cells: percentages of cells 
that expressed DBP were 32.56% in the PML Kd population in Ctrl.DNA cells 
(Fig4.15A&B). 
 
Fig.4.15. FACS analysis of early gene expression in PML Kd and EV cells. Cells were plated 
at a density of 0.8×10
6
 or 2.2×10
6
 per dish in 60 and 100 mm
2
  dishes respectively for 24 
hours. Cells were infected at moi of 5 with Ad5wt300 for 20 hours. Cells were then fixed, 
permeabilized and stained with anti-DBP monoclonal Abs as primary antibodies, followed 
by Alexa-fluor488 Gt anti-Mouse Abs staining. A. DBP fluorescence in PML Kd cells . B. DBP 
fluorescence in Ctrl.DNA cells. The grey curves represent the mock infected cells 
(background) while the black curve represent the positive infected cells. 
 
This is consistent with the analysis of DBP fluoresence in PML-II Kd cells compared 
to EV cells (Fig4.4) in which the percentage of cells that showed DBP positive 
staining was 50.79% in PML-II Kd cells in comparison with 44.1% in EV cells. To 
summarize, it seems that total PML proteins play a negative role in Ad5 late gene 
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expression as viral gene expression increases with PML removal. This removal of 
course includes removal of PML-II, shown earlier to be important in determining 
the productivity of infection. 
4.5 Discussion 
The functional knockdown of all PML isoforms via the common PML exon3 target 
displayed a clear increased level of hexon RNA and protein expression compared to 
the control cells. However, this increased viral gene expression with total PML 
removal was less dramatic than the effect of PML-II removal alone. This suggests 
that some aspects of PML function lost in an exon 3 knockdown are beneficial to 
the virus and potentially offset the negative influence of PML-II. This result is very 
consistent with what is mentioned in the literature about the interelation between 
PML & PML-NB and DNA & RNA viruses. One of the major functions of PML proteins 
is an involvement in antiviral responses against the invading viruses. PML proteins 
comprise some of many proteins that are upregulated with the interferon 
treatment (α, β and γ) in different human cell types and they could mediate their 
antiviral effect through IFN-induced responses (Chelbi-Alix et al., 1995, Regad, 
2001b). Those proteins are involved in confronting the virus infection invitro and in 
vivo. For example, it was found the replication rate of influenza virus is decreased 
with the overexpression of either PML-IV or PML-VI in human adenocarcinoma 
Caco-2 cells. This was further confirmed by the enhanced replication of influenza 
virus with the transient knockdown of PML in Caco-2  cells (Iki et al., 2005). It was 
also shown PML-/- mice were more susceptible to infection with LCMV than normal 
mice: PML suppressed viral multiplication, since virus titers were 50 times more in  
PML-/- mice than the control group (Bonilla et al., 2002). PML-II knockdown showed 
consistent effects on the Ad5 life cycle in both transient and permanent knockdown 
scenarios. In transient interference with PML-II mRNA in HeLa cells, there was 
greater hexon expression and increases in viral DNA copy number.  This was further 
confirmed by experiments in stabley knocked-down cells in which early and late 
viral RNA and protein expression were increased significantly and consistently in 
repeated experiments. The yield of infectious progeny virus was affected in a 
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parallel way and showed significant increase over two time points (24 and 48 hours) 
with PML-II removal. 
Quantitatively, PML-II Kd cells showed a greater percentage of cells  expressing late 
proteins following infection than the control cells. These results agree with a 
number of studies that have pointed to the involvement of PML-II in restricting viral 
gene expression or replication.  For example, in HuH7 cells both transient 
interference with PML-II or over-expressing of PML-II suggested a negative role for 
PML-II in the AAV life cycle. While knockdown of PML-II increased transduction by 
recombinantAAV, PML-II overexpression resulted in inhibition of vector production, 
genome replication and second strand synthesis. Furthermore, the production and 
infectivity of wild type AAV2 was inhibited by over-xpression of PML-II (Mitchell et 
al., 2014). However, the conclusion that PML-II is a negative regulator of the Ad5 
life cycle is totally contradictory to the work of Berscheminski et al., (2013), who 
defined PML-II as a coactivator of E1A-13S transactivation (Berscheminski et al., 
2013). In fact there are many basic differences between this present study and the 
work of Berscheminiski et al., (2010). The latter study mainly depended on 
exogenous over-expression of E1A13S or PML-II or both. Even when its ability to 
activate adenovirus transcription was analysed in cooperation with endogenous 
PML, PML-II was not able to activate the transcription of E2 region when it was 
overexpressed alone. The increase in transcription was detected only when an E1A 
13S plasmid was coexpressed with PML-II. 
It was necessary to understand how PML-II could affect Ad5 gene expression and 
replication. The straightforward explanation for the greater progress of infection in 
the absence of PML-II would be a decreased level of the type I interferon response 
(Chen et al., 2015). However this was not the only reason since blocking the 
interferon response by IRF3 knockdown in EV cells did not mimic the effect of PML-
II removal, i.e. it did not reduce the gap in viral gene expression between PML-II Kd  
and EV cells significantly.This factor was also demonstrated to be an effective agent 
when both wt300 and InOrf3 mutants were treated with IFN-α 24 hours prior to 
infection as the mutant was less affected in PML-II Kd cells where the interferon 
response was lower. 
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The other conceivable factor that might have contributed here is the greatly 
increased level of hsp70 in PML-II Kd cells when compared with control cells. 
Removal of this factor had a greater contribution in increasing viral gene expression 
than the interferon blocking state. The hsp70 chaperone seems important in 
translocating the hexon from the cytoplasm to the nucleus and hence its removal 
probably reduced the rate of virus assembly and maturation. However, whilst 
potentially of some significance in the productivity of infection, this cannot explain 
the positive effect of PML-II removal on hexon expression. 
The increased level of hsp70 expression, the decreased level of  NF-kB response in 
PML-II Kd cells and finally the published role of hsp70 in down regulating TNF-α 
induced NF-kB activation, collectively, motivated us to attempt to correlate the 
hsp70 increase with the decreased TNF-α induced NF-kB activation.To test this idea, 
it was important to define the role of an activated or blocked NF-kB response in the 
Ad5 life cycle. In fact, this signalling pathway proved to beneficial to the virus given 
that viral gene expression was increased with TNF-α treatment or decreased with 
NF-kB blockage, a finding which discounted a beneficial effect of hsp70 via 
inhibition of NF-kB. This result could be explained by the observation that NF-kB 
could negatively regulate the interferon response and IFN-stimulated genes. 
However, it is important to recall that the weight of evidence is for NF-kB acting 
positively in the IFN response. 
It was possible that PML-II might regulate the IFN response through elevating the 
level of hsp70 expression, i.e. that the reduced IFN response was due to elevated 
hsp70. However, hsp70 knockdown actually increased the level of ISG56 mRNA in 
both cell lines under either mock or infection conditions. This result disagrees with 
a study that pointed to a positive correllation between IFN and the hsp70 response. 
In genetically modified mice (stably expressing hsp70 in neurons), a high level of IFN 
response was detected in comparison with the non-modified mice (Kim et al., 
2013). However, most of these studies were achieved in mouse immune cells and 
others were performed by using recombinant hsp70 prepared in E.coli. This 
preparation of hsp70 in bacteria is likely to be contaminated with 
lipopolysaccharide which is recognised as a cytokine inducer through a Toll-like 
receptor 4-mediated signal transduction pathway and it was shown that TNF-α 
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induction was completely due to this contaminating factor (Gao and Tsan, 2003). In 
contrast, the results presented here are consistent with those of D’Onofrio et 
al.,(1993), who found that increased hsp70 expression in HTLV-1 infected  primary 
cord blood-derived mononuclear cells was suppressed IFN treatment. 
 
Regardless of which mechanism could dominate in this augmented gene expression 
or replication, the data produced here shown and robust evidence supporting the 
idea that PML-II plays a negative role in the Ad5 life cycle at the normal  growth 
temperature (37  ̊C).  
To summarize, both the reduced interferon response and the increased hsp70 
expression are contributing to enhanced Ad5 gene expression in the absence of 
PML-II. Despite the fact that both IFN and NF-kB responses cooperate with each 
other against the viral infection (Hiscott, 2007), and both of them were low in PML-
II Kd cells, it is possible, that in Ad5 infection, NF-kB activity was altered and started 
to work in favour of productive virus infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
 
 
 
 
 
 
Chapter 5 : Role of PML-II and mild heat stress in 
adenovirus gene expression 
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5.1 Introduction 
5.1.1 Heat shock upregulated genes in HeLa cells  
 
Exposing HeLa cells to high temperature (42 ̊C) can increase the expression of a 
large set of genes, especially the heat shock genes that encode for chaperones 
which assist in protein folding and their cofactors. These highly expressed proteins 
which show about 10 fold upregulation from their normal level include: hsp70, 
hsp40, hsp105, hsp110, hsp47 (SERPINH2), and a modulator of hsp70 activity 
(BAG3). Another group of proteins, induced between 4 to 10 fold by heat stress, 
comprise regulators of chaperone function such as Hsp70-interacting protein ST13, 
Hsp90 co-chaperone TEBP, and FK506 binding protein 4. All other groups of genes 
that are specifically elevated by heat shock to levels similar to the chaperone 
regulators are listed in Table 5.1. 
Table 5.1.List of genes that are up-regulated to a similar level of HSPs regulators (fold 
change 4 to 10) (Murray et al., 2004) 
 
In a unique pattern for cancer cells and not primary cells, heat-shocked HeLa cells 
display no evidence for any cell cycle arrest. They showed more accumulated 
transcripts of signal transduction molecules and transcription factors such as c-fos 
 Function Gene name 
1 Post translational 
modification 
transglutaminase and proline 4-hydroxylase α 
1 and 2 
2 Protein degradation 
pathways 
proteasomal subunit PSMD10 and Siah-
interacting protein 
3 Signal transduction G protein GNAS, transcription factor GABPB2 
and GADD45 α 
4 Membrane transport and 
signalling 
phospholamban, monoamine transporter 
SLC22A3, and leukocyte receptor cluster 4 
5 Metabolic processes ArylamineN-methyltransferase and a 
cytochrome b5 reductase 
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and c-jun between 8 and 24 hours after heat shock (Murray et al., 2004). Activating 
transcription factor 3 (ATF3) was one of the most up-regulated genes in 43 ̊C heat-
shocked hepatocytes which were left to recover for 2 hours (Kus-Liskiewicz et al., 
2013). This factor has an important role in protecting cells from UV- induced 
apoptosis and has a suggested role in cell cycle arrest as it helps fibroblasts 
transition from a growth phase to another (Lu et al., 2006). 
5.1.2 Cellular response to adenovirus infection 
 
Adenovirus infection leads to a regular decline in cellular transcription and 
translation while the virus keeps its own transcription increasing, ultimately 
dominating cellular activity. In a DNA microarray experiment that dissected viral 
and cellular gene activities during Ad12 infection, one of the remarkable negative 
impacts of infection was the diminished expression of MHC I genes (Dorn et al., 
2005). This effect was noticed earlier when MHC I expression was reduced in cells in 
cells infected with Ad12 or cells that are expressing E3/19k protein. This reduction 
is due to the binding of E3/19k to HLA in a mechanism by which adenovirus evades 
the immune response through affecting the cytotoxic T cells response (Burgert and 
Kvist, 1985). Expression of MHC I is further inhibited with TNF-α stimulation since 
the latter increases E3/19k transcription (Deryckere and Burgert, 1996). 
Time post Ad12 infection was critical to determine which group of genes was up-
regulated or down-regulated and how. Regarding the immune response, the related 
genes: IFN-α inducible protein (GIP2), IFN-α inducible protein with tetratricopeptide 
(IFIT2) and IFN-α induced protein with tetratricopeptide 1 (IFIT1) all were down-
regulated at later time points, 24, 32 and 48 hours post-infection. In contrast, at an 
earlier time point (12 hours post infection), GIP2, IFTI2 and IFTI1 were strongly up-
regulated to 10 to 30 fold. IL-6 expression was up-regulated after 24 hours post-
infection and increased about two-fold from its original level at 12 hours post 
infection (Dorn et al., 2005). This explains how adenovirus manipulates the cellular 
machinery in order to exploit the advantageous factor and escape the innate 
immune response. 
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5.1.3 The shared features between the cellular response to adenovirus 
infection and heat shock 
 
In fact, both stimuli of adenovirus infection and heat shock cause up-regulation of 
certain transcription factors which eventually modulate the production of 
interferon and other cellular cytokines. For example, cells respond to these two 
stresses by increasing the level of c-fos transcription within about 8 hours post 
infection or stress. This transcription factor helps to enhance the viral ability in 
transformation and at the same time promotes the interferon response through an 
AP-1 dependent mechanism (Murray et al., 2004, Su et al., 1995) 
5.1.4 PML, c-fos and AP-1 activation  
 
It has been reported that PML and c-fos can cooperate with each other to enhance 
the AP-1 transcriptional activity in Cos-1 cells (Vallian et al., 1998b). This correlates 
PML and c- fos with a probable role in enhancing the interferon response through 
AP-1 transcriptional activation. 
5.2 Aims of the chapter work described in this Chapter 
Linking together the similarities in the cellular response to both heat shock and 
adenovirus infection could be beneficial in preparing the cell to counter the viral 
infection.  If stress renders cells to become more resistant to virus infection, would 
PML-II have a role in that alteration in susceptibility to infection? The approach to 
test this hypothesis was to expose HeLa cells to a slightly elevated temperature and 
then to analyze the outcome of infection after such stress and normal conditions in 
presence and absence of PML or PML-II.  
The experimental design was to heat shock HeLa cells to 40  ̊C for 3 hours, then 
return them to 37  ̊C before infecting them with Ad5wt300 for 20 hours and finally 
analyzing viral gene expression. In parallel, the effect of heat shock on the 
morphology and expression of PML-NB and PML proteins respectively was 
investigated to confirm that mild heat stress did affect these components. The last 
part of the chapter is to investigate the effect of heat shock on virus infection in the 
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the presence and absence of PML or PML-II and to determine whether any effects 
correlate with effects on the innate immune response. 
5.3 Elevated temperature affects the progress of adenovirus infection 
In order to compare the development of adenovirus infection in cells that had 
experienced high or normal growth temperature, confocal microscopy analysis was 
used to compare the stages of infection achieved by a standard Ad5 dose in 
stressed and control cells. Adenovirus infection proceeds through characteristic 
stages whereby DBP is initially diffuse in the nucleus then forms increasingly 
numerous replication centres before finally late proteins accumulate in the 
cytoplasm. Two groups of cultures were either stressed for 3 hrs at 40 °C or left as 
controls at 37°C. Both cultures were infected at 37°C with Ad5wt300  at moi 10 and 
incubated for 20 hrs, then cells were fixed and reacted with antibodies against the 
DBP and late adenovirus proteins. The effect of pre-exposure to elevated 
temperature was more significant for late gene expression than the early stage. 
Immunofluorescent antibody staining showed more cells were in the late stage with 
more late protein expression (red staining) in each cell in the representative fields 
(Fig 5.1).  
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Fig.5.1. Ad5 late gene expression in control and heat shocked HeLa cells. Equivalent 
cultures (1×10
5
 cell/ml) of HeLa cells grown on cover-slips in 12- well plates were either 
stressed at 40°C for 3 hrs, or maintained at 37°C throughout (control). All cultures were 
then infected  at 37  ̊C with Ad5 wt at moi of 10, fixed at 20 hrs post-infection, 
permeabilized and stained with anti-late polyclonal Abs as primary Abs followed by staining 
with Alexa-fluor  594 Gt α Rb Abs.  Representative Fields is shown for each condition. 
 
In contrast only, a slight decrease was noticed in the number of cells showing DBP 
expression in the previously stressed cells compared to those which had been 
grown throughout at the normal growth temperature. To some extent there were 
more cells that showed more and larger replication centres in the control cultures 
in comparison with the stressed cultures (Fig.5.2). 
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Fig.5.2. Ad5 DBP expression in control and heat shocked HeLa cells. Corresponding 
cultures (1×10
5
 cell/ml) of HeLa cells grown on cover-slips in 12- well plates were either 
stressed at 40°C for 3 hrs, or maintained at 37°C throughout (control). All cultures were 
then infected at 37  C̊ with Ad5 wt at moi 10, fixed at 20 hrs post-infection, permeabilized 
and stained with anti-DBP monoclonal Abs as primary Abs followed by staining with Alexa-
fluor  488 Gt α M. Abs. Three representative field is shown for each condition. 
To substantiate the effect of prior heat stress on Ad5 gene expression and since the 
effect of treatments and infections were clearer and more consistent at lower 
multiplicities, a lower multiplicity of infection was used and Western blotting 
analysis was implemented as another approach to verify the immunofluorescence 
data. Comparable cultures were either heat shocked or left to grow at normal 
conditions, then infected at 37°C with Ad5 at moi of 2.5 for 20 hours. Both immuno-
fluorescence and WB data were consistent with the previous results (Fig.5.3 A and 
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B). Random fields from stressed or control samples were selected to count the 
percentage of cells that show late gene expression. Percentages of cells that 
showed late gene expression was more in the control cells while it reduced to 30% 
of its value in the stressed cells. The WB result supported the IF data: hexon and 
penton bands had diminished with the stress compared to their expression in the 
control cells (Fig 5.3B).  
 
Fig.5.3. Ad5 gene expression in stressed and normal conditions. HeLa cells were seeded at 
a density of 1×10
5
 /ml for 24 hours either direct to the bottom of plate or on cover-slips. 
Cultures were either heat shocked for 3 hours or left to grow at normal temperature. 
Cultures were infected with Ad5 at moi of  2.5 for 20 hours. A. Cells were fixed at 20 hrs 
post-infection, permeabilized and stained either with anti-late polyclonal Abs as primary 
Abs followed by staining with Alexa-fluor  594 Gt α Rb Abs. Upper panels: culture were 
infected after incubation throughout at 37  ̊C, Lower Panels:  were infected at 40  ̊C.B. 
Protein samples were harvested for WB analysis, analysed by SDS-PAGE and western 
blotting. The membranes were probed with the appropriate Abs. Upper panel. Anti-late 
polyclonal rabbit Abs;  lower panel: anti-GAPDH mouse monoclonal Abs. 
5.3.1 Hexon mRNA expression at normal and stress condition  
 
With the intention of analysing the effect of heat stress on the development of Ad5 
infection in cells previously grown at normal or elevated temperature, hexon mRNA 
expression was measured at two time points post-infection. Two parallel cultures of 
HeLa cells were prepared, one was stressed for 3 hours  at 40 °C while the other 
was incubated as control at 37 °C. Both cultures were infected with at 37 °C Ad5 at 
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moi of 5 and samples were harvested at 12 and 16 hours post-infection. At 12 hours 
post infection in stressed cells there was a reduction in hexon mRNA to 65% of its 
level in non-stressed cells. The reduction continued at 16 hours post infection but 
with a less dramatic difference, since hexon mRNA was reduced by stress by about 
40% (Fig.5.4).  
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Fig.5.4. Ad5 hexon expression in control and heat shocked HeLa cells. . Parallel cultures (1×10
5
 cell/ml) of HeLa cells were plated in 12- well plates and 
either stressed at 40°C for 3 hrs, or maintained at 37°C throughout (control). All cultures were then infected at 37  ̊C with Ad5 wt at moi and RNA was 
harvested at 12 and 16 hours post infection. Hexon expression was quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. 
Data were calculated by the ∆∆Ct method, using GAPDH as internal control, and then normalised to the control cell value. All PCR products were subjected 
to dissociation curve analysis to ensure primer specificity. A. Hexon expression in cells previously cultured at 37  C̊  (C) and 40  ̊C  (S). B. Data from panel A 
normalised to the control value at each time point. 
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5.3.2 Progress of Ad5 infection in MRC5 cells in normal and stress 
conditions 
 
To test whether the reduced Ad5 gene expression observed after heat shock was a 
cell-line specific phenomenon or was a broader effect that could be generalised to 
normal cells, the same stress and infection conditions were applied on MRC5 
human fibroblasts. Heat treatment reduced the level of hexon mRNA by around 
80% of the level seen in infected cells maintained throughout at normal 
temperature (Fig 5.5A). The same trend of effect, but less dramatic, was noticed on 
early gene expression: E1A mRNA was reduced by 45% in the stressed cultures 
compared to the control (Fig 5.5B). This result is consistent with the previous 
results which were obtained with HeLa cells after exposing them to the higher 
temperature
Fig.5.5. Ad5 hexon and E1A expression in control and heat shocked MRC5 cells. Parallel 
cultures (1×10
5
 cell/ml) of MRC5 cells were plated in 12- well plates and either stressed at 
40°C for 3 hrs, or maintained at 37°C throughout (control). All cultures were then infected 
at 37  ̊C with Ad5 wt at moi 5 for 20 hours. Hexon and E1A expression were quantified by 
RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were 
presented by the ∆∆Ct method, using 18S RNA as internal control, and then normalised to 
the control cell value. All PCR products were subjected to dissociation curve analysis to 
ensure primer specificity. A. Hexon expression after prior culture at 37  ̊C  (C) and 40  ̊C  (S). 
B. E1A expression after prior culture at 37  ̊C  (C) and 40  ̊C  (S). 
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5.3.3 Quantitative analysis of late gene expression in stressed and 
unstressed cells  
 
All the previous results showed that mild heat shock decreases Ad5 late gene 
expression. It was therefore necessary to quantify the difference in viral gene 
expression to verify these qualitative results. To quantify the IF data previously 
shown in Fig 5.3, percentages of cells that displayed Ad5 late expression were 
counted in heat-shocked cultures or the control. The number of infected cells was 
divided by the total number (DAPI stained cells) in each experiment. The previously 
stressed cultures showed a slight decrease in percentages of cells that express the 
late protein (14%) compared to the control which reached to 22% (Fig.5.6 A). 
However, this assessment was rather subjective, based on assigning individual cells 
to be either positive or negative. 
The use of more robust approach (FACS) which could count thousands of infected 
cells in a few seconds and which provides an idea about the intensity of the viral 
protein expression in the population of positive cells, would give an accurate 
comparison between the heat shocked and the normal cell populations. The 
infected cells (black curves) are distinguished from the mock infected (the grey 
filled background curves), this separation allows the acquisition of absolute 
numbers of each positive (infected) and negative (mock) populations.  
 
Initially, the appropriateness of the Abs was tested with fixed and unfixed cells. At 
moi 10 and 20 hr post infection, there was a good separation between the 
background (uninfected) and the infected fixed cells. The DBP and late protein 
expressing cells reached to 89.5% and 74.5% respectively (data not shown). 
Standard stress and infection conditions were applied in this and subsequent 
experiments. The cells were plated out into two groups, the first was exposed to 
40  ̊C for 3 hrs and other one was assigned as a control maintained at 37  ̊C 
throughout. Both groups were then infected at 37  ̊C  at the same time with moi=5 
of wt Ad5 for 20 hrs. The proportion of cells that showed late expression (positive 
cells) was reduced in the stressed group, being 79%, 30% and 14% compared to the 
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control group in three different experiments. This drop in viral late expression is 
represented by the noticeable shifting of the gated infected cells towards the 
uninfected cells in stressed cells compared to the control in representative 
experiments (Fig 5.6 B). 
 
Fig.5.6. IF & FACS analyses of late gene expression in control and heat shocked cells. A. 
Equivalent cultures (1×10
5
 cell/ml) of HeLa cells grown on cover-slips in 12- well plates 
were either stressed at 40°C for 3 hrs, or maintained at 37 °C throughout (control). All 
cultures were then infected with Ad5 wt at 37°C at moi 5, fixed at 20 hrs post-infection, 
permeabilized and stained with anti-late polyclonal Abs as primary Abs followed by staining 
with Alexa-fluor  594 Gt α Rb Abs. Numerical data were extracted from counting the 
numbers of late infected cells and dividing that by the total number of cells in randomly 
selected stained fields.B. Cells were plated at a density of 0.8×10
6
 or 2.2×10
6
 per dish in 60 
and 100 mm
2
  dishes respectively for 24 hours, then stressed or not as in A. Cells were then 
infected at 37°C with moi of 5 with Ad5wt300 for 20 hours. Cells were then fixed, 
permeabilized and stained with anti-late polyclonal Abs as primary antibodies, followed by 
Alexa-fluor 594 Gt Gα Rb Abs staining. Left. Late gene expression in cells previously 
cultured at normal temperature. Right. Late gene expression in cells previously cultured 
under conditions of stress. The black curves represent the mock infected cells (background) 
while the grey curve represents the positive infected cells. FACS data show that the late 
gene expression decreased significantly in stressed cells compared with those which were 
grown at normal temperature (*P<0.005, n=4).  
5.3.3.1 Hexon protein expression at stress and normal conditions 
 
To quantify the alteration in the pattern of hexon expression, more specific 
quantitation was achieved to count the cells that expressed this capsid protein. The 
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same stress and infection conditions were applied here and the results were 
consistent with the alteration in total late gene expression due to the heat shock. 
The number of hexon- expressing cells declined in the stressed sample compared to 
the control and this was obvious with the complete shift in the peak of infected 
cells to be indistinguishable from the background (mock) (Fig5.7). 
 
 
Fig.5.7. FACS analysis of hexon expression in control and heat shocked cells. Cells were 
plated at a density of 0.8×10
6
 or 2.2×10
6
 per dish in 60 and 100 mm
2
  dishes respectively for 
24 hours. Cells were infected at moi of 5 with Ad5wt300 for 20 hours. Cells were then fixed, 
permeabilized and stained with anti-hexon monoclonal Abs as primary antibodies, followed 
by Alexa-fluor 488 Gtα M Abs staining. Left. Hexon expression at normal temperature. 
Right.  Hexon expression at stress. The grey curves represent the mock infected cells 
(background) while the black curve represents the positive infected cells. 
 
5.3.4 Effect of higher temperature on Ad5 gene expression 
 
Many previous publications analysed the effects of extreme heat shock on cellular 
transcription and much of such work was to expose cell lines to mild temperature 
earlier and then the higher temperature. Heat shocking cells to higher 
temperatures makes cells respond in different ways in correspondence with the 
how extreme is the elevation in temperature. For example  42°C or 44 °C, exposing 
to  44 °C inhibits cellular protein synthesis when cells start to synthesize nothing 
except limited amounts of hsp70, while a classical heat shock response was 
observed  at 42 °C (Margulis et al., 1991). In order to evaluate the effect on 
adenovirus gene expression of higher temperatures than the mild stress employed 
above, exposure to higher temperature was applied but for a shorter time. Cells 
were either exposed to 42 ̊C for 1 hour or left to grow at normal temperature and 
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then infected with Ad5 at moi of 10 for 20 hours. Consistently, shorter exposure to 
higher temperature caused a clear reduction in the number of cells that displayed 
late gene expression compared to the control conditions (Fig 5.8). 
 
 
 
Fig 5.8 Ad5 late gene expression in control and 42  C̊ heat shocked HeLa cells. Equivalent 
cultures (1×10
5
 cell/ml) of HeLa cells grown on cover-slips in 12- well plates were either 
stressed at 42°C for 1 hour, or maintained at 37°C throughout (control). All cultures were 
then infected with Ad5wt300 at 37  ̊C with moi 10, fixed at 20 hrs post-infection, 
permeabilized and stained with anti-late polyclonal Abs as primary Abs followed by staining 
with Alexa-fluor  594 Gt α Rb Abs.  Left panel; culture were infected at 37  C̊, right Panel 
were infected at 37  ̊C after incubation at 42  ̊C. 
 
5.3.5 Effect of heat stress on adenovirus genome replication 
 
The reduction in late gene expression in previously stressed cells led to the question 
of whether Ad5 genome replication might be affected by prior heat stress, since 
late gene expression depends on replication. 
5.3.5.1 Standard Curves 
The intention of this experiment was to compare the copy number of Ad5 genomic 
DNA in pre-heat-stressed and control cultures. To permit absolute quantitation, 
standard curves for both cellular and viral genomes were generated. A genomic 
GAPDH plasmid was constructed using PGEM-T and HeLa cells as source of template 
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DNA for PCR (Fig.5.9 A and B), while Ad5 plasmid pTG3602 (pTG) was made by 
(Finnen et al., 2001). These two plasmids were used to make standard curves to 
detect the copy number of Ad5 per cell. The efficiency of detection of the plasmids 
was tested and they presented accurate standard curves that make them meet the 
requirements of this experiment (Fig 5.10).  
 
Fig 5.9. Schematic diagram of GAPDH plasmid. A. pGEMT- easy vector was used to build 
genomic GAPDH plasmid, 97 bp- piece of genomic GAPDH in the intron between exons 2 
and 3. DNA piece was ligated to pGEMT-easy vector (Promega) and the product was 
sequenced using GATC sequence service. B. Agarose gel shows the GAPDH insert in PGMT-
easy vector, DNA ladder to the left and the insert is the second sample at he right side.  
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Fig 5.10 GAPDH and Ad5 plasmids qPCR amplification standard curves. A. Standard curve 
of  Ad5 (PTG)  plasmid copies. B. Standard curve of GAPDH plasmid copies. 
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5.3.5.2 Ad5 Genome Copy Number 
In order to compare Ad5 genome replication in control and previously stressed 
cells, cells were either stressed for 3hrs or left at 37 ̊C as a control and then infected 
at 37  ̊C; samples were collected 20 hrs post infection. Over repeated experiments, 
variation arose which interfered with drawing conclusions from this part of the 
work. This variation came mainly from the inconsistency in Ad5 genome copy 
number in biologically equivalent samples between different experiments. Thus an 
average of repeated experiments could be obtained only with big error bars (data 
not shown). 
To clarify whether this variation was due to a technical problem or to true biological 
variation in the cellular response to heat stress in equivalent cultures on different 
occasions, two different approaches were used. The first approach was to test the 
efficiency of DNA purification columns. The other was to make duplicates of the 
same experiment in the same day and processing them independently. 
5.3.5.3 Efficiency of purification columns 
This experiment was intended to try to find the source of variation in Ad5 copy 
number over repeated experiments. The thought was that the efficiency of the 
purification columns in recovering the viral genome might be affected by saturation 
of column capacity. DNA was extracted from two infected samples 20 hrs post 
infection, the first sample was divided into two portions (10% and 90%) and the 
second was left to be extracted in total. If column saturations were an issue, then 
these samples would give different values for Ad5 copy number. However, all the 
samples were recovered with similar efficiency by the columns since, after 
calculating the copy number from each determination, all gave equivalent values 
(Fig.5.11). Thus the conclusion is the viral DNA was extracted equally from the 
treated and untreated cultures.  
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Fig 5.11. Efficiency of DNA purification columns in recovering Ad5 genomes. Parallel 
cultures (1×10
5
 cell/ml)  of HeLa cells were plated in 12- well plates. Cultures were then 
infected with Ad5 wt at moi 5 for 20 hours. DNA was extracted  from each individual 
sample as follow: one sample was divided into two parts (10% and 90%)  which are referred 
by 1 and 2 the second sample was extracted as a total bulk. Ad5 copy number was assessed 
using Ad (pTG) and GAPDH plasmids as standards. 2 or 10 ng/well were used to quantify 
the Ad5 and GAPDH respectively. Data were calculated by dividing the GAPDH copies by 2 
(diploid genome), then dividing Ad5 copies by GAPDH and then multiplying the result by 5 
to correct for the input difference.  
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5.3.5.4 Differences in the biology of the cells 
Given the sensitivity of real time PCR analysis, which could detect any tiny variation 
in the cellular activity and gene expression over time, virus genome copy number 
was detected in duplicate samples of equivalent cultures prepared in parallel at the 
same time. The same stress conditions were applied to those two different cultures 
in the same 12-well plate and then they were infected with Ad5 at moi of 5 for 20 
hours. Infection was stopped at the same time and DNA was extracted from each 
sample to quantify the Ad5 copy number. The results showed a massive reduction 
in DNA copy number in previously stressed cells compared to the control cultures. 
Despite that, the copy number was significantly different between the duplicates, 
one of the control cell samples showed approximately 105 Ad5DNA copy/cell (Fig 
5.12A), while the other gave about 1.6 ×105Ad5DNA copy/cell (Fig 5.12B). This 
difference, though substantial, was consistently less than was observed between 
equivalent experiments carried out at different times. 
 
Fig 5.12. Ad5 genome replication at stress and normal conditions. Parallel cultures (1×10
5
 
cell/ml)  of HeLa cells were plated in 12- well plates as duplicate and either stressed at 40°C 
for 3 hrs, or maintained at 37°C throughout (control). All cultures were then infected with 
Ad5 wt at 37°C with moi 5 for 20 hours. DNA was extracted  from each individual sample 
and Ad5 copy number was assessed “as in Fig 5.10. A. First replicate. B. Second replicate 
154 
 
5.3. 6 Effect of heat stress on adenovirus genome replication at moi of 1 
 
Based on the fact that the reduction in Ad5 late gene expression was more 
pronounced at lower multiplicities of infection, and the sensitivity of qPCR assay to 
detect small amounts of Ad5 genome, cells were stressed for 3 hrs or incubated at 
37 ̊C and then infected with Ad5 at a lower moi of 1. The results in repeated 
experiments showed a clear pattern and less variability than seen at higher moi. 
The previously stressed cells displayed a significant reduction in Ad5 DNA copy 
number compared to the control (Fig.5.13). 
 
Fig 5.13. Ad5 genomic replication at stress and normal conditions at moi of 1. Parallel 
cultures (1×105 cell/ml)  of HeLa cells were plated in 12- well plates and either stressed at 
40°C for 3 hrs, or maintained at 37°C throughout (control). All cultures were then infected 
with Ad5 wt at moi 1 for 20 hours. DNA was extracted  from each individual sample and 
Ad5 copy number was assessed using Ad(PTG) and GAPDH plasmids. 2 or 10 ng/well were 
used to quantify the Ad5 and GAPDH respectively. Data were calculated by dividing the 
GAPDH copies by 2, then dividing Ad5 copies by GAPDH and then multiplying the result by 
5.  
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Statistics showed significant decrease in Ad5 genome replication with stress 
compared to the control conditions at *P<0.05 (Fig.5.14). 
 
Fig 5.14. Statistical analysis of Ad5 replication at stress and normal conditions. Data show 
a significant decrease in Ad5 replication in pre-stressed cells ( *P<0.05, n=5) 
5.4 Proposed mechanisms of stress-induced restriction of Ad5 
infection 
5.4.1 Role of PML-II in reduced Ad5 gene expression 
 
PML is an IFN up-regulated gene and PML-II isoform positively regulates the type I 
interferon response. PML is also mobilised in response to heat stress and other 
stresses, so the aim was to investigate the role of PML and PML-II in the reduction 
of adenovirus gene expression in pre-stressed cells and to explore any possible 
relationship between PML-II and Ad5 infection, heat shock and the innate immune 
response. The first step was to address the response of PML and PML-II to the mild 
elevation in temperature employed as a stress throughout this study then to 
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analyse the heat-mediated restriction of Ad5 in the presence and absence of PML 
and PML-II. 
5.4.1.1 Effect of high temperature treatment on PML NB 
 
The first objective was to characterise the response of PML proteins and PML NB to 
stress. Initially, a stress condition of exposure to elevated temperature of 40 °C for 
3 hrs was chosen for analysis. Depending upon the outcome of initial analyses, the 
intention was to adjust these conditions to define an optimal scenario for 
investigating the effects of cell stress upon virus infection. A series of replicate 
cultures were either exposed to 40˚C or incubated as control for 3hrs at 37  ̊C and 
individual cultures were harvested every 30 minutes either for western blotting or 
immunofluorescence. The main PML band that is around 130 KDa (which comprises 
PML-I and PML-II) started to reduce after 1.5 hr (Fig.5.15A). In contrast, the 90 KDa 
PML band (isoforms III-V) showed an expression similar to the control after the 
same period of exposure. By immunofluorescence, PML NB as previously reported 
(Eskiw et al., 2003) manifested bright focused staining in control samples while in 
treated cells they became fewer in number and there was an increased diffuse 
staining (Fig 5.15B). Diffused staining was characteristic for the heat treatment 
which was more obvious after 90 minutes of exposure to 40˚C  then the bright 
staining starts to appear again after removing the stress. 
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Fig.5.15. Effect of 40˚C treatment on PML protein expression and organization in PML NB 
in Hela cells. Replica cultures were subjected to sequential periods at 37  ̊C and 40  ̊C  and 
harvested at the times indicated. A.  PML proteins were detected by Western blotting 
analysis of control and heat treated  samples using a polyclonal anti- PML antiserum. B. 
Confocal images of cells stained with anti- PML (primary antibodies) and Alexa fluor 594 
goat anti-rabbit IgG (H+L), either at 37°C or after heat stress. 
5.4.1.2 Effect of elevated temperature treatment on PML-II 
 
In a more specific and detailed investigation, the effects of heat stress on three PML 
isoforms were investigated, PML I, PML V in addition to PML-II were analysed. In 
fact every individual band responded to the elevated temperature in a unique way. 
In time that PML-I oscillated with the change in temperature, PML-V showed a 
steady decrease pattern with the increased temperature (results not shown). while 
a PML-II related band showed an increase with the increased temperature. In fact, 
anti-PML-II antibodies detect predominantly a lower band (around the 55k in 
protein marker ladder) in HeLa cells, this band is believed to be another small 
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variant of PML-II. The evidence that we have that this band is PML-II related rather 
than background is that it disappeared with PML-II knockdown (exon7b-shRNA), it 
could be detected only by anti-PML-II antibodies but not anti-PML or anti-PML-I 
with the induction with IFNα (unpublished data).The band we detected was around 
55K which we think is a truncated or cleaved form of PML II. 
PML II protein was also detected by immunofluoresence to study whether its 
location was altered in response to the stress. In contrast to the control, PML II 
increased in amount and NB numbers and showed increased diffuse staining 
directly after 30 min of temperature elevation.  
 
 
Fig.5.16. Effect of 40˚C treatment on PML-II protein expression and organization in PML 
NB in Hela cells. Replica cultures were subjected to sequential periods at 37 C and 40 C  
harvested at the times indicated (A)  PML proteins were then detected by western blotting 
analysis of PML bands in control and heat treated  samples using a polyclonal anti- PML-II 
antiserum. (B) Confocal image of cells stained with anti- PML-II (primary antibodies) and 
Alexa fluor 594 goat anti-rabbit IgG (H+L). 
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5.4.1.3 Effect of heat stress on viral gene expression in presence and absence of 
PML-II 
To explore whether PML-II has any role in the observed reduction of viral gene 
expression following stress, the idea was to analyse the progress of Ad5 infection in 
HeLa cells in presence or absence of PML-II. PML-II Kd cells and EV cells (Chapter3) 
were used as a well-characterised cell line system that provides conditions where 
PML-II is stably present or absent. PML-II Kd and EV cells were either heat-shocked 
at 40  ̊C for 3 hours or left to grow normally at 37  ̊C, then both types of cells were 
infected at 37  ̊C at the same time with Ad5 at moi of 5 for 20 hours. In control, 
unstressed cells, PML-II-Kd cells showed more hexon mRNA expression compared 
to Ctrl.DNA cells (Fig.5.17); this result is consistent with the previous results 
(Chapter 4), since PML-II Kd cells support Ad5 gene expression better. 
The general effect of heat stress on hexon expression observed in standard HeLa 
cells didn’t change in Ctrl.DNA cells since they showed less hexon mRNA level with 
the heat shock. In contrast, PML-II Kd cells expressed more hexon mRNA with the 
stress conditions compared to the control temperature (Fig.5.17).  
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Fig.5.17. Ad5 hexon expression at control and previously heat PML-II Kd and Ctrl.DNA 
cells. Parallel cultures (1×105 cell/ml) of PML-II Kd and Ctrl.DNA cells were plated in 12- well 
plates and either stressed at 40°C for 3 hrs, or maintained at 37°C throughout (control). All 
cultures were then infected at 37°C with Ad5 wt300 at moi 5 for 20 hours post infection. 
Hexon was quantified by RT-qPCR using 10 ng/well of complementary DNA (cDNA) as a 
template. Data were presented by the ∆∆Ct method, using 18S RNA as internal control, and 
then normalised to the control cell value. All PCR products were subjected to dissociation 
curve analysis to ensure primer specificity.  
To confirm and support the above results about the role of PML-II in reduced Ad5 
gene expression and replication in previously heat-stressed cells, the effect of heat 
shock on viral gene expression in the presence and absence of PML-II was analysed 
at the protein level. Cells were stressed and infected as above and extracts 
prepared for western blot analysis. Similar to the mRNA analysis, EV cells showed 
more or less the same effect of reduced Ad5 late gene expression after heat stress 
(Fig.5.18; lane 4 at 37  ̊C &40  ̊C). However, a stress-induced difference was 
observed in the pattern of Ad5 gene expression in PML-II Kd cells; they showed 
more hexon expression with the stressed conditions (Fig.5.18; lane1 at 37  ̊C 
&40  ̊C), while the other late proteins in the same samples, penton and L1IIIa 
showed less expression with the stress. Thus these results show that PML-II does 
play a role in the stress-induced effect on Ad5 infection as its absence alters Ad5 
late gene expression. 
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Fig.5.18. Ad5 gene expression in pre-stressed or control PML-II knockdown cells and 
control cell lines. PML-II Kd, PML-Kd, Ctrl.DNA, EV, GFP and HeLa cell lines were either heat 
stressed at at 40°C for 3 hours or left to grow at normal temperature. Cultures were then 
infected at 37  ̊C with Ad5 at moi of 5 for 20 hours. Protein samples were harvested for WB 
analysis, analysed by SDS-PAGE and western blotting. The membranes were probed with 
the appropriate Abs; anti-late polyclonal rabbit Abs (1:10K) or anti-GAPDH mouse 
monoclonal Abs (1:25k). A. Long exposure. B. Short exposure 
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5.4.1.4 Characterising heat shock protein response to mild heat stress 
With the aim of analysing the effect of mild heat treatment on the heat shock 
protein family response, a small selection of HSP mRNAs were chosen to be 
investigated (hsp60, hsp90 and hsp70). Comparing the expression of those HSPs 
was of special importance since each of them has a specific function during the 
virus life cycle. 
Hsp60, produced from the HSPD1 gene, is critical in inducing the IFN-β response 
during virus infection. It was found that hsp60 is an IRF3-interacting protein and 
that it facilitates IRF3 dimerization and activation. This activation by hsp60 was 
proved by studying the effect of both over-expression and knockdown of hsp60 on 
IFN-β induction in HEK293 cells (Lin et al., 2014). To understand whether hsp60 
expression was induced with the increased temperature, HeLa cells were either 
heat stressed for 3 hours at 40  ̊C or left as control at 37  ̊C. Hsp60 mRNA showed a 
modest 1.5-fold increase (Fig.5.19A). 
HSP90, another highly conserved chaperone, has been shown to regulate type I and 
II interferon responses. In HeLa cells, interfering with hsp90 synthesis using siRNA 
as well as some cancer treatments will block the phosphorylation of STAT1 which is 
crucial to both types of response. In the absence of hsp90, JAK1/2 kinases are 
degraded since JAK interacts with hsp90 and CDC37 and this interaction is 
destabilised by hsp90 inhibitors (Shang and Tomasi, 2006). Due to this link between 
hsp90 expression and type I and II interferon responses, hsp90 expression was 
analysed as for hsp60 above. The same stress and control conditions were applied 
and hsp90 mRNA expression was detected by RT-qPCR. Elevated temperature 
increased the expression of hsp90 about 2-fold (Fig.5.19B). To summarise, mild heat 
shock was sufficient to modestly increase the levels of two hsps that are known to 
have positive roles in the antiviral interferon response. 
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Fig.5.19. HSPs expression in control and heat shocked standard HeLa cells. Parallel 
cultures (1×10
5
 cell/ml) of HeLa cells were plated in 12- well plates and either stressed at 
40°C for 3 hrs (S), or maintained at 37°C throughout (C). HSPs were quantified by RT-qPCR 
using 10 ng/well of complementary DNA (cDNA) as a template. Data were calculated by the 
∆∆Ct method, using 18S RNA as internal control, and then normalised to the control cell 
value. All PCR products were subjected to dissociation curve analysis to ensure primer 
specificity. A. Hsp60 mRNA expression at stress and normal conditions. B. Hsp90 mRNA 
expression at stress and normal conditions. Data show significant increase in hsp60 
expression with the heat shock compared to the control conditions (*P<0.05,n=2). 
 
5.4.2 Effect of heat shock on Interferon stimulated genes (ISGs) 
 
The major shared features between stress and Ad5 infection is the early innate 
immune response which is represented by the early induced interferon response.  
The protective effect of heat shock against Ad5 infection might be attributed to an 
IFN response pre-triggered by stress. Hence, it was logical to measure the level of 
ISG56, chosen as a marker for the activation of this response under both stress and 
normal conditions. After stressing cells or leaving them at 37 ̊C, ISG56 was 
measured by RT-qPCR. ISG56 mRNA expression was increased in stressed cultures 
to about 1.7 fold compared to the control conditions (Fig 5.20). This is a very small 
increase when compared with the induction seen during an active interferon 
response.  
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Fig.5.20. ISG56 expression at control and heat shocked standard HeLa cells. Parallel 
cultures (1×10
5
 cell/ml) of HeLa cells were plated in 12- well plates and either stressed at 
40°C for 3 hrs (S), or maintained at 37°C throughout (C). ISG56 mRNA was quantified by RT-
qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were presented 
by the ∆∆Ct method, using 18S RNA as internal control, and then normalised to the control 
cell value. All PCR products were subjected to dissociation curve analysis to ensure primer 
specificity.  
5.5 Discussion  
The overall conclusion of this chapter is that pre-stressing tumour or normal cells 
makes them more resistant to Ad5 infection. This was clear with the substantial 
reduction in viral gene expression observed at both RNA and protein levels, and 
with the reduction in genomic DNA replication. The stress conditions compromised 
viral gene expression to about 80% in some FACS experiments. These findings agree 
with publications that refer to the protective role of a heat shock response against 
more extreme stress conditions or infections. In Drosophila, absence of heat shock 
factor (HSF) makes the adults more sensitive to virus infection while re-activating 
the same factor could reduce the viral replication to undetectable levels (Merkling 
et al., 2015).In general, mild hyperthermia protects against more severe stress 
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conditions. It was reported that mild heat shock could protect from subsequent 
heat-induced necrosis that is caused by heat stroke (Kourtis et al., 2012). This 
happens when C. elegans was pre-exposed to mild heat stress, when HSF1 and 
hsp16.1 regulate a Ca++-homeostasis response under heat stroke conditions. Thus 
this preconditioning response could protect cells from stimuli which could cause 
necrosis (Kourtis et al., 2012). 
Heat shock can cause an accumulation of heat shock proteins, only a few of which 
were measured in this study. Certain hsp proteins could have a direct relationship 
with the innate immune response elements. In this study the reduced Ad5 gene 
expression and replication might be attributed partially to the increased level of 
hsp90 after exposing cells to mild hyperthermia. This protein has been found to be 
a regulator of NF-kB activation. In human lung endothelial cells, chemical inhibition 
of hsp90 inhibits the NF-kB activation through preventing the recruitment of the 
latter co-activators from the target (Thangjam et al., 2014). Alternatively, hsp90 and 
cell surface hsp90 (cshsp90) were found to serve as a direct cofactor for NF-kB 
activation by Kaposi's sarcoma-associated herpesvirus (KSHV) in primary human 
cells (Defee et al., 2011) 
Considering Ad5 infection, it was reported that adenovirus infection causes 
endoplasmic reticulum (ER) overload independently from MHC-I, due to the 
accumulation of E319K protein which is retained inside the ER. This ER overload has 
a direct regulatory effect on NF-kB activation through ER-nuclear signal 
transduction. This mechanism differs from the unfolded protein response (UPR) and 
it is an important cellular response to trigger the innate immune response against 
adenovirus infection (Pahl et al., 1996). In the context of the mild heat treatment 
used in the present study it is possible that the increased hsp90 caused a prior 
activation of NF-kB which in turn prepared the cells to counteract the virus 
infection instantly. 
As previously mentioned in the introductory part of this chapter, there are shared 
features between the cellular response to ad5 infection and to elevated 
temperature, especially at the transcriptional level. C-fos is one of those shared 
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transcriptional regulators; it is elevated post-adenovirus infection and post-heat 
shock at roughly similar times. This factor has an impact on triggering the innate 
immune response like type I interferon. In cold-sensitive host-range type 5 
adenovirus mutant (5hr1) infected cloned rat embryo fibroblast (CREF) cells, levels 
of c-fos transcripts increased within 8 to 12 hours (Terris et al., 1995). This increase 
was accompanied by an increase in other host immediate early response genes like 
c-jun and jun-b. The increase in c-fos is necessary in the very early stages of 
carcinogen enhancement of viral transformation, CET (Su et al., 1995).  This 
transcription factor is also induced and its transcripts accumulate in heat shocked 
HeLa cells (Murray et al., 2004) (Fig 5.21).  
 
Fig 5.21. Schematic diagram of the shared features of the responses to heat shock and to 
adenovirus infection. Both responses induce the level of c-fos transcripts which regulates 
the cAMP function. As a consequence, AP-1 is activated leading to increase the IFN-β 
response 
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C-fos is also critical for cAMP function in suppressing the TNF-α response in 
RAW264.7 cells, a macrophage cell line (Koga et al., 2009).  cAMP is of a special 
importance in triggering adenovirus early transcription: both cAMP and E1A 
cooperate to initiate the transcription of many genes located in the early regions. It 
was found that treating adenovirus-infected S49 cells with cAMP considerably 
induced the level of AP-1 transcription factor and cytoplasmic mRNA levels of c-fos 
and jun b. Subsequently, AP-1 bound CREB binding sites in E1A-inducible promoters 
to activate transcription (Muller et al., 1989). AP-1 is one of the three transcription 
factors that comprise the enhancesome that assembles on the IFN-β promoter to 
induces ISGs transcription (Fig.5.22) (Yarilina and Ivashkiv, 2010) 
Fig.5.22. Schematic diagram of the role of AP-1 in interferon beta induction. AP-1 is one of 
three transcription factors that comprise the IFN-β enhancesome. Within a cell, when the 
stimulus (e.g virus) induces signal transduction (extra or intra cellular), the signal induces 
the level of AP-1 which binds at IFN-β promoter and subsequently increases in ISGs 
expression.  
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Another possibility to explain the reduced level of viral gene expression after stress 
could be through the c-jun pathway. This transcription factor in cooperation with 
other transcription factors like IRF3 regulate IFN-α/β to achieve the activation as a 
result of the host-virus interaction (Malmgaard, 2004). Since c-jun was also found to 
be part of the cellular response to heat shock, then its elevation in advance could 
contribute to an enhanced innate immune response against Ad5 infection. Whether 
that suggests any role for PML or PML-II is unclear as  yet. However, it is known 
that, as a part of their function as a tumour suppressor, PML proteins displays a 
pivotal role in the transcriptional activation of c-jun upon exposure to DNA damage 
stimuli like UV-radiation. PML interacts physically with c-jun and both accumulate 
leading to an apoptotic response to UV-radiation in a p53-independent manner 
(Salomoni et al., 2005) 
Turning away from the IFN response, another potential reason for the decreased 
late viral gene expression observed following heat stress is the increase in synthesis 
of p32 protein; an RNA splicing and transcription regulator. This cellular protein was 
found to be increased about two-fold when cells were exposed to 45 ̊C for 10 
minutes (Hiwasa and Sakiyama, 1986). This protein in particular has an important 
role in controlling the adenovirus major late transcription unit (MLTU) activity. P32 
over-expression substantially prevents late gene expression from the MLTU at both 
mRNA and protein levels. This effective blockage occurs through a disturbance in 
Pol II function, with a failure in transition from initiation to elongation (Ohrmalm 
and Akusjarvi, 2006). It is also possible that p32 affects the late viral gene 
expression through retaining MLTU products inside the nucleus. One of the p32 
functions that were discovered recently is its ability to retain some cellular proteins 
such as U2AF homologue inside the nucleus which suggests that this might be of 
importance in RNA alternative splicing (Heyd et al., 2008); such regulation is crucial 
for proper Ad late gene expression Adenovirus exploits p32 to deliver its own 
genome to the nucleus since confocal imaging showed coincidence in the cellular 
localisation between p32 and adenovirus pV as well as co-immunoprecipitation 
(Matthews and Russell, 1998). 
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If p32 worked through a similar mechanism on viral late gene expression then it 
would be through retaining L4-100K product inside the nucleus. The consequence 
of such retention will dramatically reduce the late viral gene expression and 
eventually the virus yield. Abolishing the ability of L4-100K to move from the 
nucleus to the cytoplasm would intensely reduce structural protein synthesis and as 
a result cause an extreme decline in virus yield  without any obvious effect on Ad5 
early gene expression or DNA replication (Koyuncu and Dobner, 2009). 
Regarding the role of PML-II in stress-reduced Ad5 gene expression and replication, 
the progress of Ad5 infection in the presence and absence of PML-II suggested a 
role of the latter in altering the pattern of late stage gene expression. Quantitative 
RNA data suggested a possible role of PML-II in that reduced gene expression after 
stress, protein analyses further verified that removing PML-II altered the relative 
expression of some late proteins with increased levels of hexon in previously 
stressed PML-II Kd cells. The absence of PML-II during stress increased L3 hexon and 
L2pV protein expression during subsequent infection which is the opposite effect of 
stress alone when all late expression was reduced. However, the restrictive effect 
of stress overcame the beneficial effect of PML-II removal when considering the 
expression of L2 penton and IIIa. Protein L4 22K and L4 33K have been shown to 
regulate the alternative splicing of MLTU RNA (Törmänen et al., 2006, Morris and 
Leppard, 2009, Farley et al., 2004) and this effect could be due to an impact of heat 
stress on the expression of these proteins from the dedicated promoter. The L4- 
22K product also has an important role in activating transcription from the major 
late promoter (MLP) and its overexpression results in two opposite effects on L2 
and L3 proteins. L4-22K overexpression causes a decrease in L3 hexon expression 
and a totally opposite effect on L2 penton expression as the latter substantially 
increased in expression (Backstrom et al., 2010, Morris and Leppard, 2009). Such 
differences might be correlated with the differences in effects of PML-II removal or 
stress or both. 
In summary, prior exposure to mild heat stress can help cells resist Ad5 infection. 
All evidence suggests a role for a pre- induced innate immune response in this 
effect through different channels; type I interferon and induction of NF-kB through 
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ER-overload or hsp90 mechanisms. Alteration in the pattern of late gene expression 
in the absence of PML-II could suggest a role for the latter and this role may be 
through modulating the IFN-β response as PML-II promotes the IFN response (Chen 
et al.,2015). 
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Chapter 6: Discussion and proposed mechanisms 
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6.1 The experimental system 
The overall aim of the work was to investigate the role of PML-II and mild heat 
shock in the adenovirus life cycle and whether there was a correlation between 
those two factors. Determining the function of any cellular protein can be achieved 
by analysis of certain markers in the presence and absence of the concerned 
protein. Cytoplasmic interference by siRNA with the messenger RNA of any protein 
is the best biologically optimised technique that was suggested to be used in this 
piece of work to silence PML or PML-II isoform expression. This powerful technique 
has its own theoretical and practical limitations and so it was eventually decided to 
move to an shRNA stable knockdown system. To understand the reasons for 
preferring the permanent knockdown rather than the transient system, it is 
necessary to explain how both systems work. In mammalian cells to ensure an 
efficient specific gene down regulation, the concerned siRNA is delivered to the 
cytoplasm either quickly using the direct microinjection technique or the slower 
way using lipofection and in this case a long continuous contact with the siRNA 
should be guaranteed. Either way, the intact siRNA is concentrated shortly at the 
nucleus, then after 4 hours the intact and the dissociated siRNA could be detected 
in the cytoplasm where it basically interferes with the mature target mRNA and this 
continues typically for 48 hours after which the effect diminishes as the siRNA is 
lost  (Jarve et al., 2007). 
In fact, siRNA kinetics is accompanied by the presence of two different RNA-
interfering silencing complexes (RISC) which contain an essential RNA processor 
protein Ago2. According to their distribution they are either large cytoplasmic 
molecule or 20x smaller nuclear component and the latter is loaded with the siRNA 
and transferred to the cytoplasm (Ohrt et al., 2008). Gene silencing by siRNA in 
mammalian cells is achieved by the cooperation between the human RNA III 
endonuclease to digest the double stranded RNA to 21-32 nucleotide siRNA product 
and Tat-RNA-binding protein (Paddison et al., 2002)n (TRBP) or PKR activating 
protein (PACT). The Ago2 splits the duplex which leads to removal the passenger 
siRNA and liberating of the guide siRNA which in presence of RISC will achieve 
repeated mRNA interference (Matranga et al., 2005). In contrast, shRNA is 
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endogenously transcribed as a slightly larger hairpin duplex, but eventually it is 
processed through the same route that siRNA goes through. shRNAs of less than 
30bp were first described as RNA gene regulators in Drosophila melanogaster with 
less silencing efficiency in mammalian cells (Paddison et al., 2002).  
The whole idea of gene silencing arose from the fact that mammalian cells 
potentially mount a substantial antiviral response against viral dsRNA intermediates 
which is represented by PKR which represses the global cellular translation 
reviewed by Rao et al., 2009.  The same mechanism could be a limitation for gene 
silencing if the small interfering RNA was of a larger size (> 30bp) as cell will direct 
the innate immune response against the incoming dsRNA (Paddison et al., 2002). 
Small siRNA and shRNA escape such responses through their small sizes and the 
secondary structure of the hairpin. In this study the whole length of a single shRNA 
strand was 30 bp including the hairpin sequence and thus would not trigger such 
responses.  
After transfecting the three lentiviral plasmids, each one of them achieves its own 
role to eventually integrate the target sequence into the cellular genome. The 
modified 3 ́ LTR-shuttle or transfer plasmid provides the genome to deliver the 
target DNA (PLKO-1 in this study); pPAX2 provides the viral protein to produce the 
mature virion, and the envelope plasmid pMD2 provides an envelope attachment 
protein VSV-G envelope in this study to give the particles infectivity. Once the 
transducing virions succeed in integrating the target piece of DNA inside the  
cellular genome then this DNA will be endogenously transcribed by RNA 
Polymerase III (Paddison et al., 2002). Similar to miRNA, shRNA is processed by 
Drosha and Dicer to transform it from pri-miRNA to mature miRNA (Lee et al., 
2003). All the rest  of the steps will be similar to siRNA processing steps apart from 
taking off the hairpin loop by Dicer/TRBP/PACt complex to liberate the double 
stranded siRNA with 2 bp overhangs reviewed by (Rao et al., 2009). The shRNA 
gene silencing pathway follows the ordinary RNAi channels: Dicer is an essential 
RNAi component to process the shRNA since the transient knockdown of Dicer 
inhibits gene down-regulation that is induced by shRNA but not siRNA. shRNA,  
expressed by transduction of mammalian cells, is seen for several weeks at least 
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(Paddison et al., 2002) and shows up to 10-fold more efficiency in loading on Dicer 
than siRNA due to its asymmetrical relative stability of the overhangs (UU) in this 
study (Rao et al., 2009, Sano et al., 2008). The reduced off-target effect of shRNA, a 
consequence of it functioning at lower peak concentrations than transfected siRNA, 
is also another significant reason to decide to use shRNA in this project since off-
target effects on the transfected cells could mean the results will be not very 
specific (Rao et al., 2009). 
Other factors that might constrain siRNA interference are the variable 
transfectibility of certain types of mammalian cells which makes delivering the 
siRNA sometimes difficult, duration of knockdown and limitations of studying a 
wide range of genes (Paddison et al., 2002). For the purpose of this project, HeLa 
cells were chosen as was mentioned earlier because of their amenability for 
adenovirus infection. In addition to that they express a good level of PML proteins 
and also they are suitable for doing IF assays because they adhere very well to 
coverslips and resist loss during the staining steps which are aggressive for other 
cells such as HEK293 cells. Early experiments which were achieved in this project in 
silencing PML or PML-II transiently with siRNAs brought to the surface some 
obstacles, firstly the stress and inconsistent transfection efficiencies over 
experiments and secondly the difficulty in infecting the previously siRNA-
transfected Hela cells with adenovirus or its mutants. Since part of this work was 
concerned with the effect of mild stress on adenovirus life cycle, prior transient 
knockdown represented an additional factor which could contribute to the 
consequences of the mild heat treatment and created variation. Also, the level of 
adenovirus gene expression and replication was too low when the pre-transfected 
cells were infected with adenovirus in early stage of this work. The other reasons 
for moving from siRNA transfection to stable shRNA expression which were 
mentioned earlier in Ch3 were the ease, cheapness, homogeneity and consistency 
over repeated experiments, all of which prompted the work in Chapter 3 to stably 
transduce HeLa cells to be deficient for PML or PML-II to study their function inside 
the cell and when it faces a challenge such as adenovirus infection. 
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What is noticed in this study, is that the functional effect of long term stable 
knockdown was more consistent and potent than the equivalent transient 
knockdown. This agrees with the fact that at the molar level (apart from the 
maximal concentrations of siRNA and shRNA), shRNA shows higher potency to 
knockdown the target gene than the siRNA (McAnuff et al., 2007).  This is due to 
the fact that Dicer substrates (shRNA) which consist of 29 bp can produce more 
potent RNAi than the smaller siRNAs without triggering an unwanted interferon 
response since shRNA is subjected to the endogenous RNA processing system which 
produce less immunogenic 5  ́ ends (Siolas et al., 2005, Kim et al., 2005, Rao et al., 
2009). However, the PML knockdown system in this project was consistent 
especially the first few weeks after selection and showed comparable knockdown 
compared to different control cell lines ranges between the 40 to 50 % physically 
and 10% to 25 % functionally at the RNA level.  
6.2 PML-II knockdown 
The PML-II isoform was specifically chosen for study for many reasons. In addition 
to its interaction with the early adenovirus protein E4Orf3 and its role in regulating 
the interferon response (Chen et al., 2015) it has a unique structure which might 
implicate it in fighting virus infection. The PML-II isoform has common features with 
the other isoforms in addition to unique characteristic features that make its 
function different to the others. This protein is encoded by the six shared exons (1 
to 6), the first three of which encode for the common N-terminal region ( cysteine 
cluster rich-394 amino acids) while the other three (4 to 6 ) are alternatively spliced 
and are hence partially responsible for the variable length of each isoform. The 
unique sequence that defines PML-II is encoded by exon 7b where our siRNA or 
shRNA are targeting to ensure the specificity of knockdown of this particular 
isoform but not any other. The C-terminal region of this isoform is rich in 
serine/proline segments which comprise 13 to 14 % of a total of 258 amino acids 
(Fagioli et al., 1992). The C-terminal region of PML-II has 8 serine-proline motifs 
which serine/threonine kinases may identify and modify (Vulliet et al., 1989). These 
kinases are of special importance in regulating the innate immune response and 
type I interferon induction. For instance, tumour progression locus 2 (are such 
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serine-threonine kinase) regulates the production of type I and type III interferon 
and restricts influenza virus replication through type I interferon signal 
transduction. Thus such kinases are involved in sensing virus infection and 
mounting a proper antiviral response that limits the consequences of the virus 
infection (Kuriakose et al., 2015). This actually links the PML-II isoform clearly with 
the innate immune response through sensing adenovirus infection in HeLa cells and 
interacting with the concerned cellular factors that raise the antiviral response.  
Designing siRNA that specifically interferes with PML-II mRNA had already been 
achieved by (Wright, 2010). This siRNA interferes with the mRNA that is encoded by 
PML-II unique exon 7b and thus the knockdown target should be the PML-II 
isoform. The sequence that encodes for the C-terminus of PML-V is excised when 
PML-II mRNA is generated by removing the 7a-7b intron. However, the PML-II 
siRNA target sequence is retained within the 3 ÚTR of PML-V mRNA so it might be 
expected that targeting PML-II could affect the level of PML-V mRNA. This 
possibility was countered by Chen et al., (2015) when the functional knockdown of 
PML-II was evaluated in comparison with that of PML-V and a clear result showed 
that regulating type I interferon was specific for PML-II but not PML-V.  
In characterising HeLa cells lacking PML-II, a long duration of PML-II knockdown was 
successfully achieved with levels of physical knockdown comparable to the 
transient knockdown achieved by siRNA in HeLa cells or MRC5 cells. At the protein 
level, the PML-II related band showed comparable physical absence compared to 
transient knockdown at a concentration reached to 125nM of PML-II siRNA or siC 
but with a better consistency. The effect of PML-II removal on NF-kB, as a mean of 
functional knockdown ranged between less than 60-90% considering the variation 
among selected batches of the knockdown or control cells. PML-II Kd cells showed 
very consistent reductions in their interferon response which agrees with the 
conclusion of Chen et al., (2015) about the effect of PML-II on such innate immune 
responses.  
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6.3 PML-II and Ad5 infection 
The characterised PML Kd or PML-II Kd cells produced by shRNA formed a 
consistent basis for investigating the role of PML-II in the adenovirus life cycle 
under normal and stress conditions. This line of study was prompted by very early 
experiments when Ad5 late gene expression and replication were evaluated in the 
presence and absence of PML-II, and reduced transiently. It was obvious that hexon 
expression and Ad5 genome copy number were increased significantly with the 
removal of PML-II in HeLa cells. Compared to different control cell lines (Ctrl.DNA 
cells, GFP Kd cells and EV cells) the viral early and late gene expression increased 
substantially at both RNA and protein levels. More extensive data were obtained 
over a time course with clearer and sharper increase in the late gene expression in 
particular. Quantitatively, the increase in late gene expression reached up to 100% 
ie 2-fold in PML-II Kd cells compared to the EV control cells. Consequently, there 
was a corresponding effect of PML-II removal on Ad5 yield, which increased 3- fold. 
Given the role of PML-II in regulating type I interferon responses, an obvious 
hypothesis was Ad5 increased its gene expression upon PML-II removal due to the 
reduced level of interferon response in PML-II Kd cells compared to EV cells. Testing 
that idea showed only a partial role of the reduced interferon response in that 
substantial increase in Ad5 gene expression. This could instead be attributed either 
to other IRF3-independent mechanisms acting to keep a substantial level of 
interferon response or to the loss of other roles of PML proteins inside the cell. A 
role of the partially reduced interferon response in elevating Ad5 gene expression 
was suggested since this was affected more when PML-II Kd and EV cells were 
infected with Orf3-deficient virus than with wt virus. This agrees with Ullman et al., 
(2007), who showed that pre-treating cells with IFN-α or IFN-β compromised the 
replication of Ad5 that lacks E4Orf3, which is necessary for rearranging PML-NB into 
track-like structures and thus disrupting their antiviral function, but not the wt 
virus. The fact that E4Orf3 is essential to establish successful Ad5 replication in an 
IFN antiviral state and this happens after the over-expression of PML as a result of 
IFN treatment suggests that the effect of this viral protein is not upstream of the 
IFN signalling pathway (Ullman et al., 2007). The effect of interferon treatment was 
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mainly on replication (Ullman et al., 2007) which might explain the more robust and 
drastic effect of PML-II depletion on late gene expression in particular than the 
early stage; the major switch to initiate the expression of Ad5 late proteins occurs 
immediately after the DNA replication starts.  
The implication of PML with interferon and virus infection is not restricted solely to 
Ad infection, it extends to infections with other DNA and RNA viruses such as HSV 
(Chee et al., 2003) or influenza A virus (Chelbi-Alix et al., 1998b). Other regulators of 
type I interferon response for example the cytoplasmic latent transcription factors 
STAT1 and STAT2, when they are phosphorylated by JAK1 and TYK2 move to the 
nucleus  to bind to IRF9 forming ISGF3 to bind to ISREs reviewed by (Ivashkiv and 
Donlin, 2014). This channel of type I interferon transcription activation in addition 
to other IRF family members may keep some of the mounted interferon response at 
a reasonable level inside EV cells but not the PML Kd cells (since this phenotype 
already shows reduced interferon response). Thus concluding the role of decreased 
IFN response in the enhanced Ad5 gene expression would not be easy given this 
enormous number of regulatory factors, since it is impossible to eliminate all of 
them from the cells simultaneously.  
6.4 Hsp70 and Ad5 infection 
The more effective factor that participated in increased Ad5 gene expression when 
PML-II was removed was hsp70, since its level was very high at both mock and 
infection conditions. The extensive analysis of the PML-II Kd stable cell line showed 
an increase in hsp70 chaperone but not other HSPs, with the highest increase -at 
the mRNA level - in hsp70B one of a pair, with hsp70A, of highly sequence- related, 
strongly heat shock-inducible hsp70 genes. This was not an artefact of transducing 
those cells or due to the selection system since transient depletion of PML-II caused 
the same specific increase in hsp70B. Hsp70B was increased by 50% with PML-II 
transient knockdown, this increase was not as drastic as that detected with the 
permanent knockdown system; this could be due to the differences in the 
percentage of cells that showed the knockdown between the transient and 
permanent removal of PML-II. Alternatively, long term PML-II knockdown many 
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cause an acumulative effect, leading to progressive elevation in hsp70. In any case, 
removing hsp70 by siRNA transient knockdown in PML-II depleted cells massively 
decreased Ad5 late gene expression back to comparable levels to those seen in EV 
control cells, demonstrating its importance to efficient Ad5 infection. This result is 
similar to the role of hsp70 in rabies virus gene expression and replication. Rabies 
infection increases hsp70 by 4 hours post infection and removing hsp70 with siRNA 
inhibits the virus life cycle (Lahaye et al., 2012). 
The significant increase in hsp70 mRNA expression in PML-II Kd cells was specific 
and not a general response triggered by the removal of PML-II, either in mock 
conditions or infection with Ad5. This was clear since the other hsp family proteins 
like hsp60 did not increase and this agrees with (Phillips et al., 1991). This suggests 
a critical function of hsp70 specifically in Ad5 gene expression. Previously it had 
been shown that there is specific and selective induction of hsp70 (but not other 
hsp family members) in Ad5 or HSV-1 infected HeLa cells compared to mock 
samples. In Ad5- infected cells, there is a detectable induced level of hsf1 
transcription factor and this induced hsf was specifically increased the transcription 
of hsp70 and peaks it at 12 hours post infection since the levels of hsp90 (another 
hsf- responsive gene) did not increase by the activated hsf1. This means that there 
is a specificity and selectivity during adenovirus infection to induce the expression 
of hsp70 rather than other hsp family proteins.  
An extensive analysis was achieved by Phillips et al., (1991) to detect the precise 
interaction between Ad5 E1A (the main virus encoded trans-activator) and the 
hsp70 promoter. An interesting finding was revealed during the analysis of 120 bp 
of the hsp70 promoter in mock and Ad5 infected cells. Hsf1 binding to the 
promoter can be measured by techniques such as DNase I foot printing. This 
detects hsf1 binding on heat shock but not (or much less) after Ad5 infection even 
though the promoter is induced. Hence, Ad5 induction of hsp70 promoter is 
considered not to be dependent on hsf1. Instead, E1A activates the hsp70 promoter 
and further experiments showed that it works via the CCAAT box in the promoters. 
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Since hsp70 is enhanced selectively and massively, Ad5 should benefit from that to 
carry on its own transcription and translation. One of the suggested roles of hsp70 
in such enhancement of Ad5 gene expression is the induction of global virus 
transcription through the interaction with E1A. A CCAAT sequence was identified to 
be the initiation site of hsp70 transcription when was identified to be an enhancer 
of the global E1A- dependent transcription (Lum et al., 1992). 
Over different and numerous experiments a high level of hsp70 expression was 
noticed in PML-II Kd cells especially hsp70A1B. This increase might be explained as 
was mentioned in Chapter 3 by a kind of compensation that the cells initiate to 
achieve the hsp70 chaperone function enabling them to overcome abnormal 
conditions. An indirect explanation could also be employed here: Daxx-hsf1 
interaction might be altered in a way that enhances the latter ́s trans-activation of 
hsp70 expression. Thus when PML-II was removed, the Daxx was liberated from its 
nuclear boundary by PML-II removal, this gave the chance to Daxx to interact with 
hsf1 trimer and interfere with the latter ́s repression by different cellular 
chaperones (Boellmann et al., 2004). 
6.5 Hsp70 and PML-II 
Hsp70 up-regulation due to removal of PML-II might be explained in an indirect 
way. PML proteins has been described as regulators of the TNF-α signalling 
pathway (Cheng and Kao, 2012) and analysis of TNF-α responsive genes (IL-6) in this 
study showed an agreement with Cheng and Kao (2012) since IL-6 level was 
reduced with PML-II removal. In addition, it was found that treatment with TNF-α 
increases the sensitivity of cells to apoptosis due to the transient inhibition of hsf1 
activation and as a consequence decreased hsp70 production (Schett et al., 2003). 
The other possible explanation for the increase in hsp70 could be through Daxx 
protein which is sequestered in PML-NB where its repressive function is inhibited by 
PML proteins (Li et al., 2000). Since Daxx is a modulator of hsp70 since it’s release 
from the NB blocks the repression of hsf1 (Boellmann et al., 2004). Hence the 
scenario that might happen here is that removing PML-II released Daxx, so ending 
the inhibitory effect that is exerted by PML on Daxx repressive function, and as a 
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result the synthesis of hsp70 is up-regulated. This hypothesis needs extensive and 
more robust data in order to test it but the initial RNA quantitation shows that Daxx 
mRNA expression is increased about 4-fold with PML-II depletion compared to the 
control (Fig. 6.1), suggesting that increased Daxx activity may indeed underlie the 
elevation in hsp70 expression upon PML-II removal. 
 
Fig.6.1. Daxx mRNA expression during transient depletion of PML-II. HeLa cells were 
seeded at a density of 1×10
5
 /ml for 24 hours, then transfected with 125 nMsiPML-II or siC 
for 48 hours. RNA samples were extracted, total Daxx mRNA was quantified by RT-qPCR 
using 10 ng/well of cDNA as a template. Data were calculated by the ∆∆Ct method, 
normalised to 18s internal control rRNA and then normalised to the control sample value. 
All PCR products were subjected to dissociation curve analysis to ensure primer specificity 
and. 
6.6 Ad5 infection of pre-stressed cells 
In order to analyse the effect of pre-stressing HeLa cells via a mild elevation in 
growth temperature on the progress of subsequent Ad infection, various 
parameters of infection were monitored in pre-stressed and control cells. Initially 
the progress of infection was followed by confocal imaging and those experiments 
formed the basis of the rest of the work described in Chapter 5. The mildly elevated 
temperature affected Ad5 late gene expression significantly at the mRNA level  but 
showed much lower and inconsistent effects on the early stages of Ad5 infection 
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when DBP expression was influenced only mildly. This was also confirmed by 
analysis of the early and late proteins using the same moi or even less since lower 
moi makes counting the infected cells in a confocal-stained field easy and fruitful. 
RNA and protein data were consistent in showing that hexon was expressed at 
lower level in cells that had been stressed pre-infection and at different time points. 
This phenomenon was not cell-specific since pre-stressed MRC5 cells also expressed 
lower hexon protein and mRNA compared to the control conditions. 
Quantitatively and over repeated FACS experiments, the pre-stressed cells 
presented less Ad5 gene expression than the controls, with more obvious effects on 
late gene expression and in particular hexon expression. Consistently, counting the 
number of cells that showed late gene expression in confocal imaging gave the 
same results. Cells exposed for shorter periods to elevated temperature also 
showed lower gene expression. Ad5 genome replication was also analysed in both 
pre-stressed and control cells. Given the sensitivity of such analysis, the system was 
very sensitive to any tiny variation in Ad5 genome copy number. Consequently the 
statistics of the repeated experiments did not give any significant difference 
between the stress and normal conditions at moi of 5. However, lower multiplicity 
(moi of 1), where the genome copy number was lower, showed statistically 
significant differences in Ad5 replication in pre-stressed cells compared to the 
control. Several possible explanations can be found for why pre-stressing cells 
impairs Ad5 infection. 
As previously mentioned mild heat shock triggered expression of a series of HSP 
family members, several of which have direct or indirect positive relationships with 
innate immune and inflammatory responses, inducing hsp90 and hsp60. At the 
same time, innate immune responses such as type I interferon are already triggered 
in different cell lines that that were pre-treated at elevated physiological 
temperature. The other cellular factor that might have a role in this particular 
reduction in Ad5 late gene expression is the RNA splicing factor, p32. This protein 
has a direct effect on reducing transcription from the MLTU and is at the same time 
one of the few proteins that continue to be expressed during heat shock (Hiwasa 
and Sakiyama, 1986). Hence, it is possible that the elevated temperature has 
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caused an increase in p32 expression which results in reducing late gene 
expression.  
The mild heat treatment employed to pre-stress showed an impact on the PML 
protein expression and morphology of PML-NB, as they showed disruption and 
increased diffused staining when examined by confocal microscopy. A PML-II 
related protein band in particular showed an increase in expression, which reached 
a maximum after 90 minutes of stress as also did the mRNA level of PML-II, which 
showed a 3-fold increase after 3 hours of mild heat stress. Such increases in PML-II 
expression encouraged us to extensively analyse Ad5 gene expression in the 
presence and absence of PML-II in pre-stressed and control cells. Initial experiments 
which compared hexon mRNA expression in PML-II Kd and Ctrl.DNA cells showed an 
obvious increase in hexon mRNA expression following stress in PML-II Kd cells 
compared to control cells which showed more or less the same level of expression 
at both condition. This result was further confirmed by protein analysis. Connecting 
these results together suggests a role for PML-II in the reduced Ad5 gene 
expression in pre-stressed cells. The over-expressed PML-II due to the treatment 
with high temperature, which reaches to 3 times more (Fig.6.2), might trigger an 
increased or accelerated innate immune response since PML proteins are already 
IFN-upregulated genes (Lavau et al., 1995). The other possible explanation is that 
PML-II over-expression could up-regulate the expression of ASF/SF2 regulator, p32 
(Petersen-Mahrt et al., 1999), which in turn would negatively affect late gene 
expression from the Ad5 MLTU. The integrated roles of PML-II in up-regulating type 
I interferon and pre-triggered innate immune responses could all work together to 
provide previously stressed cells with a mechanism which reduces Ad5 gene 
expression. 
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Fig.6.2. PML-II mRNA expression in pre-stressed and control cells. HeLa cells were seeded 
at a density of 1×10
5
 /ml for 24 hours, then transfected with 125 nM siPML-II or siC for 48 
hours. RNA samples were extracted, total Daxx mRNA was quantified by RT-qPCR using 10 
ng/well of cDNA as a template. Data were calculated by the ∆∆Ct method, normalised to 
18s internal control rRNA and then normalised to the control sample value. All PCR 
products were subjected to dissociation curve analysis to ensure primer specificity and. 
6.7 How can heat-stress inhibit Ad5 while hsp70 elevation enhances 
its replication? 
The effect of PML-II depletion in increasing viral gene expression and yield 
according to this study was attributed to the elevated hsp70 chaperone in PML-II Kd 
cells. This was the possible explanation since the elevation was very specific to 
hsp70 and hsp70B but not other HSPs such as hsp60, hence depleting the cells of 
PML-II did not initiate a general non-specific heat shock response. This specific 
elevation in hsp70 chaperone is consistent with the specific elevation of hsp70 that 
is triggered shortly after Ad infection (Phillips et al., 1991). This might explain the 
contradictory role of hsp70 in the Ad5 life cycle under normal and stressed 
conditions, since the latter initiates a global cellular response that includes all HSP 
family members. Within this study, expression of several hsp members was 
evaluated in parallel with hsp70 after mild stress; hsp60, hsp90, hsp27 and hsp100 
(Fig 6.3). All of them showed an elevation compared with unstressed control cells 
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which ranged from moderate for the first two to very dramatic for the rest (the 
study was extended to include further genes at a late stage in order to further 
validate the conclusion). Thus the pre-stress conditions studied here were 
materially different from from the PML-II depleted unstressed conditions in that a 
full range of HSPs was induced. Universal promotion in HSP members and other 
cellular factors such as p32 might mitigate or equilibrate or even overweigh the 
beneficial effect of hsp70 which would promote Ad5 gene expression if it was 
specifically stimulated. 
 
 
 
 
 
 
 
Fig.6.3. HSPs RNA expression under stress and control conditions. HeLa cells were seeded 
at a density of 1×10
5
 /ml for 24 hours, either exposed to 40  ̊C for 3 hours or left to grow at 
37  ̊C . RNA samples were extracted, total hsp70, 27 and 100 mRNA was quantified by RT-
qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were presented 
by the ∆∆Ct method and then normalised to the control sample value. All PCR products 
were subjected to dissociation curve analysis to ensure primer specificity and normalised to 
18s. 
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6.8 Conclusions and future directions 
In summary, PML-II showed an antiviral function against Ad5 which was eliminated 
to the benefit of the virus upon its permanent removal. This beneficial effect was 
due in large part to the elevated hsp70 that followed from PML-II removal since 
removal of hsp70 by siRNA  in PML-II depleted cells reduced Ad5 late gene 
expression back to its normal level. Loss of type I interferon responses had only a 
partial role in the elevated gene expression in the absence of PML-II, because 
blocking the type I interferon response in control cells only elevated hexon 
expression somewhat to levels that did not approach those seen in PML-II Kd cells. 
Possibly there is crosstalk between the heat stress and IFN pathways since 
removing hsp70 by siRNA interference caused a substantial increase in ISG56 
expression in control EV cells following Ad5 infection (Fig.6.4). Thus hsp70 induction 
during Ad5 infection normally opposes the innate response and may benefit the 
infection for that reason. 
 
Fig.6.4.ISG56 mRNA expression at transient depletion of hsp70. HeLa cells were seeded at 
a density of 1×10
5
 /ml for 24 hours, either exposed to 40  ̊C for 3 hours or left to grow at 
37  ̊C . RNA samples were extracted, total hsp70, 27 and 100 mRNA was quantified by RT-
qPCR using 10 ng/well of complementary DNA (cDNA) as a template. Data were calculated 
by the ∆∆Ct method and then normalised to the control sample value. All PCR products 
were subjected to dissociation curve analysis to ensure primer specificity and normalised to 
18s. 
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So it is possible that the progression of Ad5 infection was affected by those two 
factors; IFN and hsp70 since both of them were either reduced or up-regulated with 
PML-II removal (Fig.6.5). Moreover, PML-II has a possible role in reducing Ad5 gene 
expression after mild heat stress since PML-II depletion prior to heat stress showed 
an increase in Ad5 late gene expression compared to non-depleted stressed cells. 
 
Fig.6.5. Schematic diagram for the proposed effect of PML-II removal on Ad5 infection.  
 
This study has demonstrated two important phenomena: that Ad5 progresses 
better with the absence of PML-II and worse when it infects pre- stressed cells. 
Hence, future work would need to investigate the mechanism that explains how 
PML-II removal promoted hsp70 expression and why. The other open question is 
how the mild stress compromises the Ad5 gene expression, which pathway exactly 
was involved in that reduction and how. More extensive analysis is also needed to 
identify the PML-II related band of 55KDa molecular weight and its role in the Ad5 
life cycle. Finally, further investigation should explore the effect of pre-stressing 
cells depleting PML-II on other types of DNA or RNA viruses and in different cell 
lines. 
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Appendix 1 
Standard curves of qPCR primers 
NB: Efficiency of HSP70 was mentioned in Chen 2014 thesis 
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Appendix 2  
shRNA sequences 
PML-II-shRNA 
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